Report on Federal Awards in Accordance with OMB Circular A ... · 1. Organization and Community...

Partners HealthCare System,Inc. and AffiliatesReport on Federal Awards inAccordance with OMB Circular A-133September 30, 2010EIN 04-3230035

Partners HealthCare System, Inc. and AffiliatesReport on Federal Awards in Accordance with OMB Circular A-133IndexSeptember 30, 2010

Page(s)

Part I - Financial Statements

Report of Independent Auditors ...................................................................................................................1

Consolidated Financial Statements and Notes to Consolidated Financial Statements.........................2–44

Schedule of Expenditures of Federal Awards and Notes to Schedule ofExpenditures of Federal Awards..........................................................................................................45–79

Part II - Reports on Compliance and Internal Controls

Report of Independent Auditors on Internal Control over Financial Reporting and onCompliance and Other Matters Based on an Audit of Financial Statements Performed inAccordance with Government Auditing Standards ..............................................................................80–82

Report of Independent Auditors on Compliance with Requirements Applicable to EachMajor Program and on Internal Control over Compliance in Accordance withOMB Circular A-133 .............................................................................................................................83–84

Part III - Findings

Schedule of Findings and Questioned Costs.......................................................................................85–88

Summary Schedule of the Status of prior Audit Findings ..........................................................................89

Management's Views and Corrective Action Plan………………………………………………………………90

Part I

Financial Statements

To the Board of Directors of

Partners HealthCare System, Inc. and Affiliates

In our opinion, the accompanying balance sheets and the related statements ofassets and cash flows present fairly, in all material respects, the financial position of Partners HealthCareSystem, Inc. and Affiliates ("Partners HealthCare") at Septemberoperations, its changes in net assets and its cash flows for the years then ended, in conformity with accountingprinciples generally accepted in the United States of America. Theseresponsibility of Partners HealthCare management. Our rfinancial statements based on our audits. We conducted our audits of these statements in accordance withauditing standards generally accepted in the United States of America and the standards applicable tofinancial audits contained in Government Auditing StandardsStates. Those standards require that we plan and perform the audit to obtain reasonable assurance aboutwhether the financial statements are freebasis, evidence supporting the amounts and disclosures in the financial statements, assessing the accountingprinciples used and significant estimates made by management, and evaluating thepresentation. We believe that our audits provide a reasonable basis for our opinion.

In accordance with Government Auditing Standardson our consideration of Partners Healcompliance with certain provisions of laws, regulations, contracts and grant agreements and other matters forthe year ended September 30, 2010. The purpose of that report is to descinternal control over financial reporting and compliance and the results of that testing, and not to provide anopinion on the internal control over financial reporting or on compliance. That report is an integral part ofaudit performed in accordance withthe results of our audit.

Our audit was conducted for the purpose of forming an opinion on the basic financial statements taken as awhole. The accompanying Schedule of Expenditures of Federal Awards for the year ended September2010 is presented for purposes of additional analysis as required by U.S. Office of Management and BudgetCircular A-133, Audits of States, Local Governments, and Nonof the basic financial statements. Such information has been subjected to the auditing procedures applied inthe audit of the basic financial statements and, in our opinion, is fairly stated in all material respto the basic financial statements taken as a whole.

December 10, 2010

Report of Independent Auditors


In our opinion, the accompanying balance sheets and the related statements of operations, changes in netassets and cash flows present fairly, in all material respects, the financial position of Partners HealthCareSystem, Inc. and Affiliates ("Partners HealthCare") at September 30, 2010 and 2009, and the results of its

its changes in net assets and its cash flows for the years then ended, in conformity with accountingprinciples generally accepted in the United States of America. These financial statements are theresponsibility of Partners HealthCare management. Our responsibility is to express an opinion on thesefinancial statements based on our audits. We conducted our audits of these statements in accordance withauditing standards generally accepted in the United States of America and the standards applicable to

Government Auditing Standards, issued by the Comptroller General of the UnitedStates. Those standards require that we plan and perform the audit to obtain reasonable assurance aboutwhether the financial statements are free of material misstatement. An audit includes examining, on a testbasis, evidence supporting the amounts and disclosures in the financial statements, assessing the accountingprinciples used and significant estimates made by management, and evaluating the overall financial statementpresentation. We believe that our audits provide a reasonable basis for our opinion.

Government Auditing Standards, we have also issued our report dated Decemberon our consideration of Partners HealthCare internal control over financial reporting and on our tests of itscompliance with certain provisions of laws, regulations, contracts and grant agreements and other matters for

30, 2010. The purpose of that report is to describe the scope of our testing ofinternal control over financial reporting and compliance and the results of that testing, and not to provide anopinion on the internal control over financial reporting or on compliance. That report is an integral part ofaudit performed in accordance with Government Auditing Standards and should be considered in assessing

Our audit was conducted for the purpose of forming an opinion on the basic financial statements taken as apanying Schedule of Expenditures of Federal Awards for the year ended September

2010 is presented for purposes of additional analysis as required by U.S. Office of Management and BudgetAudits of States, Local Governments, and Non-Profit Organizations, and is not a required part

of the basic financial statements. Such information has been subjected to the auditing procedures applied inthe audit of the basic financial statements and, in our opinion, is fairly stated in all material respto the basic financial statements taken as a whole.

operations, changes in netassets and cash flows present fairly, in all material respects, the financial position of Partners HealthCare

30, 2010 and 2009, and the results of itsits changes in net assets and its cash flows for the years then ended, in conformity with accounting

financial statements are theesponsibility is to express an opinion on these

financial statements based on our audits. We conducted our audits of these statements in accordance withauditing standards generally accepted in the United States of America and the standards applicable to

, issued by the Comptroller General of the UnitedStates. Those standards require that we plan and perform the audit to obtain reasonable assurance about

of material misstatement. An audit includes examining, on a testbasis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting

overall financial statement

, we have also issued our report dated December 10, 2010thCare internal control over financial reporting and on our tests of its

compliance with certain provisions of laws, regulations, contracts and grant agreements and other matters forribe the scope of our testing of

internal control over financial reporting and compliance and the results of that testing, and not to provide anopinion on the internal control over financial reporting or on compliance. That report is an integral part of an

and should be considered in assessing

Our audit was conducted for the purpose of forming an opinion on the basic financial statements taken as apanying Schedule of Expenditures of Federal Awards for the year ended September 30,

2010 is presented for purposes of additional analysis as required by U.S. Office of Management and Budget, and is not a required part

of the basic financial statements. Such information has been subjected to the auditing procedures applied inthe audit of the basic financial statements and, in our opinion, is fairly stated in all material respects, in relation

Partners HealthCare System, Inc. and AffiliatesConsolidated Balance SheetsSeptember 30, 2010 and 2009

The accompanying notes are an integral part of these consolidated financial statements.

2

(dollars in thousands) 2010 2009

Assets

Current assetsCash and equivalents 626,919$ 561,232$Investments 1,050,749 1,046,894Collateral held under securities lending arrangements 129,183 183,336Current portion of investments limited as to use 1,084,877 898,056Patient accounts receivable, net of allowance for bad debts2010 - $114,425; 2009 - $108,177 698,380 712,238

Research grants receivable 132,512 133,190Other current assets 252,620 261,554Receivable for settlements with third-party payers 39,472 33,330

Total current assets 4,014,712 3,829,830

Investments limited as to use, less current portion 2,106,023 1,857,459Long-term investments 838,913 829,816Pledges receivable, net and contributions receivable from trusts,less current portion 162,839 152,956

Property and equipment, net 3,749,234 3,354,069Other assets 118,614 99,715

Total assets 10,990,335$ 10,123,845$

Liabilities and Net AssetsCurrent liabilities

Current portion of long-term obligations 489,913$ 820,620$Accounts payable and accrued expenses 596,916 581,831Accrued compensation and benefits 532,410 477,325Collateral due under securities lending arrangements 129,183 183,336Current portion of accrual for settlements with third-party payers 34,144 22,516Unexpended funds on research grants 152,513 165,490

Total current liabilities 1,935,079 2,251,118

Other liabilitiesAccrual for settlements with third-party payers, less current portion 15,453 45,093Accrued professional liability 70,260 64,412Accrued employee benefits 977,836 979,288Interest rate swaps liability 271,402 184,032Accrued other 216,764 201,262

1,551,715 1,474,087

Long-term obligations, less current portion 1,977,033 1,424,027

Total liabilities 5,463,827 5,149,232

Commitments and contingencies

Net assetsUnrestricted 4,391,191 3,845,791Temporarily restricted 824,426 829,928Permanently restricted 310,891 298,894

Total net assets 5,526,508 4,974,613

Total liabilities and net assets 10,990,335$ 10,123,845$

Partners HealthCare System, Inc. and AffiliatesConsolidated Statements of OperationsYears Ended September 30, 2010 and 2009


3


Operating revenue

Net patient service revenue 6,182,451$ 5,823,741$

Direct academic and research revenue 1,045,789 967,635

Indirect academic and research revenue 324,583 286,846

Other revenue 572,488 536,638

Total operating revenue 8,125,311 7,614,860

Operating expenses

Employee compensation and benefits 4,427,300 4,129,020

Supplies and other expenses 1,905,160 1,827,557

Direct academic and research expenses 1,045,789 967,635

Depreciation and amortization 356,844 328,486

Provision for bad debts 119,861 121,051

Interest 75,677 76,662

Total operating expenses 7,930,631 7,450,411

Income from operations 194,680 164,449

Nonoperating gains (expenses)

Income (loss) from investments 109,941 (25,278)Change in fair value of nonhedging interest rate swaps (40,690) (38,955)

Gifts and other, net of expenses (37,985) (36,229)

Academic and research gifts, net of expenses 42,539 (18,362)

Total nonoperating gains (expenses), net 73,805 (118,824)

Excess of revenues over expenses 268,485 45,625

Other changes in net assets

Change in net unrealized appreciation on marketable investments 58,545 93,032

Change in fair value of hedging interest rate swaps (45,820) (46,026)

Funds utilized for property and equipment 75,420 39,855

Net assets acquired through merger 193,818 -

Other 5,412 1,618Change in funded status of defined benefit plans (10,460) (778,737)

Cumulative effect of change in defined benefit plans

measurement date - (73,051)

Increase (decrease) in unrestricted net assets 545,400$ (717,684)$

Partners HealthCare System, Inc. and AffiliatesConsolidated Statements of Changes in Net AssetsYears Ended September 30, 2010 and 2009


4

Temporarily Permanently

(dollars in thousands) Unrestricted Restricted Restricted Total

Net assets at October 1, 2008 4,563,475$ 861,910$ 301,780$ 5,727,165$

Increases (decreases)

Income from operations 164,449 - - 164,449

Loss from investments (25,278) (49,173) (1,080) (75,531)

Gifts and other (36,229) (5,606) 8,284 (33,551)

Academic and research gifts, net of expenses (18,362) - - (18,362)Change in net unrealized appreciation on

marketable investments 93,032 23,203 (1,506) 114,729

Change in fair value of interest rate swaps

Nonhedging (38,955) - - (38,955)

Hedging (46,026) - - (46,026)

Funds utilized for property and equipment 39,855 (5,595) - 34,260

Other 1,618 5,189 (8,584) (1,777)

Change in funded status of defined benefit plans (778,737) - - (778,737)

Cumulative effect of change in defined benefit plans

measurement date (73,051) - - (73,051)

Change in net assets (717,684) (31,982) (2,886) (752,552)

Net assets at September 30, 2009 3,845,791 829,928 298,894 4,974,613

Increases (decreases)Income from operations 194,680 - - 194,680

Income from investments 109,941 4,800 279 115,020

Gifts and other (37,985) 23,652 14,903 570

Academic and research gifts, net of expenses 42,539 - - 42,539

Change in net unrealized appreciation on

marketable investments 58,545 6,372 364 65,281

Change in fair value of interest rate swaps

Nonhedging (40,690) - - (40,690)

Hedging (45,820) - - (45,820)

Funds utilized for property and equipment 75,420 (38,848) - 36,572

Net assets acquired through merger 193,818 - - 193,818

Other 5,412 (1,478) (3,549) 385

Change in funded status of defined benefit plans (10,460) - - (10,460)

Change in net assets 545,400 (5,502) 11,997 551,895

Net assets at September 30, 2010 4,391,191$ 824,426$ 310,891$ 5,526,508$

Partners HealthCare System, Inc. and AffiliatesConsolidated Statements of Cash FlowsYears Ended September 30, 2010 and 2009


5


Cash flows from operating activities

Change in net assets 551,895$ (752,552)$

Adjustments to reconcile change in net assets to net cash

provided by operating activities

Net assets acquired through merger (193,818) -

Cumulative effect of change in defined benefit plans measurement date - 73,051

Change in funded status of defined benefit plans 10,460 778,737

Loss on refunding of debt 3,180 -

Change in fair value of interest rate swaps 86,510 84,981

Depreciation and amortization 356,844 328,486

Provision for bad debts 119,861 121,051

Loss on disposal of property 1,425 1,152

Net realized and change in unrealized appreciation on investments (213,105) (44,166)

Restricted contributions and investment income (73,471) (66,181)

Increase (decrease) in cash resulting from a change in

Patient accounts receivable (106,003) (90,644)

Research grants receivable 678 20,751

Other current assets 5,297 (914)

Pledges receivable and contributions receivable from trusts (6,240) 29,738Other assets (14,020) 883

Accounts payable and accrued expenses 15,038 156,819

Accrued compensation and benefits 53,972 19,854

Settlements with third-party payers (24,154) 8,683

Unexpended funds on research grants (12,977) (5,522)

Accrued employee benefits and other 10,366 16,011

Net cash provided by operating activities 571,738 680,218

Cash flows from investing activities

Purchase of property and equipment (607,039) (634,218)

Purchase of investments (482,118) (1,393,653)

Proceeds from sales of investments 303,800 1,347,866

Net cash used for investing activities (785,357) (680,005)

Cash flows from financing activities

Borrowings under line of credit - 50,000

Repayment of borrowings under line of credit - (50,000)

Payments on long-term obligations (65,098) (40,514)

Proceeds from long-term obligations, net of financing costs 504,027 227,305

Decrease (increase) in auction rate securities holdings 20,000 (50,000)

Deposits into refunding trusts (253,094) -

Restricted contributions and investment income 73,471 66,181

Net cash provided by financing activities 279,306 202,972

Net increase in cash and equivalents 65,687 203,185

Cash and equivalents at beginning of year 561,232 358,047

Cash and equivalents at end of year 626,919$ 561,232$

Partners HealthCare System, Inc. and AffiliatesNotes to Consolidated Financial StatementsSeptember 30, 2010 and 2009

(dollars in thousands)

6

1. Organization and Community Benefit Commitments

Partners HealthCare System, Inc. (PHS) is the sole member of The Massachusetts GeneralHospital (MGH), Brigham and Women's/Faulkner Hospitals, Inc. (BW/F), NSMC HealthCare, Inc.(NSMC), Newton-Wellesley Health Care System, Inc. (NWHCS), Partners Continuing Care, Inc.(PCC), and Partners International Medical Services, LLC. PHS appoints the two physicians whoare the members of Partners Community HealthCare, Inc. (PCHI). The individual serving as thePHS President and Chief Executive Officer is the sole member of Partners Harvard MedicalInternational, Inc. (PHMI). PHS, together with all of its affiliates, is referred to as "PartnersHealthCare."

Partners HealthCare currently operates two tertiary and five community acute care hospitals ineastern Massachusetts, one facility providing inpatient and outpatient mental health services andfour facilities providing inpatient and outpatient services in rehabilitation medicine and long termcare. Partners HealthCare also operates physician organizations and practices, a home healthagency, nursing homes, hospice, and a graduate level program for health professions. PartnersHealthCare provides services to patients primarily from the Greater Boston area as well as NewEngland and beyond. In addition, Partners HealthCare is a nonuniversity-based nonprofit privatemedical research enterprise and is a principal teaching affiliate of the medical and dental schools ofHarvard University.

On September 30, 2010, the Massachusetts Biomedical Research Corporation (MBRC) mergedinto The General Hospital Corporation (the General). MBRC was a tax-exempt organization,created for the purposes of promoting and supporting basic and applied biomedical and otherscientific research, owning and leasing real estate in order to enhance and to provide facilities forthe conduct of such research and other hospital-related support functions, and promoting andsupporting education in the field of medicine. MBRC purchased real estate which wassubsequently leased to and occupied by the General. MBRC has been a related party but notcontrolled by either the General or Partners HealthCare, and therefore not previously consolidatedwithin these financial statements. The merger has been accounted for at historical cost, similar toa pooling of interests, however, prior period financial statements have not been restated as theimpact of the transaction on the consolidated financial statements is not considered to be material.The effect of the merger was to increase unrestricted net assets by $193,818 on September 30,2010, which has been reported as a component of other changes in unrestricted net assets. Hadprior period financial statements been restated, net assets at October 1, 2008 and September 30,2009 would have increased by $148,993 and $170,134, respectively, and the excess of revenuesover expenses would have increased by $23,684 and $21,141 for the years ended September 30,2010 and September 30, 2009, respectively.

PHS is a tax-exempt organization under Section 501(c)(3) of the Internal Revenue Code.Substantially all affiliates of PHS (except for PCHI) are also tax-exempt organizations underSection 501(c)(3) of the Internal Revenue Code. Accordingly, no provision for income taxes relatedto these entities has been made. PCHI is a taxable entity, and as of September 30, 2010, hasavailable net operating loss carryforwards of approximately $52,000 for income tax purposes,expiring in 2012 through 2024.



7

Community BenefitPartners HealthCare's community benefit programs include working with communities to address anumber of public health issues including racial disparities, alcohol and substance abuse amongyoung people, infant mortality, domestic violence and cancer. Partners HealthCare provideseconomic opportunity for low income Boston residents by helping people advance into nursing andother healthcare careers through its public school partnerships and workforce developmentprograms. In addition, twenty-one community health centers are licensed by or affiliated withPartners HealthCare entities, providing high quality, culturally competent primary care and accessto its hospitals. Partners HealthCare invests in these health centers' infrastructure, programmingand operation and also helps with relocation, renovation, and other capital requirements.

The Massachusetts Attorney General's Community Benefits Guidelines direct health maintenanceorganizations and nonprofit acute care hospitals to prepare annual reports documenting the statusand level of their community benefit programs and initiatives. These annual reports serve theimportant purpose of providing the public with access to useful information about these programsand initiatives. Partners HealthCare files its report annually with the Attorney General. The reportsummarizes community benefit activities on a systemwide basis. In addition, each of the acutecare hospitals within Partners HealthCare has a community benefit planning and service deliverystructure and files separate community benefit reports. Partners HealthCare's nonacute carehospitals also file reports annually.

Uncompensated CarePartners HealthCare provides care to all patients regardless of their ability to pay. The cost ofproviding that care is reflected in the statements of operations. The cost related to those patientsfor which Partners HealthCare receives either partial or no reimbursement for healthcare servicesprovided is summarized as follows:

State ProgramsUncompensated CareFree care services are partially reimbursed to acute care hospitals through the statewide HealthSafety Net (HSN, formerly known as the Uncompensated Care Pool) established by theMassachusetts Health Care Reform Law (Chapter 58 of the Acts of 2006). A portion of the fundingfor the HSN is paid by hospitals through a statewide hospital assessment levied each year by theMassachusetts Legislature. All acute care hospitals in the state are assessed their share of thistotal statewide hospital assessment amount ($160,000 in 2010 and $180,000 in 2009) based oneach hospital's charges for private sector payers. Partners HealthCare's hospitals report thisassessment as a deduction from net patient service revenue.

Hospitals are reimbursed for free care based on claims for eligible patients that are submitted toand adjudicated by the HSN. Rates of payment are based on Medicare rates and paymentpolicies. In 2010, the HSN is projected to be under-funded by approximately $69,000. Thisshortfall is allocated to hospitals based on their share of total statewide patient care costs. Eachhospital’s share of the overall state shortfall cannot exceed its total free care reimbursement.Hospitals with a high proportion of free care and government funding receive more favorablereimbursement, including limiting their shortfall allocation to no more than 15%. In aggregate,Partners HealthCare acute care hospitals' share of uncompensated care funding covered 49% ofthe estimated cost of free care provided in 2010 and 72% of the estimated cost in 2009, excludingthe assessment.



8

MedicaidMedicaid is a means-tested health insurance program, jointly funded by state and federalgovernments. States administer the program and set rules for eligibility, benefits and providerpayments within broad federal guidelines. The program provides health care coverage to low-income children and families, pregnant women, long-term unemployed adults, seniors and personswith disabilities. Eligibility is determined by a variety of factors, which include income relative to thefederal poverty line, age and immigrant status, and assets.

Medicaid payments to Partners HealthCare providers do not cover the cost of services provided. Inaggregate, reimbursement from Medicaid covered 65% of the estimated cost of services providedin 2010 and 70% of the estimated cost in 2009.

Federal ProgramMedicareMedicare is a federally sponsored health insurance program for people age 65 or older, underage 65 with certain disabilities, and any age with End-Stage Renal Disease. For many years,Medicare payments have not kept pace with increases in the cost of care provided for manyhospitals. Additionally, payments to physicians have seen little or no increases over the pastseveral years. Compounding this shortfall in payments is the shift of care from higher payinginpatient services to lower paying outpatient services.

Consequently, Medicare payments to Partners HealthCare providers also do not cover the cost ofservices provided. In aggregate, reimbursement from Medicare covered 76% of the estimated costof services provided in 2010 and 75% of the estimated cost of services in 2009.



9

For free care, Medicaid and Medicare, the total estimated cost of services provided by PartnersHealthCare providers exceeds the net reimbursement received under these programs by $814,622and $745,784 for the years ended September 30, 2010 and 2009, respectively. The followingsummarizes, by program, the cost of services provided, net reimbursement and cost of services inexcess of reimbursement for each year:

2010 2009

Cost of services providedFree Care, including assessment payment to HSN of$47,671 and $54,569 in 2010 and 2009, respectively 142,857$ 145,196$

Medicaid 658,153 578,516

Medicare 1,999,692 1,882,147

2,800,702$ 2,605,859$

Net reimbursement

Free Care 36,296$ 50,622$Medicaid 427,539 402,859Medicare 1,522,245 1,406,594

1,986,080$ 1,860,075$

Cost of services in excess of reimbursementFree Care 106,561$ 94,574$Medicaid 230,614 175,657Medicare 477,447 475,553

814,622$ 745,784$

Years EndedSeptember 30,

Bad DebtsIn addition to free care and inadequate funding from the Medicaid and Medicare programs, thereare significant losses related to self-pay patients who fail to make payment for services rendered orinsured patients who fail to remit co-payments and deductibles as required under the applicablehealth insurance arrangement. The provision for bad debts of $119,861 in 2010 and $121,051 in2009 represents charges for services provided that are deemed to be uncollectible. The estimatedcost of providing these services was approximately $44,791 and $42,942 for 2010 and 2009,respectively.

2. Summary of Significant Accounting Policies

Basis of AccountingThe accompanying consolidated financial statements have been prepared on the accrual basis ofaccounting and include the accounts of PHS and its affiliates. Significant interaffiliate accounts andtransactions have been eliminated.



10

Use of EstimatesThe preparation of financial statements in conformity with accounting principles generally acceptedin the United States of America requires management to make estimates and assumptions thataffect the reported amounts of assets and liabilities and disclosure of contingent assets andliabilities at the date of the financial statements and the reported amounts of revenues andexpenses during the reporting period. Actual results could differ from those estimates. Significantestimates are made in the areas of patient accounts receivable, research grants receivable,pledges receivable, investments, receivables and accruals for settlements with third-party payers,accrued professional liability, accrued compensation and employee benefits, and accrued other.

Fair Value of Financial InstrumentsThe fair value of financial instruments approximates the carrying amount reported in theconsolidated balance sheets for cash and equivalents, investments, investments limited as to use,collateral held under securities lending arrangements, patient accounts receivable, research grantsreceivable, accounts payable, collateral due under securities lending arrangements, and interestrate swaps. More information can be found in Note 4, Fair Value Measurements.

Cash and EquivalentsCash and equivalents represent money market and highly liquid debt instruments with a maturity atthe date of purchase of three months or less.

InvestmentsInvestments in equity securities with readily determinable fair values and all investments in debtsecurities (marketable investments) are measured at fair value based on quoted market prices.The change in net unrealized appreciation on these marketable investments is excluded fromexcess of revenues over expenses.

Alternative investments, including hedge funds and private equities, do not have readilyascertainable market values. Alternative investments are valued by the investment manager andassessed for reasonableness by management using the following methodology: investments insecurities sold short or traded on a national securities exchange are valued based on quotedmarket prices; investments in securities that are not traded and restricted securities of publiccompanies are valued based on amounts reported by the fund manager and evaluated bymanagement. The reported value of these investments represents the amount PartnersHealthCare would have expected to receive if it had liquidated its investments at the balance sheetdate on a nondistressed basis. Investments in hedge funds, private equity, private debt and otherprivate partnerships (collectively, “private partnerships”), for which Partners HealthCare owns morethan 5% of the overall investment are generally recorded as equity method investments. Thechange in value of equity method investments is included in excess of revenues over expenses asa component of income from investments. All other investments are recorded at cost.

Income from investments (including realized gains and losses, change in value of equity methodinvestments, interest, dividends, and endowment income distributions) is included in excess ofrevenues over expenses unless the income or loss is restricted by donor or law. Income frominvestments is reported net of investment-related expenses.



11

Investments whose cost exceeds fair value are reviewed each quarter to determine whether theseinvestments are other-than-temporarily impaired. Externally managed marketable investments withfair value below cost are considered to be other-than-temporarily impaired and, accordingly, theunrealized depreciation is recognized as realized losses through a write-down in the cost basis ofthese investments. All other investments are subject to a further review, which considers factorsincluding the anticipated holding period for the investment and the extent and duration of belowcost valuation. A similar write-down is recorded when the impairment on these investments hasbeen judged to be other-than-temporary.

Depending on any donor-imposed restrictions on the underlying investments, the amount of thewrite-down is reported as a realized loss in either temporarily restricted net assets or in excess ofrevenues over expenses as a component of income from investments, with no adjustment in thecost basis for subsequent recoveries in fair value.

Partners HealthCare has an endowment spending policy for pooled endowment funds. A fixeddistribution rate for spending is determined each year which will come from either income and/ornet accumulated appreciation in market value.

Investments Limited as to UseInvestments limited as to use primarily include assets whose use is contractually limited by externalparties and assets set aside by the boards (or management) for identified purposes, over which theboards (or management) retain control and may, at their discretion, subsequently use for otherpurposes. Certain investments corresponding to deferred compensation are accounted for suchthat all income and appreciation (depreciation) is recorded as a direct addition (reduction) to theasset balance and corresponding liability balance.

Securities LoanedInvestments that have been loaned to another institution are reported as pledged assets withininvestments in the consolidated financial statements. Cash or investments held by the custodianon behalf of Partners HealthCare as collateral on the securities lending transaction are alsoreported as assets on the balance sheet. Because the collateral must be returned in the future, acorresponding liability is also reported in the consolidated financial statements.



12

Derivative InstrumentsDerivatives are recognized on the balance sheet at fair value. Partners HealthCare designates atinception whether the derivative contract is considered hedging or nonhedging for accountingpurposes. For hedges, Partners HealthCare formally documents at inception all relationshipsbetween hedging instruments and hedged items, as well as its risk management objectives andstrategies for undertaking various accounting hedges. Partners HealthCare uses its derivatives,designated as hedging for accounting purposes, as cash flow hedges. Cash flow hedges are usedto minimize the variability in cash flows of interest-bearing liabilities or forecasted transactionscaused by changes in interest rates. Changes in the fair value of derivatives designated forhedging activities that are highly effective as hedges are excluded from excess of revenues overexpenses. Hedge ineffectiveness, if any, is recorded in excess of revenues over expenses. Fornon-hedging derivatives, changes in the fair value are recorded in excess of revenues overexpenses.

Patient Accounts ReceivablePartners HealthCare receives payments for services rendered from federal and state agencies(under the Medicare and Medicaid programs), managed care payers, commercial insurancecompanies and patients. Patient accounts receivable are reported net of contractual allowancesand reserves for denials, uncompensated care, and doubtful accounts. The level of reserves isbased upon management's assessment of historical and expected net collections, business andeconomic conditions, trends in federal and state governmental and private employer health carecoverage and other collection indicators.

Research Grants ReceivablePartners HealthCare receives research funding from departments and agencies of the U.S.Government, industry and corporate sponsors, and other private sponsors. Research grantsreceivable include amounts due from these sponsors of externally funded research. The amountshave been billed or are billable to the sponsor, or in limited circumstances, represent acceleratedspending in anticipation of future funding. Research grants receivable are reported net of reservesfor uncollectible accounts.

Property and EquipmentProperty and equipment is reported on the basis of cost less accumulated depreciation. Donateditems are recorded at fair value at the date of contribution. All research grants received for capitalare recorded in the year of expenditure as a change in net assets. Property and equipment isreviewed for recoverability whenever events or changes in circumstances indicate that its carryingamount may not be recoverable. Depreciation of property and equipment is calculated by use ofthe straight-line method at rates intended to depreciate the cost of assets over their estimateduseful lives, which generally range from three to forty years. Interest costs incurred on borrowedfunds during the period of construction of capital assets are capitalized, net of any interest earned,as a component of the cost of acquiring those assets.



13

Asset Retirement ObligationsAsset retirement obligations, reported in accrued other, are legal obligations associated with theretirement of long-lived assets. These liabilities are initially recorded at fair value and the relatedasset retirement costs are capitalized by increasing the carrying amount of the related assets bythe same amount as the liability. Asset retirement costs are subsequently depreciated over theuseful lives of the related assets. Partners HealthCare records changes in the liability resultingfrom the passage of time and revisions to either the timing or the amount of the original estimate ofundiscounted cash flows. Partners HealthCare reduces these liabilities when the relatedobligations are settled.

Other AssetsOther assets consist of long-term receivables, deferred financing costs, intangible assets,investments in healthcare related limited partnerships and benefit assets for over-funded definedbenefit plans. Deferred financing costs are amortized over the terms of the related obligations.

The excess of the purchase price over the fair value of tangible assets of physician groupsacquired is being amortized over periods ranging from five years to twenty years based on theestimated period of benefits from the acquisition. The carrying value of other assets is reviewed ifthe facts and circumstances suggest that it may be impaired.

Compensated AbsencesIn accordance with formal policies concerning vacation and other compensated absences, accrualsof $186,921 and $176,515 were recorded as of September 30, 2010 and 2009, respectively.

Unexpended Funds on Research GrantsResearch grants received in advance of corresponding grant expenditures are accounted for as adirect addition to investments limited as to use and unexpended funds on research grants.

Self-Insurance ReservesPartners HealthCare is generally self-insured for employee healthcare, disability, workers'compensation and certain other employee benefits. These costs are accounted for on an accrualbasis to include estimates of future payments for claims incurred.

Net AssetsPermanently restricted net assets include the historical dollar amounts of gifts, and income andgains, which are required by donors to be permanently retained. Temporarily restricted net assetsinclude gifts, and income and gains on permanently restricted net assets which can be expendedbut for which restrictions have not yet been met. Such restrictions include purpose restrictionswhere donors have specified the purpose for which the net assets are to be spent, or timerestrictions imposed by donors or implied by the nature of the gift (capital projects, pledges to bepaid in the future, life income funds) or by interpretations of law (gains available for appropriationbut not appropriated in the current period). Unrestricted net assets include all the remaining netassets of Partners HealthCare. See Note 12 for further information on the composition of restrictednet assets.



14

Realized gains and losses are classified as unrestricted net assets unless they are restricted by thedonor or law. Unless permanently restricted by the donor, realized gains and unrealized netappreciation on permanently restricted gifts are classified as temporarily restricted untilappropriated for spending by Partners HealthCare in accordance with policies established byPartners HealthCare and the Uniform Prudent Management of Institutional Funds Act (UPMIFA)enacted by The Commonwealth of Massachusetts in July 2009. Net losses on permanentlyrestricted endowment funds are classified as a reduction to unrestricted net assets until such timeas the fair value of these funds exceeds historical cost.

Gifts and GrantsUnconditional promises to give cash and other assets to Partners HealthCare are reported at fairvalue at the date the promise is received. Conditional promises to give are recognized when theconditions are substantially met. Gifts are reported as either temporarily or permanently restrictedsupport if they are received with donor stipulations that limit the use of the donated assets. Donor-restricted contributions whose restrictions are met within the same year as received are reported asunrestricted gifts in the accompanying financial statements.

Gifts of long-lived assets with explicit restrictions that specify use of assets and gifts of cash orother assets that must be used to acquire long-lived assets are reported as additions to temporarilyrestricted net assets if the assets are not placed in service during the year.

Grants and contracts normally provide for the recovery of direct and indirect costs, subject to audit.Partners HealthCare recognizes revenue associated with direct and indirect costs as direct costsare incurred. The recovery of indirect costs is based on predetermined rates for U.S. Governmentgrants and contracts and negotiated rates for other grants and contracts.

Statement of OperationsAll activities of Partners HealthCare deemed by management to be ongoing, major and central tothe provision of healthcare services, training and research activities are reported as operatingrevenue and expenses. Other activities are deemed to be nonoperating and include unrestrictedgifts (net of fundraising expenses), net change in unexpended academic and research gifts,change in fair value of nonhedging interest rate swaps, and substantially all income (loss) frominvestments. Academic and research gifts largely consist of donor contributions (and the relatedinvestment income including realized gains and losses) designated to support the clinical, teachingor research efforts of a physician or department as directed by the donor. These gifts are reportedas unrestricted, net of related support expenses, as any donor restrictions are of a general naturethat are inherent in the normal activities of the organization and do not require classification ofthese gifts as temporarily or permanently restricted.

Partners HealthCare recognizes changes in third-party payer settlements and other estimates inthe year of the change in estimate. For the years ended September 30, 2010 and 2009,adjustments to prior year estimates resulted in an increase to income from operations of $21,071and $5,144, respectively.



15

Effective October 1, 2007, the Centers for Medicare and Medicaid Services (CMS) adopted theMS-DRG patient classification system (MS-DRGs) for inpatient services to better recognizeseverity of illness in Medicare payment rates for acute care hospitals. The adoption of MS-DRGsresulted in the expansion of the number of diagnosis related groups (DRGs), a system ofclassifying patients for purposes of inpatient reimbursement. By increasing the number of DRGsand more fully taking into account patients' severity of illness in Medicare payment rates for acutecare hospitals, the use of MS-DRGs encourages hospitals to improve their documentation andcoding of patient diagnoses. CMS has determined that the adoption of the MS-DRGs hasincreased aggregate payments to hospitals due to additional documentation and coding without acorresponding increase in actual patient severity of illness.

CMS is required by its enabling statute to maintain budget neutrality by prospectively adjusting theMedicare payment rate to eliminate the effect of changes in DRG classification that do not reflectreal changes in case-mix. Congress mandated that CMS recoup any overpayments made tohospitals in 2008 and 2009 resulting from increased coding and documentation. CMS hascalculated the overpayments, net of rate reductions already assessed against hospitals, to be 1.9%in 2008 and an additional 2% in 2009. CMS intends to recoup these overpayments through equalrate reductions in 2011 and 2012.

Partners HealthCare has recorded the estimated overpayment amounts received as deferredrevenue. Management believes this accounting treatment better reflects the financial impact of thisrate methodology and more accurately presents the recognition of revenue. As ofSeptember 30, 2010, the estimated amount to be recouped is $38,509 and will be amortizedequally into net patient service revenue in fiscal years 2011 and 2012.

The statements of operations include excess of revenues over expenses. Changes in unrestrictednet assets which are excluded from excess of revenues over expenses include change in netunrealized appreciation on marketable investments, change in fair value of hedging interest rateswaps, contributions of long-lived assets (including assets acquired using contributions which bydonor restriction were to be used for acquisition of such assets) and change in funded status ofdefined benefit plans.

Net Patient Service RevenuePartners HealthCare maintains agreements with CMS of the United States Department of Healthand Human Services (DHHS) under the Medicare Program, The Commonwealth of Massachusettsunder the Medical Assistance Program (Medicaid) and various managed care payers that governpayment for services rendered to patients covered by these agreements. The agreementsgenerally provide for per case or per diem rates or payments based on discounted charges forinpatient care and discounted charges or fee schedules for outpatient care. Certain "pay forperformance" contracts also provide for payments that are contingent upon meeting agreed uponquality and efficiency measures.



16

Net patient service revenue is reported at estimated net realizable amounts from patients, third-party payers, and others for services rendered and includes estimated retroactive revenueadjustments due to future audits, reviews and investigations. Retroactive adjustments areconsidered in the recognition of revenue on an estimated basis in the period the related servicesare rendered, and such amounts are adjusted in future periods as adjustments become known oras years are no longer subject to such audits, reviews and investigations. Contracts, laws andregulations governing the Medicare, Medicaid, and HSN programs (Note 1) and managed carepayer arrangements are complex and subject to interpretation. As a result, there is at least areasonable possibility that recorded estimates will change by a material amount in the near term. Aportion of the accrual for settlements with third-party payers has been classified as long-termbecause such amounts, by their nature or by virtue of regulation or legislation, will not be paidwithin one year.

Charity CarePartners HealthCare provides either full or partial charity care to patients who cannot afford to payfor their medical services based on income and family size. Charity care is generally available toqualifying patients for medically necessary services. Partners HealthCare reports certain baddebts related to emergency services as charity care. Charity care is reported at gross charges withan offsetting allowance, as there is no expectation of collection. Accordingly, there is no net patientservice revenue related to charity care.

Other RevenueOther revenue includes institutional revenue (for example, billing for services provided to otherhealthcare providers), royalties and management services.

ReclassificationCertain amounts in the 2009 financial statements have been reclassified to conform with the 2010presentation. All research funds with credit balances are reported as liabilities, as a component ofunexpended funds on research grants, to more accurately reflect the nature of these balances.Previously, certain of these credit balances were reported as a component of research grantsreceivable. The impact of this reclassification was to increase grants receivable and unexpendedfunds on research grants by $20,154 as of September 30, 2009, with a corresponding reclassbetween cash and current portion of investments limited as to use.



17

3. Investments and Investments Limited as to Use

Investments are either separately invested or included in pooled investment funds. The PartnersHealthCare System Pooled Investment Accounts (Partnership) is structured as a single generalpartnership composed of four investment pools, with PHS and substantially all of its affiliatesparticipating in the pools as partners. Each partner's interest in the Partnership is based on itsunderlying investments in one or more of the four separate pools. Amounts included in theinvestment pools are accounted for using the fair value method whereby each partner is assigned anumber of units based on the fair value of the assets of a pool at the time of entry of the funds intothe pool. Current fair value is used to determine the number of units allocated to additionalamounts placed in a pool and to value withdrawals from a pool. Income from investments of thepools, including realized gains and losses, is allocated on a unitized basis to a partner based onthe partner's share of units in a pool.

The Partnership invests in private partnerships whose assets include equity, fixed income, andother investments. As of September 30, 2010, Partners HealthCare has unfunded commitments ofapproximately $316,709 which will be drawn down by the various general partners over the nextseveral years. The maximum annual drawdown is expected to be less than 2% of investments andinvestments limited as to use.

Investments and investments limited as to use are recorded in the balance sheet as follows:

2010 2009

Current assets

Investments 1,050,749$ 1,046,894$Current portion of investments limited as to use 1,084,877 898,056

2,135,626 1,944,950

Investments limited as to use, less current portion 2,106,023 1,857,459Long-term investments 838,913 829,816

5,080,562$ 4,632,225$

September 30,



18

Investments limited as to use consist of the following:

Current Long-Term Current Long-Term

Portion Portion Portion Portion

Internally designated funds

Reserved for capital expenditures 534,900$ -$ 542,345$ -$

Unexpended academic and research gifts - 1,677,428 - 1,515,184

Deferred compensation - 139,679 - 123,236

Other 321,344 235,249 143,208 164,412

856,244 2,052,356 685,553 1,802,832

Externally limited funds

Unexpended funds on research 152,513 - 165,490 -

Contributions held for others 26,951 - 27,718 -

Professional liability trust fund - 44,541 - 40,410

Held by trustees under debt and other

agreements 49,169 9,126 19,295 14,217

228,633 53,667 212,503 54,627

1,084,877$ 2,106,023$ 898,056$ 1,857,459$

September 30, 2010 September 30, 2009

Investments and investments limited as to use are reported at either fair value or on the equity orcost methods of accounting. The composition of these investments, segregated between pooledinvestments and those that are separately invested, is as follows:

On Equity On Cost

At Fair Value Method Method Total

Pooled investments

Invested cash equivalents 109,653$ -$ -$ 109,653$

Separately managed investments 1,852,860 - - 1,852,860

Mutual funds 296,137 - - 296,137

Commingled funds 347,949 - - 347,949Private partnerships - 631,554 1,446,045 2,077,599

2,606,599 631,554 1,446,045 4,684,198

Separately invested

Invested cash equivalents 137,053 - - 137,053

Equities 26,184 - 4,965 31,149

U.S. Government and domestic fixed

income securities 4,760 - - 4,760

Mutual funds 141,377 - - 141,377

Other 8,104 - 73,921 82,025

317,478 - 78,886 396,364

2,924,077$ 631,554$ 1,524,931$ 5,080,562$

September 30, 2010



19

Separately managed investments include cash and equivalents of $124,094, equities of $529,917and fixed income securities of $1,198,849 as of September 30, 2010.

On Equity On Cost

At Fair Value Method Method Total

Pooled investments

Invested cash equivalents 42,690$ -$ -$ 42,690$

Separately managed investments 1,584,055 - - 1,584,055

Mutual funds 401,548 - - 401,548

Commingled funds 330,670 - - 330,670

Private partnerships - 542,023 1,343,485 1,885,508

2,358,963 542,023 1,343,485 4,244,471

Separately invested

Invested cash equivalents 171,640 - - 171,640

Equities 24,880 - 3,527 28,407

U.S. Government and domestic fixed

income securities 5,106 - - 5,106

Mutual funds 122,695 - - 122,695

Other 7,813 - 52,093 59,906

332,134 - 55,620 387,754

2,691,097$ 542,023$ 1,399,105$ 4,632,225$

September 30, 2009

Separately managed investments include cash and equivalents of $56,874, equities of $446,291and fixed income securities of $1,080,890 as of September 30, 2009.

For the private partnerships reflected in the balance sheet at cost, the difference (unrecordedunrealized appreciation) between the value reported by the investment managers and the cost forthese investments was $439,927 and $261,914 as of September 30, 2010 and 2009, respectively.

The fair value and gross unrealized depreciation of investments and investments limited as to use,with a fair value less than cost, that are not deemed to be other-than-temporarily impaired atSeptember 30, 2010 are as follows:

Gross Gross

Fair Unrealized Fair Unrealized

Value Depreciation Value Depreciation

Pooled investments

Mutual funds -$ -$ 261,899$ (41,485)$

Separately invested

Equities - - 17,074 (2,265)

U.S. Government and domestic

fixed income securities - - 1,548 (646)

Mutual funds - - 487 (12)External trusts - - 7,013 (1,433)

- - 26,122 (4,356)

-$ -$ 288,021$ (45,841)$

Less than 12 Months 12 Months or Greater



20

In addition, for certain private partnerships recorded at cost, gross unrealized depreciationamounted to $48,099 as of September 30, 2010, with $18,613 of that amount unrealized for 12months or greater.

Investment income and gains (losses) from cash and equivalents, investments (including long-term) and investments limited as to use are comprised of the following:

2010 2009

Unrestricted

Dividends, interest and other income 62,498$ 59,163$

Endowment income distributions, net of reinvested gains 25,070 27,569

Net realized gains (losses) on investments

Realized gains 77,552 25,293

Other-than-temporary impairment (17,213) (93,402)

Change in value of equity method investments 54,454 19,105

Recovery (losses) on endowment funds 1,629 (787)

Total investment activity included in excess of

revenues over expenses 203,990 36,941

Change in net unrealized appreciation on marketable

investments 58,545 93,032

Total unrestricted investment activity 262,535 129,973

Temporarily restricted

Dividends and interest income 4,694 4,759

Endowment income distributions (31,069) (34,262)

Net realized gains (losses) on investments

Realized gains (losses) 18,411 (1,167)

Other-than-temporary impairment (2,823) (23,444)

(10,787) (54,114)

Change in value of equity method investments 15,557 4,941

Change in net unrealized appreciation on marketable investments 8,000 22,416

(Recovery) losses on endowment funds (1,629) 787

21,928 28,144

Total temporarily restricted investment activity 11,141 (25,970)

Permanently restricted

Dividends and interest income 21 22

Net realized gains (losses) on investments 258 (1,102)

Change in net unrealized appreciation on investments 364 (1,506)

Total permanently restricted investment activity 643 (2,586)

274,319$ 101,417$

Years Ended

September 30,



21

Investment income (loss) included in operating results and excess of revenues over expenses arecomprised of the following:

2010 2009

Investment income included in operations and reported in

Other revenue 9,157$ 8,940$

Investment income (loss) included in nonoperating gains

(expenses) and reported inIncome (loss) from investments 109,941 (25,278)

Academic and research gifts, net of expenses 84,892 53,279

Total investment activity included in excess ofrevenues over expenses 203,990$ 36,941$

Years Ended

September 30,

Securities LendingThe Partnership may lend securities to qualified financial institutions through a programadministered by the Partnership custodian. All loans are callable at any time and are fullycollateralized. Income is earned based on the collateral held and invested during the period oflending. Cash collateral requirements are 102% and 105% for domestic and foreign securities,respectively. The custodian continually monitors borrowers' creditworthiness and protects againstborrower default through full indemnification. If a borrower failed to return a loaned security whosemarket value has increased over the amount in collateral, the custodian will cover the difference.The custodian will also cover operational losses, such as the failure of the borrower to makesubstitute dividend payments to the lender.

The fair value of loaned securities and related collateral at September 30, 2010 and 2009 is asfollows:

Loaned LoanedSecurities Collateral Securities Collateral

Equities, U.S. government, domesticand foreign fixed income securities 125,172$ 129,183$ 178,276$ 183,336$

20092010

Income generated by the Partnership from securities lending arrangements was $237 and $1,346for the years ended September 30, 2010 and 2009, respectively.

4. Fair Value Measurements

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liabilityin an orderly transaction between market participants at the measurement date (also referred to as"exit price"). Therefore, a fair value measurement should be determined based on the assumptionsthat market participants would use in pricing the asset or liability. In determining fair value, the useof various valuation approaches, including market, income and cost approaches, is permitted.



22

Fair Value HierarchyA fair value hierarchy has been established based on whether the inputs to valuation techniquesare observable or unobservable. Observable inputs reflect market data obtained from independentsources, while unobservable inputs reflect the reporting entity's assumptions about the inputsmarket participants would use. The fair value hierarchy requires the reporting entity to maximizethe use of observable inputs and minimize the use of unobservable inputs when measuring fairvalue. In addition, for hierarchy classification purposes, the reporting entity should not look throughthe form of an investment to the nature of the underlying securities held by an investee.

The hierarchy is described below.

Level 1 - Valuations using quoted prices in active markets for identical assets or liabilities.Valuations of these products do not require a significant degree of judgment. Level 1assets and liabilities primarily include debt and equity securities that are traded in anactive exchange market.

Level 2 - Valuations using observable inputs other than Level 1 prices such as quoted prices inactive markets for similar assets or liabilities; quoted prices for identical or similarassets or liabilities in markets that are not active; broker or dealer quotations; or otherinputs that are observable or can be corroborated by observable market data forsubstantially the full term of the assets or liabilities. Level 2 assets and liabilitiesprimarily include debt securities with quoted prices that are traded less frequentlythan exchange-traded instruments as well as debt securities and derivative contractswhose value is determined using a pricing model with inputs that are observable inthe market or can be derived principally from or corroborated by observable marketdata.

Level 3 - Valuations using unobservable inputs that are supported by little or no market activityand are significant to the fair value of the assets or liabilities. Level 3 includes assetsand liabilities whose value is determined using pricing models, discounted cash flowmethodologies, or similar techniques reflecting the reporting entity's assumptionsabout the assumptions market participants would use as well as those requiringsignificant management judgment.

Valuation TechniquesPooled investments (except for private partnerships), separately invested cash equivalents, debtand equity securities, and collateral due under securities lending arrangements are classified withinLevel 1 or Level 2 of the fair value hierarchy as they are valued using quoted market prices, brokeror dealer quotations, or other observable pricing sources. Certain types of investments areclassified within Level 3 of the fair value hierarchy because they trade infrequently and thereforehave little or no observable inputs with which to measure fair value.

The valuation of interest rate swaps is determined using widely accepted valuation techniques,including discounted cash flow analysis on the expected cash flows of each derivative. Thisanalysis reflects the contractual terms of the derivatives, including the period to maturity, and usesobservable market-based inputs, including interest rate curves and implied volatilities.

The following tables summarize fair value measurements at September 30, 2010 and 2009 forfinancial assets and liabilities measured at fair value on a recurring basis:



23

Quoted Prices Significant

Fair Value in Active Other Significant

at Markets for Observable Unobservable

September 30, Identical Items Inputs Inputs

2010 (Level 1) (Level 2) (Level 3)

Assets

Pooled investments

Invested cash equivalents 109,653$ 12,187$ 97,466$ -$

Separately managed investments 1,852,860 531,214 1,321,646 -

Mutual funds 296,137 296,137 - -

Commingled funds 347,949 - 347,949 -

2,606,599 839,538 1,767,061 -

Separately invested

Invested cash equivalents 137,053 137,053 - -

Equities 26,184 20,884 1,963 3,337


fixed income securities 4,760 3,298 1,462 -

Mutual funds 141,377 141,377 - -

Other 8,104 120 - 7,984

317,478 302,732 3,425 11,321

2,924,077$ 1,142,270$ 1,770,486$ 11,321$

Collateral held under securities

lending arrangements 129,183$ 129,183$

Liabilities

Interest rate swaps 271,402$ 271,402$

Fair Value Measurements Using



24






Assets

Pooled investments

Invested cash equivalents 42,690$ 13,948$ 28,742$ -$

Separately managed investments 1,584,055 450,863 1,133,192 -

Mutual funds 401,548 401,548 - -


2,358,963 866,359 1,492,604 -

Separately invested

Invested cash equivalents 171,640 171,640 - -

Equities 24,880 17,607 2,652 4,621


fixed income securities 5,106 3,645 1,461 -

Mutual funds 122,695 122,695 - -

Other 7,813 158 - 7,655

332,134 315,745 4,113 12,276

2,691,097$ 1,182,104$ 1,496,717$ 12,276$

Collateral held under securitieslending arrangements 183,336$ 183,336$

LiabilitiesInterest rate swaps 180,795$ 180,795$


During the years ended September 30, 2010 and 2009, the changes in the fair value of the assetsmeasured using significant unobservable inputs (Level 3) were comprised of the following:

2010 2009

Balance at beginning of year 12,276$ 13,326$

Total gains (losses)

Dividends and interest 47 54

Realized gains (losses) 213 (67)

Unrealized appreciation (depreciation) 408 (871)

Purchases and sales, net (1,623) (166)

Balance at end of year 11,321$ 12,276$



25

5. Pledges Receivable and Contributions Receivable from Trusts

Pledges receivable represent unconditional promises to give and are net of allowances foruncollectible amounts. Pledges are recorded at the present value of their estimated future cashflows. Pledges collectible within one year are classified as other current assets, net of allowances,and total $93,036 and $96,679 as of September 30, 2010 and 2009, respectively. Estimated cashflows due after one year are discounted using published treasury bond and note yields that arecommensurate with estimated collection risks. The blended discount rate was 0.9% and 1.4% for2010 and 2009, respectively. Pledges are expected to be collected as follows:

2010 2009

Amounts dueWithin one year 106,672$ 119,460$In one to five years 134,556 157,955

In more than five years 19,830 14,238

Total pledges receivable 261,058 291,653

Less: Unamortized discount 5,535 7,721

255,523 283,932

Less: Allowance for uncollectibles 23,640 57,097

Net pledges receivable 231,883 226,835

Contributions receivable from trusts 23,992 22,800

255,875$ 249,635$

September 30,

6. Property and Equipment

Property and equipment consists of the following:

2010 2009

Land and land improvements 156,877$ 128,537$

Buildings and building improvements 4,110,842 3,571,103Equipment 1,237,484 1,160,878

Construction in progress 691,337 509,497

6,196,540 5,370,015

Accumulated depreciation (2,447,306) (2,015,946)

Property and equipment, net 3,749,234$ 3,354,069$

September 30,

Depreciation expense for the years ended September 30, 2010 and 2009 was $352,736 and$324,535, respectively. Interest costs, net of interest earned, aggregating $19,661 and $10,559were capitalized in 2010 and 2009, respectively.



26

For the years ended September 30, 2010 and 2009, fully depreciated assets with an original cost of$109,387 and $91,627, respectively, were written off.

7. Long-Term Obligations

Long-term obligations issued by PHS and its affiliates consist of the following:

2010 2009

Massachusetts Health and Educational Facilities Authority Revenue Bonds

Partners HealthCare System Series A, average interest rate of 5.13%,

final maturity in 2011 6,863$ 114,463$

Partners HealthCare System Series B, average interest rate of 5.25%,

final maturity in 2029 80,134 162,909

Partners HealthCare System Series C, average interest rate of 5.77%,


Partners HealthCare System Series D, variable interest rate of 0.24% and

0.29% at September 30, 2010 and 2009, respectively, final maturity in 2038 304,405 305,670

Partners HealthCare System Series E, average interest rate of 5.00%,


Partners HealthCare System Series F, average fixed interest rate of 4.99%,

variable interest rate of 0.31% and 0.63% at September 30, 2010 and 2009,

respectively, final maturity in 2040 390,156 395,751

Partners HealthCare System Series G, average fixed interest rate of 4.90%,

variable interest rate of 0.44% and 0.74% at September 30, 2010 and 2009,


Partners HealthCare System Series H, variable interest rate of 0.34% and


Partners HealthCare System Series I, average fixed interest rate of 4.73%,

variable interest rate of 0.23% and 0.28%, at September 30, 2010 and 2009,


Partners HealthCare System Series J, average interest rate of 4.98%,

final maturity in 2039 508,931 -

Partners HealthCare System Series P, variable interest rate of 0.24% and


Massachusetts General Hospital Series F, average interest rate of

6.25%, final maturity in 2012 - 26,407

Partners HealthCare System Series 2007 taxable bonds, average interest rate

of 6.26%, final maturity in 2037 100,000 100,000

Other obligations 6,787 -

Capital lease obligations 4,458 3,474

2,496,946 2,294,647

Less current portion 489,913 820,620

Less auction rate securities held 30,000 50,000

1,977,033$ 1,424,027$

September 30,

As of September 30, 2010 and 2009, Partners HealthCare was holding $30,000 and $50,000,respectively, of the Series F and Series G Revenue Bonds issued as auction rate securities (ARS).Although not legally extinguished, the bonds have been reflected as extinguished under generallyaccepted accounting principles.



27

Aggregate maturities and payments of long term obligations during the next five years andthereafter, and other amounts classified as current liabilities, are as follows:

Bonds Bonds

Supported by Supported by

Partners Standby BondScheduled HealthCare PurchaseMaturities Liquidity Agreements Total

2011 38,108$ 403,400$ 48,405$ 489,913$

2012 41,129 - - 41,129

2013 40,170 - - 40,170

2014 41,848 - - 41,8482015 39,380 - - 39,380

Thereafter 1,844,506 - - 1,844,506

2,045,141$ 403,400$ 48,405$ 2,496,946$

The scheduled maturities represent annual payments as required under debt repaymentschedules. The current portion of long-term obligations includes the payments scheduled to bemade in fiscal 2011 along with variable rate bonds supported by Partners HealthCare liquidity andvariable rate demand bonds (VRDBs) supported by standby bond purchase agreements withfinancial institutions that expire prior to September 30, 2011. The variable rate bonds supported byself liquidity provide the bondholder with an option to tender the bonds to Partners HealthCare.The VRDBs supported by standby bond purchase agreements provide the bondholder with anoption to tender the bonds to the liquidity provider. Generally accepted accounting principlesrequire bonds backed by standby bond purchase agreements expiring within one year of thebalance sheet date to be classified as a current liability.

The fair value of long-term obligations was $2,563,706 and $2,284,473 as of September 30, 2010and 2009, respectively. The carrying amount of the variable rate debt is a reasonable estimate ofits fair value. The fair value of the fixed rate debt is estimated based on quoted market prices forthe same or similar issues.

Interest expense approximates interest paid, net of capitalized interest, during the years endedSeptember 30, 2010 and 2009.

Massachusetts Health and Educational Facilities Authority (Authority) Revenue BondsIn January 2010, PHS issued Partners HealthCare System Series J Revenue Bonds of $499,410 infixed rate mode, plus bond premium of $9,768. The bond proceeds, net of issuance costs of$5,151, were used to finance certain capital projects totaling $249,904 and to refund a portion ofPartners HealthCare System Series A Revenue Bonds ($101,915) that were insured and issued asfixed rate bonds, a portion of Partners HealthCare System Series B Revenue Bonds ($77,033) thatwere issued as fixed rate bonds, and Partners HealthCare System Series G Revenue Bonds($75,175) that were insured and issued as ARS.



28

In May 2009, PHS issued Partners HealthCare System Series I Revenue Bonds of $225,000, plusbond premium of $4,977. The bond proceeds, net of issuance costs of $2,672, were used tofinance certain capital projects totaling $227,305. The Series I Bonds were issued in threesubseries, with $50,000 of VRDBs supported by self-liquidity, $50,000 of VRDBs supported by astandby bond purchase agreement, and $125,000 of fixed rate bonds. In addition, PartnersHealthCare terminated the insurance contract on the $150,000 Partners HealthCare System SeriesP Revenue Bonds and remarketed the bonds with new liquidity facilities.

As of September 30, 2010, approximately $18,440 of refunded revenue bonds, which areconsidered extinguished for accounting purposes, remain outstanding and will be fully redeemedby 2012.

Partners HealthCare Series 2007 taxable bonds and the Authority's Series A through J bonds andthe Series P loan to PHS (PHS Bonds) are unsecured general obligations of PHS supported byguarantees from BW/F, The Brigham and Women's Hospital, Inc. (BWH), MGH and the Generalwhich may be suspended under certain conditions.

PHS bond agreements contain certain covenants, including a minimum debt service coverage ratioand limitations on additional indebtedness and asset transfers.

Credit AgreementIn June 2009, Partners HealthCare terminated its $50,000 Revolving Line of Credit and enteredinto a $150,000 Credit Agreement (the "Agreement") with several banks that provides access tosame day funds. Advances under the Agreement bear a variable rate of interest based on theLondon Interbank Offered Rate (LIBOR). There were no amounts outstanding under theAgreement as of September 30, 2010. The Agreement expires in June 2012.

DerivativesPartners HealthCare uses derivative financial instruments principally to manage interest rate riskand has entered into derivatives to lock in fixed rates for anticipated issuances and refunding ofdebt. By using derivative financial instruments to manage the risk of changes in interest rates,Partners HealthCare exposes itself to credit risk and market risk. Credit risk is the failure of thecounterparty to perform under the terms of the derivative contracts. When the fair value of aderivative contract is positive, the counterparty has a liability to Partners HealthCare, which createscredit risk. Partners HealthCare minimizes its credit risk by entering into derivative agreementswith several counterparties and requiring the counterparty to post collateral for the benefit ofPartners HealthCare based on the credit rating of the counterparty and the fair value of thederivative contract. When the fair value of a derivative contract is negative, Partners HealthCarehas a liability to the counterparty and, therefore, it does not possess credit risk. PartnersHealthCare may be required to post collateral for the benefit of the counterparty. Market risk is theadverse effect on the value of a financial instrument that results from a change in interest rates.The market risk associated with interest rate changes is managed by establishing and monitoringparameters that limit the types and degree of market risk that may be undertaken.



29

Partners HealthCare maintains interest rate swap programs on certain of its variable rate revenuebonds. These bonds expose Partners HealthCare to variability in interest payments due tochanges in interest rates. Management believes that it is prudent to limit the variability of itsinterest payments. To meet this objective and to take advantage of low interest rates, PartnersHealthCare entered into various interest rate swap agreements to manage fluctuations in cashflows resulting from interest rate risk. These agreements involve the exchange of fixed ratepayments by Partners HealthCare for variable rate payments from several counterparties, basedon a percentage of LIBOR.

In April 2010, PHS terminated an $80,000 interest rate swap associated with the Series G-6 Bondsbecause the bond owner exercised an interest rate conversion option. Partners HealthCarereceived a termination payment of $4,096, and the interest rate on the Series G-6 Bonds wasconverted from the Securities Industry and Financial Markets Association index (SIFMA) plus 11basis points to SIFMA plus 88.25 basis points until June 2017.

The following is a summary of the outstanding positions under these interest rate swap agreementsat September 30, 2010:

Notional Maturity Date Rate

Bond Series Amount (July) Paid Rate Received Hedging Status

2003 D1,D2 150,000$ 2035 4.40% 67% 1-month LIBOR Nonhedging

2003 D5,D6 27,300 2015 5.11% 67% 6-month LIBOR Hedging

2005 F1,F2 150,000 2040 3.63% 67% 1-month LIBOR Nonhedging

2005 F3,F4 56,200 2025 5.11% 67% 6-month LIBOR Hedging

2007 G2 75,000 2042 3.46% 67% 1-month LIBOR Nonhedging

2008 H1 75,000 2042 3.46% 67% 1-month LIBOR Nonhedging

2009 I1,I2 100,000 2044 3.71% 67% 1-month LIBOR Hedging

2011 100,000 2046 3.74% 67% 1-month LIBOR Hedging




Partners HealthCare designates its interest rate swaps that are used to minimize the variability incash flows of interest-bearing liabilities or forecasted transactions caused by changes in interestrates as hedging instruments at the inception of each contract, with the intention of maintaininghedge accounting treatment over the term of the agreement. However, circumstances may arisewhereby the variability in cash flows exceeds the threshold for hedging qualification or the structureof the bonds is changed, resulting in de-designation of the hedge. Effective December 31, 2007,Partners HealthCare de-designated $450,000 of its interest rate swaps as they ceased to qualifyfor hedge accounting.

Hedging swaps are designated as cash flow hedges; accordingly, the change in fair value of theeffective portion of the hedge is reflected as a change in unrestricted net assets and the ineffectiveportion of the hedge is reflected as a component of nonoperating gains (expenses) in theconsolidated statements of operations. Nonhedging swaps are either swaps that have been de-designated as hedges or not designated as hedging instruments at the inception of the agreement;accordingly, the change in fair value is recorded as a component of nonoperating gains (expenses)in the consolidated statements of operations.



30

The fair value of interest rate swaps is as follows:

September 30,

Balance Sheet Location 2010 2009

Derivatives designated as hedging instrumentsInterest rate swaps liability 143,621$ 94,529$

Derivatives not designated as hedging instrumentsOther assets - 3,237Interest rate swaps liability 127,781 89,503

The effects of interest rate swaps on the consolidated statements of operations are as follows:

Amount of Gain (Loss) Amount of Gain (Loss)

Recognized in Recognized in Excess

Changes in Unrestricted of Revenues

Net Assets Over Expenses

Years Ended Years Ended

September 30, September 30,

Statement of Operations Location 2010 2009 2010 2009

Derivatives designated as hedging instruments

Change in fair value of hedging interest rate swaps (46,638)$ (46,844)$ -$ -$

Amortization of swaption premiums 1,486 1,484

Hedge ineffectiveness (3,939) 139

Derivatives not designated as hedging instruments

Change in fair value of nonhedging interest rate swaps (37,419) (39,760)

Reclassification of net asset balance upon hedge

de-designation 818 818 (818) (818)

(45,820)$ (46,026)$ (40,690)$ (38,955)$

Partners HealthCare's derivative contracts contain provisions that require collateral to be postedunder certain circumstances. The collateral thresholds reflect the current credit ratings issued bymajor credit rating agencies on Partners HealthCare's and the counterparty's debt. Declines inPartners HealthCare's or the counterparty's credit ratings would result in decreases in the collateralthresholds and consequently, the potential for additional collateral postings by Partners HealthCareor the counterparty. As of September 30, 2010 and 2009, the aggregate fair value of all derivativeinstruments was a net liability of $271,402 and $180,795, respectively, for which PartnersHealthCare had posted collateral of $48,948 and $10,730, respectively. Partners HealthCare hasestablished procedures to ensure that liquidity is available to meet collateral posting requirements.

Upon the occurrence of certain events of default or termination events identified in the derivativecontracts, either Partners HealthCare or the counterparty could terminate the contracts inaccordance with their terms. Termination results in the payment of a termination amount by oneparty that attempts to compensate the other party for its economic losses. If interest rates at thetime of termination are lower than those specified in the derivatives contract, Partners HealthCarewill make a payment to the counterparty. Conversely, if interest rates at such time are higher, thecounterparty will make a payment to Partners HealthCare.



31

Partners HealthCare also enters into foreign currency options and futures primarily as hedges onsecurities and indices. Forward contracts are used as currency hedges. These agreements arelimited in use and generally do not exceed one year.

8. Commitments

LeasesPartners HealthCare has capital and noncancelable operating leases for certain buildings andequipment. Minimum future lease commitments under noncancelable leases for the next five yearsand thereafter are as follows:

Capital OperatingLeases Leases

2011 1,510$ 166,318$2012 1,490 152,284

2013 980 143,756

2014 747 133,7792015 252 121,374Thereafter - 649,506

Total lease payments 4,979 1,367,017$

Less amount representing interest 521

Capital lease obligations at September 30, 2010 4,458$

Rental expense under operating leases approximated $209,785 in 2010 and $195,928 in 2009.

Construction ProjectsThe General is constructing a building (the Lunder Building) that will house a relocated andexpanded radiation oncology department, expanded emergency services, three levels of operatingand procedure suites, and 150 neurosciences and medical oncology intensive care and acute carebeds. In addition, space will be dedicated to a new sterile processing department and a centralreceiving dock. As of September 30, 2010, costs incurred in connection with the new buildingapproximated $390,887, with approximately $138,231 in outstanding construction contracts.Planning and construction began in November 2006 and the total project cost is expected to beapproximately $686,600, with occupancy scheduled for 2011.

In October 2005, PHS paid $4,750 in exchange for the development rights to certain parcels ofland in Charleston, Massachusetts (Yards End), the planned site of a new facility for SpauldingRehabilitation Hospital Corporation (Spaulding). Spaulding's share of the purchase price was$2,048. In November 2008, Spaulding received approval from PHS to proceed with final designand permitting for a 132-bed hospital at Yards End, and in November 2009, Spaulding receivedapproval from PHS to complete the project for a total cost estimated at $225,000. In July 2010Spaulding's DON for the new facility was approved by the Massachusetts Department of PublicHealth and ground breaking for the new facility was held in October 2010.



32

9. Pension and Postretirement Healthcare Benefit Plans

Substantially all employees of Partners HealthCare are covered under various noncontributorydefined benefit pension plans and various defined contribution pension plans. In addition, certainaffiliates provide subsidized healthcare benefits for retired employees on a self-insured basis, withthe benefit obligation being partially funded. These benefits are administered through an insurancecompany and are accounted for on the accrual basis, which includes an estimate of futurepayments for claims incurred.

In 2009, Partners HealthCare changed its defined benefit plans measurement date from June 30 toSeptember 30. This measurement date change resulted in an increase in liabilities of $17,754, adecrease in assets of $55,297 and a decrease in unrestricted net assets of $73,051.

Total expense for these plans consists of the following:

2010 2009

Defined benefit plans 151,573$ 116,339$Defined contribution plans 118,237 112,071

Postretirement healthcare benefit plans 7,852 6,710

277,662$ 235,120$

Years EndedSeptember 30,

Information regarding benefit obligations, plan assets, funded status, expected cash flows and netperiod benefit cost follows within this footnote.

Benefit Obligations

Defined Benefit Pension PlansChange in Benefit Obligations 2010 2009 2010 2009

Benefit obligations at beginning of year 2,819,575$ 2,218,756$ 87,880$ 72,040$

Service cost 162,594 104,999 3,879 2,573Interest cost 168,154 157,013 4,772 4,972Plan amendments (1,380) 32,374 - -Actuarial loss 42,947 645,313 3,671 11,888Benefits paid (185,167) (113,167) (4,144) (4,085)Expenses paid (7,382) (5,754) - -Employee contributions - - 5,209 4,514Adjustment for change inmeasurement date - (219,959) - (4,022)

Benefit obligations at end of year 2,999,341$ 2,819,575$ 101,267$ 87,880$

PostretirementHealthcare Benefit Plans



33

The accumulated benefit obligation for all defined benefit pension plans at the end of 2010 and2009 was $2,768,122 and $2,547,861, respectively.

Weighted-Average Assumptions Used to

Determine End of Year Benefit Obligation 2010 2009 2010 2009

Discount rate 5.50% 5.75% 4.00% - 5.50% 4.55% - 5.75%Rate of compensation increase

Professional staff 5.05% 6.02% N/A N/A

Other than professional staff 3.00 - 4.10% 5.00% - 5.10% N/A N/A

Healthcare cost trend rate for next year N/A N/A 8.00% 8.50%

Rate to which the cost trend rate is to decline N/A N/A 5.00% 5.00%

Year that rate reaches the ultimate trend rate N/A N/A 2017 2017

Defined Benefit Pension Plans Benefit Plans

Postretirement Healthcare

Assumed healthcare cost trend rates have a significant effect on the amounts reported for thehealthcare plans. A one-percentage-point change in assumed healthcare cost trend rates wouldhave the following effect:

Effect on postretirement benefit obligation 1,491$ (1,371)$

One-Percentage-Point One-Percentage-Point

Increase Decrease

Plan Assets

Change in Plan Assets 2010 2009 2010 2009

Fair value of plan assets at beginning

of year 2,052,797$ 2,291,426$ 20,479$ 16,176$

Actual return on plan assets 213,136 55,888 1,614 682

Employer contributions 188,613 98,234 4,144 3,566

Employee contributions - - 5,209 4,514

Benefits paid (185,167) (113,167) (4,144) (4,085)

Expenses paid (7,382) (5,754) - -

Adjustment for change in

measurement date - (273,830) - (374)

Fair value of plan assets at end of year 2,261,997$ 2,052,797$ 27,302$ 20,479$

Defined Benefit Pension Plans

Postretirement

Healthcare Benefit Plans

The assets of the defined benefit pension plans are aggregated in a single master trust (MasterTrust) and managed as one asset pool. The investment objective for the Master Trust is to achievethe highest reasonable total return after considering (i) plan liabilities, (ii) funding status andprojected cash flows, (iii) projected market returns, valuations and correlations for various assetclasses, and (iv) Partners HealthCare’s ability and willingness to incur market risk.



34

Oversight of the management of Partners HealthCare's investable assets, including the MasterTrust, is provided by the Investment Committee of the Board of Directors. The Committee seeks toadd incremental returns by manager selection and asset allocation (increasing/decreasingallocations within allowable ranges based on current and projected valuations). The Committee issupported by a professional staff, an outside investment consultant, and a pension actuarialconsultant.

Partners HealthCare utilizes a policy benchmark allocation that balances projected returns,correlations and volatility of various asset classes within the overall risk tolerance. The allocationsare actively managed based on relative valuations among and within asset classes and theperceived ability of managers to outperform passive benchmarks. Exposure by asset class is thesum of the net exposures reported by each manager. Asset performance is monitored monthly andthe portfolio is rebalanced if asset classes exceed explicit ranges.

The following table presents the policy benchmark allocation components (and allowable ranges)and the reported exposures of the Master Trust at September 30, 2010:

Policy ReportedBenchmarks Exposures

Domestic equity 22 % 20 %Foreign developed equity 23 % 21 %Emerging markets equity 7 % 10 %Private equity 8 % 8 %

Total equity (+/- 15%) 60 % 59 %Fixed income (+/- 10%) 20 % 23 %Inflation defensive (+/- 10%) 10 % 5 %Cash and other (+/- 10%) 10 % 13 %

100 % 100 %

Inflation defensive strategies include investments in real estate assets, commodities, timber andinflation protection bonds. Other exposures include currency and volatility based strategies.

Within the Master Trust, assets are allocated to managers with investment mandates that mayrange from a single sub-asset class to very broad mandates; with restrictions that range from long-only to unconstrained; and with management structures ranging from separately managed funds tomutual/commingled funds to private partnerships. Less market sensitive managers employabsolute return, long/short equity and diversified strategies, which in the aggregate are expected togenerate positive returns on a consistent basis. Investment risks (concentration, correlation,valuation, liquidity, leverage, mandate compliance, etc.) are measured at the manager level as wellas the pool level. The active risk of the Master Trust is determined by a statistical regression of themost recent two (2) year return series to that of the policy benchmark.



35

The following table presents the capital allocations by manager mandate within the Master Trust atSeptember 30, 2010. Some managers, particularly Real assets and Less market sensitivemanagers, invest allocated capital among multiple policy benchmark asset classes.

$ %

Traditional U.S. equity 288,142$ 13 %Traditional foreign developed equity 364,556 16 %Traditional emerging markets equity 203,951 9 %Private equity 131,721 6 %Real assets 217,880 10 %Less market sensitive managers 685,508 30 %Fixed income managers 370,239 16 %

2,261,997$ 100 %

Capital Allocations

The postretirement healthcare benefit plans assets are invested in mutual funds, with the objectiveof achieving returns to satisfy plan obligations, with a level of volatility commensurate with PartnersHealthCare's overall financial profile.

The following table presents plan assets, by form of ownership, as of September 30, 2010 and2009 measured at fair value on a recurring basis using the fair value hierarchy defined in Note 4:






Defined Benefit Pension PlansInvested cash equivalents 10,419$ 10,419$ -$ -$Separately managed investments 589,289 296,607 292,682 -

Mutual funds 133,238 133,238 - -


Private partnerships 1,329,892 - - 1,329,892

2,261,997 440,264 491,841 1,329,892

Postretirement Healthcare Benefit PlansMutual funds 27,302 24,020 3,282 -

Total plan assets 2,289,299$ 464,284$ 495,123$ 1,329,892$




36


Fair Value in Active Other Significantat Markets for Observable Unobservable

September 30, Identical Items Inputs Inputs2009 (Level 1) (Level 2) (Level 3)

Defined Benefit Pension PlansInvested cash equivalents 50,949$ 50,949$ -$ -$Separately managed investments 562,264 345,961 216,303 -

Mutual funds 169,287 169,287 - -Commingled funds 185,297 - 185,297 -Private partnerships 1,085,000 - - 1,085,000

2,052,797 566,197 401,600 1,085,000

Postretirement Healthcare Benefit Plans

Mutual funds 20,479 17,428 3,051 -

Total plan assets 2,073,276$ 583,625$ 404,651$ 1,085,000$


During the year ended September 30, 2010, the change in the fair value of the assets measuredusing significant unobservable inputs (Level 3) is comprised of the following:

Balance at beginning of year 1,085,000$

Total gains (losses)Dividends and interest 1,245

Realized gains (losses) 10,537Unrealized appreciation (depreciation) 108,302

Purchases and sales, net 124,808

Balance at end of year 1,329,892$



37

Funded StatusThe funded status of the plans recognized in the balance sheet and the amounts recognized inunrestricted net assets, follows:

End of Year 2010 2009 2010 2009

Fair value of plan assets at measurement date 2,261,997$ 2,052,797$ 27,302$ 20,479$

Benefit obligations at measurement date (2,999,341) (2,819,575) (101,267) (87,880)

Funded status (737,344)$ (766,778)$ (73,965)$ (67,401)$

Amounts recognized in the balance sheet

consist of

Current liabilities (3,904)$ (3,061)$ (3,575)$ (3,305)$

Long-term liabilities (733,440) (763,717) (70,390) (64,096)

(737,344)$ (766,778)$ (73,965)$ (67,401)$

Amounts not yet recognized in net periodic

benefit cost and included in unrestricted

net assets consist ofActuarial net loss (gain) 706,713$ 699,955$ 17,929$ 15,094$

Prior service cost (credit) 11,135 10,289 (82) (103)

717,848$ 710,244$ 17,847$ 14,991$

Amounts recognized in unrestricted net assets

consist ofCurrent year actuarial (gain) loss 23,066$ 765,517$ 3,579$ 12,324$

Amortization of actuarial gain (loss) (16,308) 6,768 (743) (301)

Current year prior service (credit) cost (1,380) 32,373 - -

Amortization of prior service credit (cost) 2,226 (37,964) 20 20

7,604$ 766,694$ 2,856$ 12,043$


Postretirement


At the end of 2010 and 2009, the projected benefit obligation, accumulated benefit obligation, andfair value of plan assets for pension plans with an accumulated benefit obligation in excess of planassets, were as follows:

Accumulated Benefit Obligation in Excess of Plan Assets 2010 2009

Projected benefit obligation 2,999,341$ 2,819,575$

Accumulated benefit obligation 2,768,122 2,547,861

Fair value of plan assets 2,261,997 2,052,797



38

Expected Cash FlowsInformation about the expected cash flows for the defined benefit and postretirement healthcarebenefit plans are as follows:

Defined

BenefitPension

Plans

Expected employer contributions

2011 175,319$ 4,804$

Medicare

Subsidy

Expected benefit payments (receipts)2011 111,381$ 5,124$ (320)$

2012 118,399 5,522 (313)2013 131,608 5,829 (303)

2014 145,643 6,190 (291)2015 158,140 6,527 (275)2016 and thereafter 1,024,153 30,717 (1,097)

PostretirementHealthcare Benefit Plans

Net Periodic Benefit Cost

2010 2009 2010 2009

Service cost 162,594$ 104,999$ 3,879$ 2,573$Interest cost 168,154 157,013 4,772 4,972

Expected return on plan assets (193,257) (176,869) (1,522) (1,116)Amortization of

Prior service cost (credit) (2,226) 37,964 (20) (20)

Actuarial net (gain) loss 16,308 (6,768) 743 301

Net periodic benefit cost 151,573$ 116,339$ 7,852$ 6,710$


Postretirement


Amounts expected to be amortized from unrestricted net assets into net periodic benefit cost duringthe year ending September 30, 2011, are as follows:

Actuarial net loss 22,574$ 904$

Prior service cost (credit) 1,285 (20)


Benefit PlansDefined Benefit Pension Plans



39

Weighted-Average Assumptions Used

to Determine Net Periodic Pension and

Postretirement Cost 2010 2009 2010 2009

Discount rate 5.75% 7.65% 4.55 - 5.75% 6.50% - 7.65%

Expected return on plan assets 8.25% 8.25% 7.50% 7.50%

Rate of compensation increase

Professional staff 6.02% 6.02% N/A N/A

Other than professional staff 5.00 - 5.10% 5.00% - 5.10% N/A N/A

Healthcare cost trend rate for this year N/A N/A 8.50% 9.00%

Rate to which the cost trend rate is to decline N/A N/A 5.00% 5.00%

Year that rate reaches the ultimate trend rate N/A N/A 2017 2017


Benefit PlansDefined Benefit Pension Plans

Partners HealthCare uses a long term return assumption which is validated annually by obtaininglong term asset return, volatility and correlation projections for relevant asset class indexes;modifying volatility and correlations to reflect the actual historical experience of the activemanagers; calculating the expected return using benchmark weights and indexes; and, comparingthe return assumption to the sum of the expected return and the historical outperformance of theactual return versus the benchmark. Partners HealthCare regularly monitors the active risk of theMaster Trust by a statistical regression of the return series of the actual portfolio to that of thepolicy benchmark.

Assumed healthcare cost trend rates have a significant effect on the amounts reported for thehealth care plans. A one-percentage-point change in assumed healthcare cost trend rates wouldhave the following effect:

Effect on service and interest cost 78$ (72)$

One-Percentage-Point One-Percentage-Point

Increase Decrease

10. Professional Liability Insurance

Partners HealthCare insures substantially all of its professional and general liability risk on aclaims-made basis in cooperation with other organizations in the Greater Boston area through acaptive insurance company, Controlled Risk Insurance Company Ltd. (CRICO). The policy coversclaims made during its term, but not those occurrences for which claims may be made afterexpiration of the policy, except for certain tail liabilities which CRICO has assumed on anoccurrence basis through December 31, 2010. Management intends to renew its coverage on aclaims-made basis and has no reason to believe that it will be prevented from such renewal.

PHS owns 10% of CRICO. The investment is accounted for on the cost basis of accounting. Inaddition, Partners HealthCare follows the accounting policy of establishing reserves to cover allprofessional liability claims incurred but not reported to the insurance company as of the end of theyear (tail liability), excluding the tail liability assumed by CRICO. These reserves have beenestimated by consulting actuaries on a discounted basis using an interest rate of 4.75% and 5.75%at September 30, 2010 and 2009, respectively.



40

Management is not aware of any claims against Partners HealthCare or factors affecting CRICOthat would cause the expense for professional liability risks to vary materially from the amountprovided.

11. Concentration of Credit Risk

Financial instruments that potentially subject Partners HealthCare to concentration of credit riskconsist of patient accounts receivable, research grants receivable, pledges receivable, certaininvestments and interest rate swaps.

Partners HealthCare receives a significant portion of its payments for services rendered from alimited number of government and commercial third-party payers, including Medicare, Medicaid,Blue Cross and Blue Shield of Massachusetts, Harvard Pilgrim Health Care and Tufts Health Plan.Research funding is provided through many government and private sponsors. Pledges receivableare due from multiple donors. Partners HealthCare assesses the credit risk for pledges based onhistory and the financial wherewithal of donors, most of which are individuals or organizations wellknown to Partners HealthCare.

Investments, which include government and agency securities, stocks and corporate bonds, andprivate partnerships and other investments are not concentrated in any corporation or industry orwith any single counterparty. Alternative investments are less liquid than Partners HealthCare'sother investments. The reported values of the alternative investments may differ significantly fromthe values that would have been used had a ready market for those securities existed. Theseinstruments may contain elements of both credit and market risk. Such risks include, but are notlimited to, limited liquidity, absence of oversight, dependence upon key individuals, emphasis onspeculative investments, and nondisclosure of portfolio composition.

12. Restricted Net Assets

Restricted net assets are available for the following purposes:

2010 2009

Temporarily restrictedCharity care 100,626$ 99,850$Buildings and equipment 191,370 220,773

Clinical care, research and academic 532,430 509,305

824,426$ 829,928$

Permanently restrictedCharity care 19,134$ 19,042$Buildings and equipment 2,433 2,433Clinical care, research and academic 289,324 277,419

310,891$ 298,894$

September 30,



41

EndowmentPartners HealthCare's endowment consists of over 1,000 individual funds established for a varietyof purposes. The endowment includes both donor-restricted endowment funds and fundsdesignated by the boards to function as endowments. As required by generally acceptedaccounting principles, net assets associated with endowment funds, including funds designated bythe boards to function as endowments, are classified and reported as restricted or unrestrictedbased on the existence or absence of donor-imposed restrictions.

Partners HealthCare has interpreted UPMIFA as requiring the preservation of the value of theoriginal gift of the donor-restricted endowment funds absent explicit donor stipulations to thecontrary. As a result of this interpretation, Partners HealthCare classifies as permanently restrictednet assets (a) the original value of gifts donated to the permanent endowment, (b) the original valueof subsequent gifts donated to the permanent endowment, and (c) accumulations to the permanentendowment made in accordance with the direction of the applicable donor gift instrument at thetime the accumulation is added to the fund. The remaining portion of the donor-restrictedendowment that is not classified in permanently restricted net assets is classified as temporarilyrestricted net assets until those amounts are appropriated for expenditure by Partners HealthCarein a manner consistent with the standard of prudence prescribed by UPMIFA. In accordance withUPMIFA, Partners HealthCare considers several factors in making a determination to appropriateor accumulate donor-restricted endowment funds. These factors include: the duration andpreservation of the fund; the purposes of the organization and the donor-restricted endowmentfund; general economic conditions; the possible effect of inflation and deflation; the expected totalreturn from income and the appreciation of investments; other resources of the organization; andthe investment policies of the organization.

Endowment Funds with DeficitsFrom time to time, the value of assets associated with individual donor-restricted endowment fundsmay fall below the value of the initial and subsequent donor gift amounts. When such endowmentdeficits exist, they are classified as a reduction to unrestricted net assets. Deficits of this naturereported in unrestricted net assets were $1,699 and $3,328 at September 30, 2010 and 2009,respectively. These deficits resulted from unfavorable market fluctuations that occurred after theinvestment of new permanently restricted contributions or subsequent endowment additions.

The following presents the endowment net asset composition by type of fund as ofSeptember 30, 2010 and 2009 and the changes in endowment assets for the years endedSeptember 30, 2010 and 2009:

Endowment Net Asset

Composition by Type of Fund as of Temporarily Permanently

September 30, 2010 Unrestricted Restricted Restricted Total

Donor-restricted endowment funds (1,699)$ 431,757$ 298,168$ 728,226$

Board-designated endowment funds 807,179 - - 807,179

Total funds 805,480$ 431,757$ 298,168$ 1,535,405$



42

Changes in Endowment Net Assets

for the Year Ended Temporarily Permanently


Endowment net assets atSeptember 30, 2009 715,764$ 423,331$ 286,522$ 1,425,617$

Investment return

Investment income 4,746 3,903 15 8,664

Net realized and unrealized

appreciation (depreciation) 69,830 37,631 270 107,731

Total investment return 74,576 41,534 285 116,395

Contributions 3,869 - 14,910 18,779

Appropriation of endowment assets

for expenditure (31,071) (33,199) - (64,270)

Other changes 42,342 91 (3,549) 38,884

Total changes 89,716 8,426 11,646 109,788


Endowment Net Asset

Composition by Type of Fund as of Temporarily Permanently


Donor-restricted endowment funds (3,328)$ 423,331$ 286,522$ 706,525$

Board-designated endowment funds 719,092 - - 719,092

Total funds 715,764$ 423,331$ 286,522$ 1,425,617$

Changes in Endowment Net Assetsfor the Year Ended Temporarily Permanently


Endowment net assets atOctober 1, 2008 742,835$ 450,791$ 286,917$ 1,480,543$

Investment return

Investment income 4,290 3,578 29 7,897

Net realized and unrealized

appreciation (depreciation) 1,362 3,069 (129) 4,302

Total investment return 5,652 6,647 (100) 12,199

Contributions 4,470 - 8,289 12,759

Appropriation of endowment assets

for expenditure (34,304) (34,013) - (68,317)

Other changes (2,889) (94) (8,584) (11,567)

Total changes (27,071) (27,460) (395) (54,926)




43

Conditional PledgeDuring 2009, the General signed an agreement (Ragon Agreement) with The MassachusettsInstitute of Technology (MIT), The President and Fellows of Harvard College (Harvard), and ThePhillip and Susan Ragon Foundation (Ragon Foundation), to establish the Phillip T. and Susan M.Ragon Institute (Ragon Institute) as a joint research center of the General, MIT and Harvard withthe purpose of harnessing the potential of the immune response to combat and conquer humandiseases, integrating biomedical research with emerging engineering technologies (with the maininitial focus being the development of an AIDS vaccine), and educating and training scientists. TheRagon Foundation committed to provide funding for the Ragon Institute of $100,000 over ten yearsthrough the General (as the administrative home for the Ragon Institute), beginning retroactively onJanuary 1, 2008. The Ragon Foundation has the ability to slow, suspend, or eliminate fundingbased on restrictions described in the Ragon Agreement. Additionally, any funding not paid byDecember 31, 2017 will no longer be due by the Ragon Foundation. Due to the conditions withinthe Agreement, funding is recognized when received, with no pledge receivable recorded for thebalance of the commitment.

Through September 30, 2010, total funding of $34,000 was received, with $10,000 received for theyear ended September 30, 2010, and total net expenses of $18,995 were incurred, including$9,254 for the year ended September 30, 2010. As of September 30, 2010, unspent funding of$15,005 has been recorded as temporarily restricted net assets, to be released to unrestricted netassets after qualifying expenses have been incurred.

13. Functional Expenses

Total operating expenses by function are as follows:

2010 2009

Healthcare services 5,797,672$ 5,478,895$Research and academic 1,370,372 1,254,481General and administrative 762,587 717,035

7,930,631$ 7,450,411$

Years Ended

September 30,

14. Contingencies

Partners HealthCare is subject to complaints, claims and litigation which have risen in the normalcourse of business. In addition, Partners HealthCare is subject to reviews by various federal andstate government agencies to assure compliance with applicable laws, some of which are subjectto different interpretations. Recently, governmental review of compliance by healthcare institutions,including Partners HealthCare, has increased.



44

15. Subsequent Events

Partners HealthCare has assessed the impact of subsequent events through December 10, 2010,the date the audited financial statements were issued, and has concluded that there were no suchevents that require adjustment to the audited financial statements or disclosure in the notes to theaudited financial statements.

Partners HealthCare System, Inc. and AffiliatesSchedule of Expenditures of Federal Awards

Year Ended September 30, 2010

RESEARCH AND DEVELOPMENT DIRECT PROGRAM CLUSTER

CFDA Agency/Program CFDA # BWH MGH McLean Other Total

Department of Agriculture

Distance Learning and Telemedicine Loans and Grants 10.855 (27,210)$ -$ -$ -$ (27,210)$

Subtotal - Department of Agriculture (27,210) - - - (27,210)

Department of Defense

Air Force Defense Research Sciences Program 12.800 177,130 177,130

Basic and Applied Scientific Research 12.300 67,286 478,150 545,436

Basic Scientific Research 12.431 477,756 477,756

Basic, Applied, and Advanced Research in Science and 12.630 738,729 738,729

Engineering

Military Medical Research and Development 12.420 4,904,471 13,029,726 266,966 18,201,163

Research and Technology Development 12.910 354,628 354,628

Subtotal - Department of Defense 4,971,757 15,256,119 266,966 - 20,494,842

Department of Education

National Institute on Disability and Rehabilitation Research 84.133 (14,509) (14,509)

Subtotal - Department of Education - - - (14,509) (14,509)

Department of Health and Human Services

Academic Research Enhancement Award 93.390 272,019 (21,516) 250,503

Advancing System Improvements to Support Targets for Healthy 93.088 505,839 505,839

People 2010

Aging Research 93.866 13,781,412 10,989,597 (236,065) 865,707 25,400,651

Alcohol Research Programs 93.273 161,102 497,266 710,367 1,368,735

Allergy, Immunology and Transplantation Research 93.855 22,547,466 40,668,317 63,215,783

Arthritis, Musculoskeletal and Skin Diseases Research 93.846 8,868,745 5,482,530 127,242 14,478,517

Assistance for Torture Victims 93.604 391,397 391,397

Biological Basis Research in the Neurosciences 93.854 (215) (215)

Biomedical Research and Research Training 93.859 10,024,147 22,768,405 439,887 33,232,439

Biomedical Research Technology 93.371 64,151 64,151

Blood Diseases and Resources Research 93.839 3,440,989 5,421,765 8,862,754

Cancer Biology Research 93.396 6,276,162 8,559,179 14,835,341

Cancer Cause and Prevention Research 93.393 20,183,648 3,650,446 23,834,094

Cancer Centers Support Grants 93.397 3,952,592 519,526 4,472,118

Cancer Control 93.399 1,321,963 379,767 1,701,730

Cancer Detection and Diagnosis Research 93.394 6,130,417 6,404,830 12,535,247

Cancer Research Manpower 93.398 310,566 706,477 1,017,043

Cancer Treatment Research 93.395 1,605,195 15,979,112 17,584,307

Cardiovascular Diseases Research 93.837 33,978,319 16,841,923 273,752 51,093,994

Center for Medical Rehabilitation Research 93.929 147,266 147,266

Centers for Disease Control and Prevention Investigations and 93.283 3,143,972 3,143,972

Technical Assistance

Child Health and Human Development Extramural Research 93.865 2,417,241 6,658,531 (78,706) 8,997,066

Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 15,217,566 23,692,216 38,909,782

Digestive Diseases and Nutrition Research 93.848 (25,773) 5,304,911 5,279,138

Discovery and Applied Research for Technological Innovations 93.286 6,783,807 8,612,163 15,395,970

to Improve Human Health

Drug Abuse and Addiction Research Programs 93.279 118,209 6,021,113 5,296,634 11,435,956

Drug-Free Communities Support Program Grants 93.276 11,887 11,887

Environmental Health 93.113 4,070,172 87,800 4,157,972

Extramural Research Programs in the Neurosciences and 93.853 12,038,111 41,352,064 2,069,363 55,459,538

Neurological Disorders

Fogarty International Research Collaboration Award 93.934 687 687

Food and Drug Administration Research 93.103 239,316 239,316

General Clinical Research Centers 93.333 (2,211) (2,211)

Head Start 93.600 10,925 10,925

HIV Demonstration, Research, Public and Professional 93.941 704 704

Education Projects

Human Genome Research 93.172 1,701,961 254,386 1,956,347

International Research and Research Training 93.989 48,367 48,367

Kidney Diseases, Urology and Hematology Research 93.849 810,304 2,246,882 3,057,186

Lung Diseases Research 93.838 25,337,845 3,790,898 29,128,743

Maternal and Child Health Federal Consolidated Programs 93.110 3,739,556 3,739,556

Medical Library Assistance 93.879 3,703,004 95,800 3,798,804

Mental Health Research Grants 93.242 6,068,246 24,236,436 10,021,385 40,326,067

Microbiology and Infectious Diseases Research 93.856 (383) 17,286 16,903

National Center for Research Resources 93.389 10,232,301 6,002,645 16,234,946

National Center on Sleep Disorders Research 93.233 2,462,367 2,462,367

National Institutes of Health Contracts 93. 5,240,166 4,957,306 892,372 11,089,844

Nursing Research 93.361 442,874 442,874

Occupational Safety and Health Program 93.262 743,365 743,365

Oral Diseases and Disorders Research 93.121 5,302,138 1,033,153 6,335,291

Population Research 93.864 548,606 1,775,872 2,324,478

The accompanying notes are an integral part of the schedule of expenditures of federal awards.

45



RESEARCH AND DEVELOPMENT DIRECT PROGRAM CLUSTER


Refugee and Entrant Assistance Wilson/Fish Program 93.583 (82,389) (82,389)

Research and Training in Complementary and Alternative 93.213 673,930 3,245,141 142,020 4,061,091

Medicine

Research on Healthcare Costs, Quality and Outcomes 93.226 2,401,254 896,935 3,298,189

Research Related to Deafness and Communication Disorders 93.173 325,795 1,233,382 (42,122) 1,517,055

Research, Treatment and Education Programs on Lyme 93.942 (4,310) (4,310)

Disease in the United States

Substance Abuse and Mental Health Services Projects of 93.243 15,409 15,409

Regional and National Significance

Trans-NIH Recovery Act Research Support 93.701 38,652,990 39,319,956 3,864,402 139,135 81,976,483

Trans-NIH Research Support 93.310 1,107,552 4,392,236 5,499,788

Vision Research 93.867 2,996,407 1,577,813 4,574,220

Subtotal - Department of Health and Human Services 282,396,657 333,563,774 23,079,537 1,553,102 640,593,070

Department of Homeland Security

Assistance to Firefighters Grant 97.044 639,605 639,605

Aviation Research Grants 97.069 34,776 34,776

Subtotal - Department of Homeland Security 674,381 - - - 674,381

Department of Justice

Drug-Free Communities Support Program Grants 16.729 166 166

Subtotal - Department of Justice - 166 - - 166

Department of Transportation

Aviation Research Grants 20.108 (3,230) (3,230)

Subtotal - Department of Transportation (3,230) - - - (3,230)

Department of Veterans Affairs

Veterans Rehabilitation Alcohol and Drug Dependence 64.019 732,627 51,587 784,214

Subtotal - Department of Veterans Affairs 732,627 51,587 - - 784,214

National Aeronautics and Space Administration

Aerospace Education Services Program 43.001 383,361 501,966 885,327

Subtotal - National Aeronautics and Space Administration 383,361 501,966 - - 885,327

National Science Foundation

Biological Sciences 47.074 458,846 458,846

Education and Human Resources 47.076 174,511 122,460 296,971

Engineering Grants 47.041 131,627 12,999 144,626

Geosciences 47.050 9,432 9,432

Mathematical and Physical Sciences 47.049 38,924 38,924

Social, Behavioral, and Economic Sciences 47.075 328,882 328,882

Trans-NSF Recovery Act Research Support 47.082 86,024 482,092 568,116

Subtotal - National Science Foundation 86,024 1,624,314 122,460 12,999 1,845,797

U.S. Department of State

Academic Exchange Programs - Graduate Students 19.400 279,955 214,008 493,963

Middle East Partnership Initiative (MEPI) 19.500 1,871 1,871

Subtotal - U.S. Department of State 281,826 214,008 - - 495,834

Total Research and Development Direct

Program Cluster 289,496,193$ 351,211,934$ 23,468,963$ 1,551,592$ 665,728,682$

RESEARCH AND DEVELOPMENT CONSTRUCTION PROGRAM CLUSTER


Trans-NIH Recovery Act Research Support 93.701 172,801$ 172,801$

Subtotal - Department of Health and Human Services 172,801 - - - 172,801Total Research and Development Construction

Program Cluster 172,801$ - - - 172,801$


46



RESEARCH AND DEVELOPMENT PASSED THROUGH OTHER ORGANIZATIONS

CFDA Agency/Program Pass-Through Sponsor CFDA # Pass-Through Number BWH MGH McLean Other Total

Department of Commerce

Advanced Technology Program Anima Cell Metrology 11.612 70NANB7H7011 -$ 12,943$ -$ -$ 12,943$

Subtotal - Department of Commerce - 12,943 - - 12,943


Air Force Defense Research Sciences Program Luna Innovations 12.800 FA9550-07-C-0091 (198) (198)

Basic and Applied Scientific Research Johns Hopkins University 12.300 2000869430 39,516 39,516

Basic, Applied, and Advanced Research in Science and Boston University 12.630 W911NF-06-2-0040 37,545 37,545

Engineering Massachusetts Institute of Technology 12.630 FA95500710101 34,683 34,683

Military Medical Research and Development AdMeTech 12.420 DAMD17-03-2-0055 27,338 27,338

AdMeTech 12.420 W81XWH-09-1-0552 28,541 28,541

Beth Israel Deaconess Medical Center 12.420 W81XWH-09-1-0695 23,848 23,848

Boston Medical Center 12.420 W81XWH-06-1-0309 131,262 131,262

Brigham and Women's Hospital 12.420 W81XWH-08-2-0159 88,844 88,844

Brigham and Women's Hospital 12.420 W81XWH-09-2-0003 1,788 1,788

Children's Hospital Medical Center, Cincinnati 12.420 W81XWH-04-1-0273 2,488 2,488

Children's Hospital Medical Center, Cincinnati 12.420 W81XWH-09-1-0135 21,236 21,236

Children's Hospital of Boston 12.420 W81XWH-09-2-0001 5,538 5,538

CIMIT 12.420 DAMD1702-2-0006 3,718 3,718

CIMIT 12.420 DAMD17-02-2-0006 472,052 472,052

CIMIT 12.420 W81XWH-07-2-0011 187,957 104,268 292,225

CIMIT 12.420 W81XWH-08-2-0126 213,991 213,991

CIMIT 12.420 W81XWH-09-2-0001 489,667 489,667

CIMIT 12.420 W81XWH-09-2-001 7,267 7,267

CIMIT 12.420 1,557 1,557

CIMIT 12.420 DAMD17-02-2-0006 501,275 501,275

CIMIT 12.420 W81XWH-07-2-0011 (122,215) (122,215)

CIMIT 12.420 W81XWH-09-2-0001 74,891 74,891

CIMIT 12.420 101,603 101,603

Dana Farber Cancer Institute 12.420 W81XWH-06-1-0261 (2,307) (2,307)

Dana Farber Cancer Institute 12.420 W81XWH-09-1-0150 89,422 89,422

Emory University 12.420 DAMD17-03-2-0033 729 729

GlaxoSmithKline 12.420 W81XWH-08-1-0322 198,452 198,452

HemCon 12.420 60,709 60,709

House Ear Institute 12.420 HEIp.o.108005/DAMD17 (23,708) (23,708)

Mass General Hospital-CIMIT 12.420 CIMIT-DAMD17-02-2-00 (886) (886)

Mass General Hospital-CIMIT 12.420 DAMD170220006 (602) (602)

Mass General Hospital-CIMIT 12.420 DAMD17-02-2-0006 (656) (656)

Mass General Hospital-CIMIT 12.420 W81XWH-07-2-0011 156 156

Mass General Hospital-CIMIT 12.420 3,947 3,947

Massachusetts General Hospital 12.420 W81XWH-07-2-0011 (37,002) (37,002)

Massachusetts General Hospital 12.420 W81XWH-07-2-0011 (567) (567)

Simbex, LLC 12.420 W81XWH-06-C-0392 (36,851) (36,851)

Spaulding Rehabilitation Hospital 12.420 PT074968/W81XWH-08-2 75,985 75,985

Spaulding Rehabilitation Hospital 12.420 W81XWH-08-2-0159 76,049 76,049

The Michael Stern Parkinson's Research Fund 12.420 W81XWH-05-1-0555 1,118,316 1,118,316

U.S. Army Medical Research Acquisition 12.420 W81XWH-09-1-0705 199,748 199,748

U.S. Army Medical Research Acquisition 12.420 W81XWH-07-2-0011 45,541 45,541

University of Alabama, Birmingham 12.420 DAMD17-98-1-8611 (20,100) (20,100)

University of California at San Diego 12.420 W81XWH-08-2-0159 291,211 262,859 554,070

University of California at San Francisco 12.420 NF04IIRA (527) (527)

University of California at San Francisco 12.420 W81XWH-05-1-0265 11 11

University of North Carolina, Chapel Hill 12.420 DAMD17-03-2-0052 38,886 38,886

University of Pittsburgh 12.420 W81XWH-07-1-0716 631 631

University of Rochester 12.420 W81XWH-07-1-0007 269,625 269,625

University of Rochester 12.420 W81XWH-07-1-0626 (2,193) (2,193)

Military Medical Research and Development University of Texas, MD Anderson Cancer 12.420 W81XWH-10-1-0001 01 51,896 51,896

Subtotal - Department of Defense 2,085,898 1,386,565 1,332,307 332,464 5,137,234


47





Department of Education

National Institute on Disability and Rehabilitation Research Carolinas Medical Center 84.133 H133A080035 84,069 84,069

Craig Hospital 84.133 H133A060038 8,147 8,147

JFK Johnson Rehabilitation Institute 84.133 H133A070030 18,254 18,254

Oregon Health & Science University (OHSU) 84.133 11,024 11,024

Subtotal - Department of Education - 11,024 - 110,470 121,494

Department of Energy

Office of Science Financial Assistance Program Harvard Medical School 81.049 DE-FG02-02ER63445 450 450

The MIND Institute 81.049 DE-FG02.07ER64415 4 4

The MIND Institute 81.049 (32,953) (32,953)

Subtotal - Department of Energy 450 (32,949) - - (32,499)


Aging Research Bedford VA Research Corp., Inc. (BRCI) 93.866 R01-AG020654-05 (130,782) (130,782)

Boston University 93.866 1R01AG031896-01A2 80,102 80,102

Boston University 93.866 5R01AG009661-15 533 533

Brigham and Women's Hospital 93.866 2P01AG015379-12 421,471 421,471

Brigham and Women's Hospital 93.866 5P01AG015379-10 (113,402) (113,402)

Brigham and Women's Hospital 93.866 5P01AG015379-12 667,060 667,060

Brigham and Women's Hospital 93.866 5R01AG027435-04 689,340 689,340

Broad Institute 93.866 1R01AG036042-01 12,249 12,249

Broad Institute 93.866 1RO1AG030146-01 2,450 2,450

Burnham Institute 93.866 1R21AG032044-01A2 10,532 10,532

CIMIT 93.866 1U01AG032699-01 91,618 91,618

CIMIT 93.866 1U01AG032700-02 48,858 48,858

CIMIT 93.866 2P50AG005134-27 104,487 104,487

CIMIT 93.866 3R01AG032349-02S1 35,941 35,941

Columbia University 93.866 1R01AG034189-01A1 11,135 11,135

Columbia University 93.866 5P01AG023028-03 (50,664) (50,664)

Columbia University 93.866 5R01AG007370-20 289,561 289,561

Fred Hutchinson Cancer Research Center 93.866 5U01AG032699-02 133,530 133,530

Harvard Medical School 93.866 2T32AG00222-16 (4,285) (4,285)

Harvard School of Public Health 93.866 2U01AG027669-04 300,876 300,876

Harvard School of Public Health 93.866 5P30AG024409-03 (119) (119)

Harvard School of Public Health 93.866 5R21AG030632-02 37,420 37,420

Hebrew Rehabilitation Center for Aged 93.866 1P01AG031720-01A2 18,902 18,902

Hebrew Rehabilitation Center for Aged 93.866 5P01AG004390-24 (98,374) (98,374)

Hebrew Rehabilitation Center for Aged 93.866 5P01AG004390-25 12,275 12,275

Hebrew Rehabilitation Center for Aged 93.866 5P01AG04390-24 (31,005) (31,005)

Mass General Hospital-CIMIT 93.866 5P01AG004953-23 27,179 27,179

Mass General Hospital-CIMIT 93.866 5P50AG005134-25 (1,119) (1,119)

Massachusetts Institute of Technology 93.866 5R01AG029601-03 10,576 10,576

National Bureau of Economic Research 93.866 P01 AG031098 158,071 158,071

NCIRE- 93.866 5U54AG024904-05 187,882 187,882

Northwestern University 93.866 1R21AG027471-02 4,199 4,199

President and Fellows of Harvard College 93.866 5P01AG032952-02 89,328 89,328

Research Foundation for Mental Hygiene 93.866 5P01AG017617-05 (54,773) (54,773)

Research Foundation for Mental Hygiene 93.866 5P01AG017617-10 33,685 33,685

Research Foundation for Mental Hygiene 93.866 5R01AG016381 (1,647) (1,647)

Research Foundation for Mental Hygiene 93.866 5R01AG016381-08 35,213 35,213

Rush University Medical Center 93.866 1R01AG030146-03 75,339 75,339



Spaulding Rehabilitation Hospital 93.866 1R01AG032052-01A2 49,632 49,632

Tufts University 93.866 R01-AG033016 58,450 58,450

Tufts University School of Medicine 93.866 5R01AG018844-08 81,329 81,329

University of California at San Diego 93.866 2R01AG022381-07 81,317 81,317

University of California at San Diego 93.866 5U01AG010483-19 2,782 2,782

University of California at San Diego 93.866 U01AG024904 45,881 45,881

University of California at San Diego 93.866 U01AG10483 32,897 32,897

University of California at Santa Barbara 93.866 5U01AG033931-04 (146,560) (146,560)


48





Aging Research University of Connecticut Health Center 93.866 5R01AG022092-05 10,144 10,144

University of North Carolina, Chapel Hill 93.866 7R01AG023178-05 162,807 162,807

University of Pennsylvania 93.866 1U01AG032984-01 27,136 27,136

University of Pittsburgh 93.866 1R01AG026463-04 6,927 6,927

University of Washington - Seattle 93.866 5U01AG016976-10 (31,165) (31,165)

University of Washington - Seattle 93.866 5U01AG016976-12 37,700 37,700

University of Wisconsin 93.866 1R01AG029624-01 29,524 29,524

Washington University 93.866 5U01AG032438-03 16,297 16,297

AIDS Education and Training Centers University of Massachusetts at Worcester 93.145 6H4AHA00050-08 00 14,670 14,670

Alcohol Research Programs Boston University 93.273 5R01AA007112-22 119,590 119,590

Boston University 93.273 5R37AA007112-18 9,649 9,649

Brigham and Women's Hospital 93.273 5RO1AAO16318-03 9,089 9,089

Natural Pharmacia International 93.273 2R44AA015220-03 6,887 6,887

Natural Pharmacia International, Inc. 93.273 5R44AA015220-05 343,974 343,974

Research Triangle Institute International 93.273 5R01AA012788-07 737 737

Trustees of Boston University 93.273 2R01AA007112-23 133,201 133,201

Wake Forest University 93.273 5R01AA016748-03 131,713 131,713

Allergy, Immunology and Transplantation Research AmberGen, Inc. 93.855 2R44AI052525-03-A1 34,971 34,971

Avid Therapeutics, Inc. 93.855 IR43AI084295-01 21,363 21,363

Beth Israel Deaconess Medical Center 93.855 5U01AI069412-04 613,070 613,070



BioScale, Inc. 93.855 5R44AI067050-04 145,794 145,794

Boston Biomedical Research Institute 93.855 1R01AI087452-01 81,766 81,766

Brigham and Women's Hospital 93.855 2U01AI063623-06 181,415 181,415

Brigham and Women's Hospital 93.855 5U01AI063623-05 (17,558) (17,558)



Broad Institute 93.855 5U01AI074575-02 389,505 389,505

Center for Blood Research, Inc. 93.855 5P01AI052343-04 (25,901) (25,901)

Children's Hospital of Boston 93.855 1 U01 AI077816-02 18,497 18,497

Children's Hospital of Boston 93.855 1 U01 AI077816-03 63,328 63,328

Children's Hospital of Boston 93.855 1U01AI077816-01 (10,460) (10,460)

Children's Hospital of Boston 93.855 5 R01 AI037901-12 18,809 18,809

Children's Hospital of Boston 93.855 5R01AI037691-15 4,074 4,074


Children's Hospital of Boston 93.855 5U01AI077816-02 1,467 1,467

Children's Hospital of Boston 93.855 U01AI055801-03 (3,228) (3,228)

CIMIT 93.855 4R37A1042006-14 8,827 8,827

CIMIT 93.855 5R01AI058736-07 44,727 44,727

Cornell University 93.855 5P50MH058911-10 (19,769) (19,769)

Dana Farber Cancer Institute 93.855 3U19AI057330-05S1 6,242 6,242

Dana Farber Cancer Institute 93.855 5 P01 AI029530-13 6 6

Dana Farber Cancer Institute 93.855 5P01AI045757-08 (69,412) (69,412)

Dana Farber Cancer Institute 93.855 5P01AI045757-11 748,117 748,117

Dana Farber Cancer Institute 93.855 5U19AI029530-18 5,481 5,481

Dana Farber Cancer Institute 93.855 5U19AI067751-05 325,699 325,699

Dartmouth Medical School 93.855 2P01AG019783-08 13,959 13,959

Duke University 93.855 5 U19AI067854-05 42,361 42,361

Duke University 93.855 5U19AI067854-05 14,208 374,486 388,694

Duke University Medical Center 93.855 2U19AI056363-06 32,268 32,268

Emory University 93.855 5P01AI080192-02 540,017 540,017

Emory University 93.855 5U19 A1051731-07 264,777 264,777

Emory University 93.855 5U19AI051731-08 155,113 155,113

Emory University 93.855 S372451 129,824 129,824

Feinstein Institute for Medical Research 93.855 7U19AI056362-06 (55,320) 113,911 58,591

Feinstein Institute for Medical Research 93.855 U19 AI056362 4,167 4,167

Fred Hutchinson Cancer Research Center 93.855 5 U01 AI068614-02 1,910 1,910

Fred Hutchinson Cancer Research Center 93.855 5 U01 AI068614-03 (148,313) (148,313)

Fred Hutchinson Cancer Research Center 93.855 5 U01AI068614-02 188,684 188,684

Fred Hutchinson Cancer Research Center 93.855 5U01AI068614-05 171,312 171,312

Fred Hutchinson Cancer Research Center 93.855 5U01AI68614-05 762,235 762,235

Harvard Medical School 93.855 1P01AI078897-03 446,508 446,508


49





Allergy, Immunology and Transplantation Research Harvard Medical School 93.855 2P01AI054904-06A1 261,946 261,946

Harvard Medical School 93.855 2P01AI056299-06A1 221,794 221,794

Harvard Medical School 93.855 2U54AI057158-06 58,071 58,071



Harvard Medical School 93.855 2U54Al057159-07 320,384 320,384

Harvard Medical School 93.855 3U54AI057159-05S1 (63,611) (63,611)

Harvard Medical School 93.855 5P01AI056299-04 (19,950) (19,950)


Harvard Medical School 93.855 5P30 AI060354 04 (42,188) (42,188)

Harvard Medical School 93.855 5P30AI060354 - 05 31,634 31,634


Harvard Medical School 93.855 5P30AI060354-05 (78,071) (2,911) (80,982)


Harvard Medical School 93.855 5U01AI069412-02 (222,756) (222,756)

Harvard Medical School 93.855 5U54AI057159-05 (17,096) (22,088) (39,184)

Harvard Medical School 93.855 U54AI057159-05S1 (26,316) (26,316)

Harvard Medical School Centers for Aids 93.855 2P30AI060354-06 94,506 94,506

Harvard Medical School Centers for Aids 93.855 5P30AI060354-05 (26,127) (26,127)

Harvard Medical School Centers for Aids 93.855 P30AI060354-05 55,819 55,819

Harvard School of Public Health 93.855 1 R01AI077623-01A1 278 278

Harvard School of Public Health 93.855 1R01AI083036-01 15,918 15,918

Harvard School of Public Health 93.855 5U01AI066454-06 45,613 45,613



Harvard University Center for AIDS Research 93.855 2P30AI060354-06 12,030 12,030

Harvard University Center for AIDS Research 93.855 5P30 AI060354-05 24,996 24,996

Harvard University Center for AIDS Research 93.855 P30 AI060354-06 22,691 22,691

Idaho Technology, Inc. 93.855 1R43AI082843-01 47,607 47,607

Joslin Diabetes Center 93.855 5P01AI054904-04 (3) (3)

Mass General Hospital-CIMIT 93.855 5R37AI042006-12 62,190 62,190

Mass General Hospital-CIMIT 93.855 5R37AI042006-13 46,093 46,093

Mass General Hospital-CIMIT 93.855 5U01AI052403-05 (1,529) (1,529)

Mass General Hospital-CIMIT 93.855 5U01AI069472-04 552,865 552,865

Minitube of America, Inc 93.855 1R41AI082853-01A1 45,171 45,171

Mount Sinai School of Medicine 93.855 5 U01 AI070107-04 297,572 297,572

Mount Sinai School of Medicine 93.855 5U01AI070107-04 575,858 575,858

North Carolina State University 93.855 9R01AI071915-05 332,611 332,611

Northeastern University 93.855 5R01AI076372-02 127,930 127,930

Oklahoma Medical Research Foundation 93.855 7R01AI063274-04 521 521

Osel, Inc. 93.855 R33AI071978 (3,659) (3,659)

President and Fellows of Harvard College 93.855 1U01NS050560-01-A2 359 359

President and Fellows of Harvard College 93.855 2P01AI054904-06A1 461,735 461,735

President and Fellows of Harvard College 93.855 2P01AI056299-06A1 354,929 354,929

President and Fellows of Harvard College 93.855 2P30AI060354-05 9,038 9,038

President and Fellows of Harvard College 93.855 2P30AI060354-06 140,166 814,220 954,386

President and Fellows of Harvard College 93.855 2U54AI057159 99,790 99,790

President and Fellows of Harvard College 93.855 2U54AI057159-06 33,817 33,817

President and Fellows of Harvard College 93.855 2U54AI057159-07 174,856 31,213 206,069

President and Fellows of Harvard College 93.855 5 P30AI060354-04 (3,167) (3,167)

Regents of the University of California 93.855 N01-AI-15416 42,247 42,247

Regents of the University of Minnesota 93.855 1R01AI063274-01 (9,231) (9,231)

Social and Scientific Systems, Inc. 93.855 1U01 A1068636-01 64,485 64,485

Social and Scientific Systems, Inc. 93.855 1U01AI068636-01 400,791 629,319 1,030,110

University of Alabama 93.855 003C (103) (103)

University of Colorado 93.855 5U19AI050864-08 24,971 24,971

University of Colorado Denver 93.855 122,750 122,750

University of Florida 93.855 P01AI042288 11,993 11,993

University of Kentucky Research Foundation 93.855 5R01AI068119-04 32,089 32,089

University of Pennsylvania 93.855 5P01AI041521-13 467,354 467,354

University of Texas 93.855 5R01AI053067-08 50,438 50,438

University of Texas Medical Branch 93.855 1R01AI079154-02 27,800 27,800

University of Texas Southwestern Medical 93.855 5U01AI077853-03 106,483 106,483


50





Allergy, Immunology and Transplantation Research Vanderbilt University 93.855 5R01AI077505-02 232,021 232,021

Applied Toxicological Research and Testing Genex Technologies, Inc. 93.114 5R43ES012360-02 (85,668) (85,668)

Harvard School of Public Health 93.114 2P30ES000002-46 11,827 11,827

University of California at Los Angeles 93.114 5R01ES013717-04 52,255 52,255

Arthritis, Musculoskeletal and Skin Diseases Research Boston University 93.846 5R01AR056291-04 489,741 489,741

Brigham and Women's Hospital 93.846 5P30AR042689-15 (2,906) (2,906)

California Pacific Medical Center 93.846 5R01AR052817-04 69,321 69,321

CIMIT 93.846 1R21AR056446-01A1 20,913 20,913

Dartmouth College 93.846 5P60AR048094-05 248 248

Harvard Skin Disease Research Center 93.846 5P30AR042689-15 (45,771) (45,771)

New England Research Institute, Inc. 93.846 R01-AR056992 104,377 104,377

Palo Alto Institute for Research and Education 93.846 5R01AR054822-03 66,120 66,120

The University of Texas Health Science 93.846 1R01AR057837-01A1 807 807

Thomas Jefferson University 93.846 2R01AR050087-06 22,919 22,919

University of California at San Francisco 93.846 N01-A1-15416 37,734 37,734

University of California at San Francisco 93.846 N01AI015416 1,055 1,055

University of Cincinnati 93.846 5R01AR053207-03 9,531 9,531

University of Colorado Health Sciences Center 93.846 5R01AR055104-22 175,689 175,689

University of North Carolina, Chapel Hill 93.846 1 R01 AR056328 37,632 37,632

Yale University School of Medicine 93.846 5P50AR054086-04 393,591 393,591

Assistance for Torture Victims Gulf Coast Jewish Family Services, Inc. 93.604 ZT0075 84,234 84,234

Assistance Programs for Chronic Disease Prevention Crohn's And Colitis Foundation Of America 93.945 5U01DP000340-03 423,307 423,307

and Control

Biological Basis Research in the Neurosciences McLean Hospital 93.854 5P50NS039793-10 159,149 159,149

McLean Hospital 93.854 5R01NS041263-05 (987) (987)

Biomedical Research and Research Training President and Fellows of Harvard College 93.859 1U54GM088558-01 28,513 28,513

Brigham and Women's Hospital 93.859 1R01GM086433-01A1 6,294 6,294

Brigham and Women's Hospital 93.859 5P01GM061354-07 467,305 467,305

Georgia State University 93.859 5R01GM081749-03 84,538 84,538

Harvard Medical School 93.859 5P01GM047467-18 19,688 19,688

Harvard Pilgrim Health Care 93.859 1U01 GM076672 17,097 17,097

Harvard Pilgrim Health Care 93.859 3U01GM076672-04S1 45,406 45,406

Harvard School of Public Health 93.859 1U54GM088558-01 225,202 225,202

Kaiser Permanente Medical Care Program 93.859 5R01GM080180-02 (20,951) (20,951)

MyNeurolab.com 93.859 1R43GM06821-40-1 (5,299) (5,299)

Northwestern University 93.859 R01GM086886 80,518 80,518

Pressure Biosciences 93.859 R43GM079059-02 223,483 223,483

Regents of the University of California 93.859 7U01GM076672-05 50,088 50,088

Tufts University 93.859 5R01GM084205-02 118,445 118,445

University of California, Santa Cruz 93.859 5R01GM056062-09 42,075 42,075

University of Chicago 93.859 R01-GM087558 135,191 135,191

University of Cincinnati 93.859 5R01GM084186-03 46,949 46,949

University of Pittsburgh 93.859 5 P50GM076659-04 1,616 1,616

University of Pittsburgh 93.859 5P50GM076659-04 23,247 23,247

University of Texas Medical Branch 93.859 5P01GM066312-04 25,036 25,036

University of Virginia 93.859 R01 GM 084545-02 32,679 32,679

University of Washington 93.859 5R01GM071852-03 (8,464) (8,464)

Biomedical Research Technology QCMetrics 93.371 5R44RR019014-04 1,153 1,153

Blood Diseases and Resources Research Beth Israel Deaconess Medical Center 93.839 1R01HL092125-01A2 49,636 49,636

Boston Medical Center 93.839 2U54HL070819-06 (2,892) (2,892)

Boston Medical Center 93.839 2U54HL070819-07 258,228 258,228

Boston Medical Center 93.839 5U10HL083771-05 30,209 30,209

Boston Medical Center 93.839 5U54HL070819-05 (4,259) (4,259)

Case Western Reserve University 93.839 5R01HL085813-03 21,304 21,304

CBR Institute for Biomedical Research 93.839 5P01HL059561-10 (85,867) (85,867)

Center for Blood Research, Inc. 93.839 5P01HL056949-14 594,562 594,562

Center for Blood Research, Inc. 93.839 5U24HL074355-05 7,072 7,072

Children's Hospital 93.839 5P01HL059561-13 365,587 365,587

Children's Hospital 93.839 5T32HL07574-28 14,296 14,296

Children's Hospital 93.839 5U01 HL072291-08 56,480 56,480

Children's Hospital of Boston 93.839 1P01HL095489-01A1 5,268 5,268

Children's Hospital of Boston 93.839 5K12HL087164-04 136,933 136,933

Children's Hospital of Boston 93.839 5P01HL032262-29 215,990 215,990


51





Blood Diseases and Resources Research Children's Hospital of Boston 93.839 5P01HL059561-13 305,581 305,581

Dana Farber Cancer Institute 93.839 5P01HL070149-05 (2,076) (2,076)

Dana Farber Cancer Institute 93.839 5U01HL0629249-09 19,757 19,757

Dana Farber Cancer Institute 93.839 5U01HL069249-04 249 249

Dana Farber Cancer Institute 93.839 5U01HL069249-05 403 403

Dana Farber Cancer Institute 93.839 5U01HL069249-07 (41,676) (41,676)

New England Research Institute, Inc. 93.839 2U01HL072291 1,849 1,849

New England Research Institute, Inc. 93.839 5U01HL072291-07 275 275

New England Research Institute, Inc. 93.839 U01HL065238 6,497 6,497

New England Research Institute, Inc. 93.839 U01HL072268 165 52 217

New England Research Institute, Inc. 93.839 U10HL083721 366 366

Northwestern University 93.839 5R01HL082950-05 162,342 162,342

Washington University 93.839 1 U01HL088476-03 3,002 3,002

Washington University 93.839 1U01HL088476-01A1 1,281 1,281

Washington University 93.839 5R01HL074724-04 (5,594) (5,594)

Washington University 93.839 5U01HL088476-02 43,350 43,350

Yale University School of Medicine 93.839 5P01HL063357-10 (38,858) (38,858)

Cancer Biology Research Brigham and Women's Hospital 93.396 2U01CA084301-11 254,695 254,695

Brigham and Women's Hospital 93.396 5P01CA120964-04 168,013 168,013

Brigham and Women's Hospital 93.396 5UO1CA084301-10 (44,935) (44,935)

Children's Hospital of Boston 93.396 5P01CA045548-23 49,787 49,787

Dana Farber Cancer Institute 93.396 2P01CA095616-06 (7,432) (7,432)

Dana Farber Cancer Institute 93.396 5P01CA095616-04 (27) (27)

Dana Farber Cancer Institute 93.396 5P01CA117969-03 151,063 151,063


Dana Farber Cancer Institute 93.396 5R01CA131945-03 122,118 122,118

Dana Farber Cancer Institute 93.396 5U56CA118641-03 (1,960) (1,960)

Dana Farber Cancer Institute 93.396 U56CA118635-05 1,946 1,946

Harvard Medical School 93.396 1R01CA127990-02 123,630 123,630

Mayo Clinic 93.396 5P50CA116201-05 18,185 18,185

Mount Sinai School of Medicine 93.396 5P01CA080058-10 305,676 305,676

Mount Sinai School of Medicine 93.396 5R01CA085214-10 83,529 83,529

National Cancer Center 93.396 1R01CA138649-01A2 132,516 132,516

University of Pennsylvania 93.396 1U01CA143056-01 208,237 208,237

University of Pennsylvania 93.396 5P01CA093615-05 851 851

University of Pennsylvania 93.396 5R01CA093237 23,024 23,024

University of Texas Southwestern Medical 93.396 1U01CA141576-01 640 640

University of Wisconsin - Madison 93.396 1U01CA141583-01 317,818 317,818

Whitehead Institute for Biomedical Research 93.396 2P01CA080111-11 21,915 21,915

Cancer Cause and Prevention Research California Pacific Medical Center 93.393 1R01CA125837-01A1 31,386 31,386

Case Western Reserve University 93.393 U54CA116867 17,608 17,608

CIMIT 93.393 1R01CA137178-01A1 55,180 55,180

Columbia University 93.393 5R01CA104842-03 339 339

Columbia University 93.393 5R01CA127532-03 120,305 120,305



Dana Farber Cancer Institute 93.393 7 R01CA124908-04 51,157 51,157

Florida State University 93.393 5R01CA069222-11 52,636 52,636

Fox Chase Cancer Center 93.393 5R01CA109332-04 (2,370) (2,370)

Fred Hutchinson Cancer Research Center 93.393 1U01CA137088-01A1 143,117 143,117

Harvard Medical School 93.393 5R01CA101034-4 15,241 15,241

Harvard School of Public Health 93.393 5P01CA55075-18 509,917 509,917

Harvard School of Public Health 93.393 5R01CA050385-20 (73,116) (73,116)

Harvard School of Public Health 93.393 5R01CA050385-22 911,000 911,000


Harvard School of Public Health 93.393 5R01CA067262-10 (553) (553)




Imperial College of Science, London 93.393 7R01 CA114205-03 51,308 51,308

Imperial College of Science, London 93.393 7R01CA114205-03 290,924 290,924

Mayo Clinic Rochester 93.393 1R01CA140286-01A1 44,823 44,823

President and Fellows of Harvard College 93.393 5R01CA074386-11 195,518 195,518


52





Cancer Cause and Prevention Research President and Fellows of Harvard College 93.393 5R01CA095589-06 171,914 171,914

Robert Wood Johnson Medical School 93.393 1R01CA116399-01-A1 (4,421) (4,421)

Trustees of Dartmouth College 93.393 2R01CA103642-06A1 75,356 75,356

University of California at San Francisco 93.393 5P01CA130818-02 119,936 119,936

University of California at San Francisco 93.393 5R01CA101849-04 150 150

University of Minnesota 93.393 U01 CA088204-09 49,397 49,397

University of Minnesota 93.393 U01CA088204 36,691 36,691

University of North Carolina, Chapel Hill 93.393 5R01CA074015-10 1,583 1,583

University of Pennsylvania 93.393 2R01CA083115-06 5,517 5,517

University of Texas, MD Anderson Cancer 93.393 5R01CA119215-04 106,652 106,652

Vanderbilt University 93.393 3R01CA118229-03S1 65,394 65,394

Washington University 93.393 1R01CA127435-03 125,549 125,549

Whitehead Institute 93.393 1R01CA146445-01 171,051 171,051

Cancer Centers Support Grants Beth Israel Deaconess Medical Center 93.397 2P50CA101942-05 24,624 24,624

Beth Israel Deaconess Medical Center 93.397 2P50CA101942-06A1 387,471 362,693 750,164

Beth Israel Deaconess Medical Center 93.397 3P50CA101942-05S1 (886) (886)

Beth Israel Deaconess Medical Center 93.397 5P50CA089393-10 6,486 6,486

Beth Israel Deaconess Medical Center 93.397 5P50CA101942-04 (750) (750)

Beth Israel Deaconess Medical Center 93.397 5P50CA101942-05 (3,779) (3,779)

Beth Israel Deaconess Medical Center 93.397 5P50CA101942-05S1 (40,489) (40,489)

Brigham and Women's Hospital 93.397 1P50CA093683-06A2 42,874 42,874


Brigham and Women's Hospital 93.397 2 P50 CA093683-06A2 32,174 32,174

Brigham and Women's Hospital 93.397 2 P50 CA093683-07 21,435 21,435


Brigham and Women's Hospital 93.397 3P50CA093683-05S2 (23,059) (23,059)

Brigham and Women's Hospital 93.397 3P50CA105009-04S1 48,767 48,767

Brigham and Women's Hospital 93.397 5P50CA105009-02 (23,338) (23,338)


Brigham and Women's Hospital 93.397 5P50CA105009-04 (21,546) (21,546)


Brigham and Women's Hospital 93.397 5P50CA105009-05S1 99,039 99,039

Dana Farber Cancer Institute 93.397 1P50CA127003-02 299 299



Dana Farber Cancer Institute 93.397 2P50CA090578 367,881 367,881



Dana Farber Cancer Institute 93.397 3P50 CA089393-09S2 137,245 137,245

Dana Farber Cancer Institute 93.397 3P50CA089393-09S4 183,316 183,316



Dana Farber Cancer Institute 93.397 5P01DK050654-10 126 126



Dana Farber Cancer Institute 93.397 5P30CA006516-41 723 723

Dana Farber Cancer Institute 93.397 5P30CA006516-45 45,371 111,705 157,076


Dana Farber Cancer Institute 93.397 5P30CA006516-46 1,745,502 1,557,380 3,302,882



Dana Farber Cancer Institute 93.397 5P50CA089393-08 (2,211) (57,618) (59,829)









Dana Farber Cancer Institute 93.397 5U54CA112962-03 5,112 5,112

Dana Farber Cancer Institute 93.397 P30CA006516-45 6,581 6,581

Dana Farber/Harvard Cancer Center 93.397 5P30CA006516-45 140,576 140,576


53





Cancer Centers Support Grants Dana Farber/Harvard Cancer Center 93.397 5P30CA06516-44 73,669 73,669

Dana Farber/Harvard Cancer Center 93.397 5P50CA127003-03 146,494 146,494

Dana Farber/Harvard Cancer Center 93.397 5PO1CA089393-09 37,374 37,374

Dana Farber/Harvard Cancer Center 93.397 P50 CA127003-02 3,781 3,781

Massachusetts Institute of Technology 93.397 1U54CA143874-01 97,210 97,210

Massachusetts Institute of Technology 93.397 5U54CA126515-04 494,607 494,607

MD Anderson Cancer Center 93.397 5P50CA083639-10 62,648 62,648

NIH-NCI National Cancer Institute 93.397 5P50CA105009-03 (25,027) (25,027)

University of Texas 93.397 1U54CA143837-01 129,404 129,404

University of Texas, MD Anderson Cancer 93.397 5P50CA083639-05-S1 (7,052) (7,052)

Cancer Control American College of Radiology 93.399 5U10CA021661-20 (30,364) (30,364)

Brigham and Women's Hospital 93.399 5R21CA121906-02 4 4

Brigham and Women's Hospital 93.399 5U01CA086381-04 2,305 2,305

Brigham and Women's Hospital 93.399 5U01CA086381-10 119,341 119,341

Brigham and Women's Hospital 93.399 5U01CA086381-10S1 132,664 132,664

Butler Hospital 93.399 5P50CA084719-10 (3,338) (3,338)


Dana Farber/Harvard Cancer Center 93.399 2P50CA090381-06 (10,532) (10,532)

Dartmouth College 93.399 5R01CA107124-03 346 346


Implant Sciences 93.399 R43CA092924-01 (5,050) (5,050)

Johns Hopkins University 93.399 5U01CA084986-08 477 477

Massachusetts Institute of Technology 93.399 5U54CA119349-05 242,115 642,089 884,204

National Childhood Cancer Foundation 93.399 5U10CA098543-02 272 272

President and Fellows of Harvard College 93.399 1P50CA148596-01 8,075 8,075

President and Fellows of Harvard College 93.399 3U01CA114644-05 5,539 5,539

President and Fellows of Harvard College 93.399 12,482 12,482

University of Arizona 93.399 5R03CA125821-02 8,905 8,905

University of Pittsburgh 93.399 1R01CA108990-01-A1 12,268 12,268

Cancer Detection and Diagnosis Research American College of Radiology 93.394 5U01CA080098 192,212 192,212

American College of Radiology 93.394 5U01CA080098-10 2,502 2,502

Ascension Technology Corporation 93.394 2R42CA115112-02A2 177,369 177,369

Brigham and Women's Hospital 93.394 5R01CA120528-05 19,448 19,448

Brigham and Women's Hospital 93.394 5R01CA131044-03 26,490 26,490

Brigham and Women's Hospital 93.394 5R21CA111949-02 15 15

Brigham and Women's Hospital 93.394 5R33CA100315-04 (750) (750)

Broad Institute 93.394 5U24CA126476-03 (41,623) (41,623)

Broad Institute 93.394 6U24CA126476-04 128,918 128,918

Dana Farber Cancer Institute 93.394 5R01CA114465-05 13,179 7,536 20,715

Fred Hutchinson Cancer Research Center 93.394 2P01CA091955-06 80,984 80,984

Georgetown University Medical Center 93.394 5R01CA124377-03 110,945 110,945

IHC Healthcare d/b/a LDS Hospital 93.394 HHSN268200425210C (41) (41)

Mass General Hospital-CIMIT 93.394 5R01CA115746-05 124,262 124,262

Massachusetts Institute of Technology 93.394 5R01CA979660-5 (15,060) (15,060)

Physical Sciences, Inc. 93.394 2R42CA114896-02A1 21,133 21,133

Physical Sciences, Inc. 93.394 2R44CA117218-03 36,797 36,797

Regents of the University of California 93.394 2000 G FP690 (1,016) (1,016)

Tufts University 93.394 R21CA114684 (444) (444)

University of Chicago 93.394 5U24CA114725-03 (401) (401)

University of Chicago 93.394 5U24CA114725-05 384,378 384,378

University of Chicago 93.394 U24CA114725-05 42,712 42,712

University of Pennsylvania 93.394 1R01CA104976-03 (19) (19)

Cancer Research Manpower Boston University Medical Center 93.398 5R25CA091958-04 (2,095) (2,095)

Dana Farber Cancer Institute 93.398 1K07CA140790-01 66,430 66,430

MD Anderson Cancer Center 93.398 5P50CA098258-05 (2,025) (2,025)

Cancer Treatment Research Acenta Discovery, Inc. 93.395 R41MH074193-02 (6,947) (6,947)

American College of Radiology Imaging 93.395 3U01CA080098 10,850 10,850

Brigham and Women's Hospital 93.395 1R01CA107164-02-A1 996 996

Dana Farber Cancer Institute 93.395 1R01CA133799-01A1 60,319 60,319

Dana Farber Cancer Institute 93.395 1R01CA135257 85,604 85,604


Dana Farber Cancer Institute 93.395 2U01 CA062490-16 (4,714) (4,714)



54





Cancer Treatment Research Dana Farber Cancer Institute 93.395 5P01CA066996-13 564,907 564,907




Dana Farber Cancer Institute 93.395 5R01CA090687-08 386 386


Dana Farber Cancer Institute 93.395 5R21CA126119-02 (3,048) (3,048)


Dana Farber Cancer Institute 93.395 5U01CA062490-17 319,742 319,742

Dana Farber Cancer Institute 93.395 5U01CA081452-08 (7,799) (7,799)

Dana Farber Cancer Institute 93.395 9P01CA142106-06A1 51,126 51,126

Dana Farber Cancer Institute 93.395 P01CA089021-07 18,161 18,161

Dana Farber Cancer Institute 93.395 R01CA106370-05A1 16,018 9,401 25,419

Dana Farber Cancer Institute 93.395 U01CA062490 (1,194) (1,194)

Duke University 93.395 7U10CA076001-04 4,418 4,418

Fidelity Foundation 93.395 32,871 32,871

Fox Chase Cancer Center 93.395 1R01CA075795-08 (2,907) (2,907)

Gynecologic Oncology Group 93.395 U10CA27469 23,140 23,140

Harvard Medical School 93.395 5P01CA078048-10 39,797 39,797

Johns Hopkins University 93.395 1U01CA137443-01 132,873 132,873

Lynntech, Inc. 93.395 2R44CA103177-02A1 209,195 209,195

Lynntech, Inc. 93.395 5R44AI68400-04 (45,647) (45,647)

Mass General Hospital-CIMIT 93.395 1R21CA117128-01-A1 (445) (445)

National Childhood Cancer Foundation 93.395 5U10CA098543-04 (14,599) (14,599)

National Childhood Cancer Foundation 93.395 5U10CA098543-07 75,273 75,273

National Childhood Cancer Foundation 93.395 5U10CA098543-08 2,794 2,794

Opto Sonics, Inc. 93.395 5R44CA114839 80,469 80,469

Physical Sciences, Inc. 93.395 43479-1551-46 2,670 2,670

Rensselaer Polytechnic Institute 93.395 5R01CA116743-05 13,799 13,799

University of California at San Diego 93.395 5P01CA081534-10 40,746 40,746

University of Chicago 93.395 5U10CA31946-26 587 587

University of Chicago 93.395 U10CA037447 216,064 216,064

University of Massachusetts at Lowell 93.395 R01CA137108-01 124,265 124,265

University of Pennsylvania 93.395 5R01CA122569-02 167,530 167,530

University of Pittsburgh 93.395 1R03CA141086-02 9,925 9,925

University of Texas, MD Anderson Cancer 93.395 5P01CA108631-04 (16,171) (16,171)

University of Texas, MD Anderson Cancer 93.395 5P01CA108631-05 230,593 230,593

University of Virginia 93.395 1 R01 CA 137071-01 R 60,494 60,494

Virginia Commonwealth University 93.395 5R21CA115260-02 (2) (2)

Cardiovascular Diseases Research Albert Einstein College of Medicine 93.837 5R01HL075619-06 76,568 76,568

Beth Israel Deaconess Medical Center 93.837 1 R01HL082717-10 14,195 14,195

Beth Israel Deaconess Medical Center 93.837 1R01HL091757-02 53 53

Beth Israel Deaconess Medical Center 93.837 1R01HL094555-01A1 97,302 97,302

Beth Israel Deaconess Medical Center 93.837 5R21 HL085720-02 (21,332) (21,332)

Beth Israel Deaconess Medical Center 93.837 5U01HL072737-06 86,333 86,333

Boston University Medical Center 93.837 1R01HL092577-02 380,841 380,841

Boston University Medical Center 93.837 1R21HL089734-01A1 (207) (207)

Boston University Medical Center 93.837 1R21HL089734-02 15,312 15,312

Boston University Medical Center 93.837 5P01HL081587-05 441,720 441,720

Brigham and Women's Hospital 93.837 1R01HL094390-01 32,613 32,613

Brigham and Women's Hospital 93.837 1U01HL084904-01 29,122 29,122





California Pacific Medical Center 93.837 29,786 29,786

Case Western Reserve University 93.837 R01 HL106410 26,819 26,819

Children's Hospital of Boston 93.837 1U01HL098147-01 118,471 118,471

Children's Hospital of Oakland 93.837 2U01HL069757-09 99,836 99,836

Children's Hospital of Philadelphia 93.837 1P20HL101820-01 40,366 40,366

CIMIT 93.837 1R01HL098280-01 35,687 35,687


55





Cardiovascular Diseases Research CIMIT 93.837 1R01HL96738-01 224,479 224,479

CIMIT 93.837 1U01HL092040-01A1 32,165 32,165

CIMIT 93.837 5P01HL018646-32 170,340 170,340

Columbia University 93.837 1R21HL091443-01A2 13,120 13,120

Duke Clinical Research Institute 93.837 1 U01 HL084904-01 24,236 24,236

Duke Clinical Research Institute 93.837 1U01HL063747-01-A2 4,879 4,879

Duke Clinical Research Institute 93.837 1U01HL084904-01 32 32

Duke Clinical Research Institute 93.837 5U01HL084904-03 19,954 19,954

Duke Clinical Research Institute 93.837 U01HL084904-04 453 453

Duke University 93.837 5R01HL072010-07 85,107 85,107

Duke University 93.837 5U01HL084904-04 20,555 20,555

E.P. Limited 93.837 2R44HL063535-04A2 23,752 23,752

Fred Hutchinson Cancer Research Center 93.837 1U01HL100395-01 250,403 250,403

Harvard Medical School 93.837 5R25HL075487-05 (4,041) (4,041)

Harvard Pilgrim Health Care 93.837 5R01HL064925-09 386,103 386,103

Harvard School of Public Health 93.837 1U01HL073286-01 (14,377) (14,377)

Harvard School of Public Health 93.837 5R01HL080644-04 (29,616) (29,616)

Harvard School of Public Health 93.837 5R01HL085710-04 106,126 106,126

Harvard School of Public Health 93.837 5R21HL077548-02 (183) (183)

Harvard School of Public Health 93.837 5U01HL073286-05 65 65

Joslin Diabetes Center 93.837 5R01HL077554-04 (1,519) (1,519)

Kaiser Foundation Research Institute 93.837 5U19HL091179-03 45,569 45,569

Lawrence Berkeley National Laboratory 93.837 1R01HL091495-01A1 95,846 95,846

Mass General Hospital-CIMIT 93.837 5U01HL080731-05 154,595 154,595

Mass General Hospital-CIMIT 93.837 5U01HL081341-04 (29,726) (29,726)

Massachusetts General Hospital 93.837 5U01HL080731-02 (21,873) (21,873)

Massachusetts Institute of Technology 93.837 1R44HL079726-03 (746) (746)

Massachusetts Institute of Technology 93.837 5710002750 49,896 49,896

Medical College of Ohio 93.837 5U01HL071550-05 8,077 8,077

Medical University of South Carolina 93.837 5R01HL086576-03 51,837 51,837

Millikelvin Technology, LLC 93.837 A202787 29,502 29,502

Mount Sinai School of Medicine 93.837 1R01HL071988-01-A1 739 739

Mount Sinai School of Medicine 93.837 7U01HL088942-03 333,178 333,178

New England Research Institute, Inc. 93.837 U10HL083721 11,324 11,324

President and Fellows of Harvard College 93.837 2R01HL035464-21A2 19,284 19,284

President and Fellows of Harvard College 93.837 5R01HL080644-06 58,848 58,848

Regents of the University of California 93.837 1R01HL091495-02 127,545 127,545

Rhode Island Hospital 93.837 5U01HL077221-03 16,709 16,709

Social and Scientific Systems, Inc. 93.837 1R01HL095132-01 2,380 2,380

Thomas Jefferson University 93.837 2U54HL070585-06 4,442 4,442

Thomas Jefferson University 93.837 5U54HL070585-07 615 615

University of California at Riverside 93.837 1R01HL089940-01A2 80,997 80,997

University of Cape Town 93.837 HHSN268200900030C 136,631 136,631

University of Iowa 93.837 1R01HL083475-02 9,194 9,194

University of Louisville 93.837 5P01HL078825-04 149,413 149,413

University of Pittsburgh 93.837 5R01HL082541-06 239,403 239,403

University of Pittsburgh 93.837 5R01HL089750-02 155,314 155,314

University of Toledo 93.837 5U01HL715560-06 39,810 39,810

University of Utah 93.837 R01HL074370-01A2 17,926 17,926

Vanderbilt University 93.837 5R01HL089755-03 163,241 163,241

Vanderbilt University 93.837 5U01HL065962-09 337,099 337,099

Vanderbilt University 93.837 RL1HL092551-04 23,325 23,325

Washington University 93.837 5U01HL087071-06 143,890 143,890

Yale University 93.837 5R01HL081153-02 99,514 99,514

Center for Medical Rehabilitation Research University of Washington - Seattle 93.929 1R21HD058049-01A2 7,843 7,843

Centers for Disease Control and Prevention Investigations Association of American Medical Colleges 93.283 U36/CCU319276 204,533 204,533

and Technical Assistance Association of American Medical Colleges 93.283 278,322 278,322

Harvard School of Public Health 93.283 U90 TP124242-05 19,415 19,415

Child Health and Human Development Extramural Research Boston University 93.865 5K08HD53706-03 15,348 15,348

Children's Hospital of Boston 93.865 5R01HD043869-05 (47,359) (47,359)

Children's Hospital of Boston 93.865 5U01HD045991-05 41,957 41,957

Cincinnati Children's Hospital Medical Center 93.865 1R01HD059140-01 277 277

Harvard School of Public Health 93.865 5R01 HD044391-05 (57,058) (57,058)


56





Child Health and Human Development Extramural Research Mass General Hospital-CIMIT 93.865 5R01HD055150-04 58,532 58,532

Mass General Hospital-CIMIT 93.865 5U54HD028138-19 485,336 485,336

Simbex, LLC 93.865 5R44HD055715-03 243,306 243,306

Trustees of Dartmouth College 93.865 5R01HD044547-08 32,039 32,039

University of Massachusetts Medical 93.865 5R21HD057402-02 34,977 34,977

University of Massachusetts Medical Cent 93.865 1R21HD057806-01 11,708 11,708

University of Pittsburgh 93.865 5R01HD046700-04 1 1

University of Rochester 93.865 5U19HD035466-10 (62,052) (62,052)

Wadsworth Center 93.865 R01HD061916-01 134,499 134,499

Wake Forest University, Bowman Gray School 93.865 5P01HD021187-04 1,438 1,438

Yale University School of Medicine 93.865 5R01HD046171-05 371 371

Community Programs to Improve Minority Health Grant Partners in Health 93.137 1 CPIMP071035-02-00 118,825 118,825

Program

Diabetes, Digestive, and Kidney Diseases Extramural Research Albert Einstein College of Medicine 93.847 5R01DK080792-02 10,885 10,885

Beth Israel Deaconess Medical Center 93.847 1R24DK083938-01 122,991 122,991

Beth Israel Deaconess Medical Center 93.847 1U19DK080652-02 422,541 422,541


Beth Israel Deaconess Medical Center 93.847 1UO1DK082919-02 116,469 116,469

Beth Israel Deaconess Medical Center 93.847 5P01DK080665-02 291,413 291,413

Beth Israel Deaconess Medical Center 93.847 5R01DK063296-06 (59,805) (59,805)



Boston Medical Center 93.847 5 P30 DK046200-17 9,135 9,135

Boston Medical Center 93.847 5P30DK046200-18 46,746 46,746

Boston Obesity Nutrition Research @ BMC 93.847 5P30DK046200-18 10,000 10,000

Boston University 93.847 5R01DK065089-03 (56,218) (56,218)

Brigham and Women's Hospital 93.847 5R01DK058845-09 34,491 34,491

Case Western Reserve University 93.847 N01-DK-62203 309,927 309,927

Children's Hospital Medical Center 93.847 5R01DK072428-04 57,086 57,086

Children's Hospital of Boston 93.847 1R01DK084001-01A1 89,898 89,898

Children's Hospital of Boston 93.847 1U19 DK080652-01 9,564 9,564

Children's Hospital of Boston 93.847 5P30DK034854-25 124,751 124,751

CIMIT 93.847 3P30DK057521-11 21,371 21,371

CIMIT 93.847 5P30DK057521-10 11,308 11,308

CIMIT 93.847 5P30DK057521-10S1 32,453 32,453

CIMIT 93.847 5R21DK077716-02 83,554 83,554

George Washington University 93.847 2U01DK061230-08 64 64

George Washington University 93.847 5U01DK061230-09 912,814 912,814

George Washington University 93.847 U01DK048489-17 154,785 154,785

Harvard Medical School 93.847 5P01DK056246-09 89,830 89,830

Joslin Diabetes Center 93.847 1 R01 DK60754 22,450 22,450

Joslin Diabetes Center 93.847 5 P30 DK036836-22 34,951 34,951

Joslin Diabetes Center 93.847 5R01DK072090-04 3,134 3,134

Joslin Diabetes Center 93.847 5R01DK073843-03 94,392 94,392

Joslin Diabetes Center 93.847 DK036836-20 (6,370) (6,370)

Joslin Diabetes Center 93.847 15,929 15,929

Mass General Hospital-CIMIT 93.847 5R01DK067397-02 (1,142) (1,142)

Massachusetts Institute of Technology 93.847 6R01DK081923-02 89,228 89,228

Montreal Heart Institute 93.847 5U01DK062432-09 86,298 86,298

National Institute of Diabetes and Digestion 93.847 5P30DK043351-20 30,057 30,057

New England Research Institute, Inc. 93.847 1R01DK080786-01A2 34,116 34,116

President and Fellows of Harvard College 93.847 1R01DK082486-01A1 31,769 31,769

President and Fellows of Harvard College 93.847 1R01DK088718-01 837 837

Trustees of Boston University 93.847 1R01DK085633-02 144,785 144,785

University of Alabama 93.847 3R01DK076771-02S1 18,833 18,833

Digestive Diseases and Nutrition Research University of California at Los Angeles 93.847 DK062290 20 20

University of North Carolina, Chapel Hill 93.847 1R21DK080408-01 743 743

University of Pennsylvania 93.847 2U01DK060990-08 3,998 3,998

University of Pittsburgh 93.847 5R01DK061451-07 (7,831) (7,831)

University of Pittsburgh 93.847 5U01DK075803-03 38,987 38,987


Boston Medical Center 93.848 5R03DK081686-02 20,236 20,236

Children's Hospital of Boston 93.848 5P30DK034854-22 (3,386) (3,386)


57





Digestive Diseases and Nutrition Research Children's Hospital of Boston 93.848 5P30DK034854-24 73,014 73,014

Children's Hospital of Boston 93.848 5P30DK034854-25 128,021 128,021

Children's Hospital of Boston 93.848 5R01DK072117-03 30,334 30,334

Children's Hospital of Boston 93.848 5R01DK075787-02 13,502 13,502

Children's Hospital of Boston 93.848 5T32DK07477-25 (5,138) (5,138)

Eagle Vision Pharmaceutical Corp 93.848 R43DK076429 (305) (305)

Harvard Clinical Nutrition Research Center 93.848 2P30DK040561-11 428 428

Montreal Heart Institute 93.848 5R01DK064869-07 183,255 183,255

Universite de Montreal 93.848 5U01DK062432-08 (19,528) (19,528)

University of California at San Francisco 93.848 1R03DK063187-01 (31) (31)

University of Texas Southwestern Medical 93.848 5U01DKO58369-10 4,299 4,299

Discovery and Applied Research for Technological Innovations Brigham and Women's Hospital 93.286 5R01EB000802-14 (65,696) (65,696)

to Improve Human Health Brigham and Women's Hospital 93.286 5U54EB005149-05 68,957 68,957

Brigham and Women's Hospital 93.286 R01EB005876 (40,398) (40,398)

Case Western Reserve University 93.286 5R01EB006203-02 (1,386) (1,386)

Dana Farber Cancer Institute 93.286 1R21EB010085-01A1 27,332 27,332

Georgetown University 93.286 5R01EB006589-03 14 14

Johns Hopkins University 93.286 1R21EB009900-01 87,624 87,624

Massachusetts Institute of Technology 93.286 5R01EB003805-05 435,538 435,538

Massachusetts Institute of Technology 93.286 5R01EB007942-03 126,444 126,444

Physical Sciences, Inc. 93.286 2R44EB000365-02-A2 (18,744) (18,744)

Rensselaer Polytechnic Institute 93.286 5R01EB000456-04 (235,713) (235,713)

Robin Medical, Inc. 93.286 5R21EB007792-03 191,807 191,807

Sunnybrook Health Science Center 93.286 7R01EB003268-10 219,085 219,085

The MIND Institute 93.286 06-540-N1&06-540-N2 (9) (9)

University of California at San Diego 93.286 1R01EB009282-01 102,337 102,337

University of California at San Francisco 93.286 1R01EB009756-01 153,760 153,760

Drug Abuse and Addiction Research Programs Boston University 93.279 5R01DA017904-04 30,498 30,498

Cornell University 93.279 5R01DA017905-06 20,626 20,626

Harvard Medical School 93.279 5R01DA011558-09 (121,822) (121,822)

Harvard School of Public Health 93.279 5 R21 DA022600-02 9,449 9,449

Lam Foundation 93.279 5 U54RR019498-04 1,819 1,819

Mass General Hospital-CIMIT 93.279 5U01DA019378-04 50,202 50,202

McLean Hospital 93.279 5U10DA015831-05 85,051 85,051

McLean Hospital 93.279 5U10DA015831-07 35,507 35,507

Massachusetts General Hospital 93.279 5R01DA022276-03 97,475 97,475

Mount Sinai School of Medicine 93.279 5P01DA008227-18 48,776 48,776

Northeastern University 93.279 1R01DA26795-01 196,475 196,475

Northeastern University 93.279 5R37DA023142 290,373 290,373

University of Chicago 93.279 5R01DA017323-02 (57,041) (57,041)

University of Chicago 93.279 R01DA014644-06 (5,015) (5,015)

University of Cincinnati 93.279 1R01DA017323-01A2 (27,099) (27,099)

University of Cincinnati 93.279 5 R01 DA14644-03 (45,236) (45,236)

University of Hawaii 93.279 5R01DA019912-03 86,828 86,828

University of Medicine and Dentistry of New Jersey 93.279 1R21DA020771-01-A1 (1,104) (1,104)

University of Pennsylvania 93.279 5R01DA022339-03 287,067 287,067

Weill-Cornell Medical College 93.279 1R01DA027379-01 119,011 119,011

Weill-Cornell Medical College 93.279 3U01DA013720-09S1 150 150

Environmental Health Broad Institute 93.113 1U01ES017155-01 (43,454) (43,454)

Broad Institute 93.113 5U01AI074575-02 (14,781) (14,781)

Broad Institute 93.113 U01ES017155 452,421 452,421

Case Western Reserve University 93.113 5R01ES013925-04 141,742 141,742

Children's Hospital of Boston 93.113 5R01ES016283-03 (47,808) (47,808)

Harvard Pilgrim Health Care 93.113 5R01ES016314-03 58,443 58,443

Harvard School of Public Health 93.113 5P01ES009825-10 214,385 214,385

Harvard School of Public Health 93.113 5R01ES009718-10 2,662 2,662






Johns Hopkins University 93.113 1P01ES018176-01 18,354 18,354

President and Fellows of Harvard College 93.113 2R01ES009718-12 47,657 47,657


58





Environmental Health President and Fellows of Harvard College 93.113 5R01ES009411-08 30,299 30,299

Extramural Research Programs in the Neurosciences and Beth Israel Deaconess Medical Center 93.853 4R01NS039466-07 12,117 12,117

Neurological Disorders Beth Israel Deaconess Medical Center 93.853 5R01NS041198-09 11,399 11,399

Beth Israel Deaconess Medical Center 93.853 7R01MH063951-05 (2,366) (2,366)

Beth Israel Deaconess Medical Center 93.853 R01 NS057127 17,034 17,034

Boston College 93.853 7R01NS040237-03 68,987 68,987

Boston University 93.853 5R01NS036711-09 (13,270) (13,270)

Boston University Medical Center 93.853 5U01NS045806-05 (757) (757)

Brigham and Women's Hospital 93.853 5R01NS055083-04 26,805 26,805

Children's Hospital of Boston 93.853 5P01NS038475-10 59,774 59,774

Children's Hospital of Boston 93.853 5P01NS040828-01 (65,521) (65,521)

Children's Hospital of Boston 93.853 5P01NS040828-05 (1,944) (1,944)

Children's Hospital of Boston 93.853 5R21NS057225-02 53,560 53,560

Children's Hospital of Boston 93.853 5U01NS040069-05 28,551 28,551

CIMIT 93.853 5P01NS024279-21 587,477 587,477

Columbia University 93.853 5R01NS027941-21 22,607 22,607

Dana Farber Cancer Institute 93.853 5R01NS044914-07 54,734 54,734

Emory University 93.853 5R01NS038455-10 20,826 20,826

Georgetown University 93.853 U54NS057405-02 25,041 25,041

Harvard Medical School 93.853 1U01NS050560-02 (3,870) (3,870)

Harvard School of Public Health 93.853 5R01NS045893-07 9,437 9,437

Harvard School of Public Health 93.853 5R01NS047467-04 (996) (996)

Harvard School of Public Health 93.853 5R01NS048517-05 3,361 3,361

Henry M Jackson Foundation 93.853 5R01NS047717-04 (6,433) (6,433)

Johns Hopkins University 93.853 1U01NS062851-01A1 66 66

Johns Hopkins University 93.853 5R01NS046309-04 1,068 1,068

Mass General Hospital-CIMIT 93.853 1R01NS049263-01-A2 (429) (429)

Mass General Hospital-CIMIT 93.853 5P50NS010828-33 69,542 69,542

Mass General Hospital-CIMIT 93.853 5P50NS051343-04 7,558 7,558

Massachusetts Eye and Ear Infirmary 93.853 1R01NS071067-01 2,906 2,906

Massachusetts Institute of Technology 93.853 16,290 16,290

Mayo Clinic 93.853 R01NS051769-04 85,639 85,639

Medical University of South Carolina 93.853 1U01NS058728-01A1 27 27

Massachusetts General Hospital 93.853 5P01NS058793-03 275,968 275,968

Molecular Insight Pharmaceuticals, Inc 93.853 1R43NS04610-90-1 145 145

MyNeurolab.com 93.853 1R43NS05560-00-1 (1,869) (1,869)

Preferred Instruments, Inc (PII) 93.853 2R43NS36869-02 (5,642) (5,642)

President and Fellows of Harvard College 93.853 5R01NS061858-02 43,026 43,026

Regents of the University of Minnesota 93.853 1U54NS065768-01 19,717 19,717

Tourette Syndrome Association 93.853 2U01NS040024-07 370,381 370,381

Tufts University 93.853 5R01NS036524-10 29,035 29,035

Tufts University School of Medicine 93.853 5R01NS036524-10 62,934 62,934

University of Alabama 93.853 5R01NS043789-05 (16,927) (16,927)

University of Alabama, Birmingham 93.853 5R01NS054246-02 300 300

University of Alabama, Birmingham 93.853 5U01NS42685-05 513 513

University of California at Los Angeles 93.853 1U01NS042372-03 (17,344) (17,344)

University of California at San Francisco 93.853 5R01NS049477-05 35,192 35,192

University of California at Santa Barbara 93.853 8U01AG033931-03 61,074 61,074

University of Cincinnati 93.853 5R01NS039512-05 236 28 264

University of Florida 93.853 2R01NS038455-08 (1,606) (1,606)

University of Iowa 93.853 5R01NS040068-06 (5,236) (5,236)

University of Massachusetts at Worcester 93.853 1U01NS064096-01A1 23,556 23,556

University of Massachusetts Medical 93.853 1R21NS064349-01A1 80,825 80,825

University of Massachusetts Medical 93.853 5R01NS038194-10 17,225 17,225

University of Missouri 93.853 5R01NS052470-03 126,922 126,922

University of North Carolina, Chapel Hill 93.853 5R01NS055754-03 123,849 123,849

University of North Carolina, Chapel Hill 93.853 5U01NS042167 6,290 6,290

University of Pittsburgh 93.853 5R01NS048178-03 13 13

University of Rochester 93.853 5U01NS050095-04 6,589 6,589


University of Rochester, Medical Center 93.853 3U54NS059065-05S2 68,552 68,552

University of Rochester, Medical Center 93.853 5R01NS045686-05 35,389 35,389

University of Utah 93.853 1R21NS067463-01 14,580 14,580


59





Extramural Research Programs in the Neurosciences and University of Wisconsin 93.853 2P01NS042803-06A2 87,352 87,352

Neurological Disorders Virginia Commonwealth University 93.853 1R01NS070715-01 53,373 53,373

Wake Forest University 93.853 R01NS058949 102,001 102,001

Washington University 93.853 5U01NS032228-12 4,836 4,836

Washington University 93.853 5U01NS042167-05 3,184 3,184

Yale University 93.853 5U01NS044876-05 482,621 482,621

Family Planning Services Action For Boston Community Development 93.217 FPHPA010203-38-00 17,230 17,230

Food and Drug Administration Research Emory University 93.103 1R01FD003517-01 85,212 85,212

Harvard Pilgrim Health Care 93.103 HHSF2232009100061 76,273 76,273

Mt. Sinai Medical 93.103 FD-R-002613 644 644

NeuroHealing Pharmaceuticals, INC. 93.103 1R01FD003337-01A1 29,832 29,832

University of Cincinnati 93.103 5R01FD003362-03 695 695

University of Kansas Medical Center 93.103 5R01FD003454-03 39,682 39,682

Grants for Faculty Development in Family Medicine Boston University 93.895 5P50GM067041-08 7,593 7,593

Human Genome Research Albert Einstein College of Medicine 93.172 5 R01HG004401-02 128,644 128,644

Broad Institute 93.172 1U54HG004570-01 (27,956) (27,956)

Broad Institute 93.172 U54HG004570 411,126 411,126

Children's Hospital of Boston 93.172 5R01HD046855-03 (5,996) (5,996)

Dana Farber Cancer Institute 93.172 5P50HG004233-04 269,553 269,553

Fred Hutchinson Cancer Research Center 93.172 5P41HG004059-04 101,566 101,566

Massachusetts Eye and Ear Infirmary 93.172 5U01HG004728-02 224,284 224,284

Pennsylvania State University 93.172 5R01HG004909-02 129,176 129,176

University of California at Berkeley 93.172 5U01HG004258-03 453,955 453,955

University of California at Berkeley 93.172 5U01HG004258-04 303,022 303,022

University of Rochester 93.172 5R01HG002449-07 940 940

Innovations in Applied Public Health Research Harvard Pilgrim Health Care 93.061 1P01HK000088-01 269,035 269,035

Harvard Pilgrim Health Care 93.061 P01 HK000016-03 (55,769) (55,769)

Harvard Pilgrim Health Care 93.061 P01HK000016-03S1 (71,762) (71,762)

Harvard School of Public Health 93.061 94,682 94,682

International Research and Research Training Vanderbilt University 93.989 5R24TW007988-04 68,706 68,706

Kidney Diseases, Urology and Hematology Research Brigham and Women's Hospital 93.849 5P50DK074030-04 (6,223) (6,223)

Duke University 93.849 5R01DK080094-02 6,763 6,763

Harvard School of Public Health 93.849 5 R01 DK045362-05 1,279 1,279

Indiana University 93.849 1P30DK079312-02 4,344 4,344

Mass General Hospital-CIMIT 93.849 5U01DK065187-06 (16,019) (16,019)

Research Foundation of State University 93.849 5U01DK063385-06 8,931 8,931

Rhode Island Hospital 93.849 1U01DK061700-02 12,187 12,187

Rhode Island Hospital 93.849 5U01DK061700-07 29,967 29,967

University of Alabama, Birmingham 93.849 5U01DK063788-07 30,362 30,362

University of California at Los Angeles 93.849 5R01DK067563-04 38,544 38,544

University of Miami 93.849 5R01DK076116-03 87,653 87,653

Lung Diseases Research Albert Einstein College of Medicine 93.838 7R01HL086667-04 18,957 18,957

Boston University 93.838 5R01HL076778-04 (3,660) (3,660)

Duke University 93.838 5U01HL084904-04 64,414 64,414

Georgia Institute of Technology 93.838 1R01HL090630-01 171,594 171,594

Harvard Pilgrim Health Care 93.838 5R01HL075504-04 (1,045) (1,045)

Harvard School of Public Health 93.838 5R01HL060710 146,270 146,270

Mount Sinai School of Medicine 93.838 1R01HL086667-02 23 23

National Jewish Medical and Research Center 93.838 1U01HL089897-01A1 434,638 434,638

NIH-NHLBI National Heart, Lung, and Blood 93.838 5R01HL082541-04 (83,310) (83,310)

Penn State University College of Medicine 93.838 5U01HL074231-05 (33,803) (33,803)

President and Fellows of Harvard College 93.838 1R01HL091933-01A2 413 413

President and Fellows of Harvard College 93.838 1R01HL092961-01AI 20,978 20,978

University of California at San Diego 93.838 5R01HL081663-05 133,142 133,142

University of California at San Francisco 93.838 5R37HL051856-15 7,225 7,225

Lung Diseases Research University of Iowa 93.838 5R21HL091808-02 113,279 113,279

University of Maryland 93.838 1R01HL091490-01A1 19,321 19,321

University of Pennsylvania 93.838 1R01HL097796-01 70,660 70,660

Xemed LLC 93.838 (46,212) (46,212)

Maternal and Child Health Federal Consolidated Programs National Coalition for Health Profession 93.110 U33MC12786 219,020 219,020

Medical Library Assistance American College of Surgeons 93.879 5G08LM009537-02 12,497 12,497

Brigham and Women's Hospital 93.879 5U54LM008748-04 (13,801) (13,801)

Brigham and Women's Hospital 93.879 5U54LM008748-05 (117,467) (117,467)


60





Medical Library Assistance Brigham and Women's Hospital 93.879 5U54LM008748-06 1,099,865 1,099,865

Partners HealthCare System, Inc. 93.879 5U54LM008748-05 15,095 15,095

The Methodist Hospital Research Institute 93.879 5G08LM008937-03 35,114 35,114

Mental Health Research Career/Scientist Development Awards Mayo Clinic 93.281 5R01GM028835-25 (12,498) (12,498)

Mental Health Research Grants Baylor College of Medicine 93.242 5R01MH074791-02 21,023 21,023

Beth Israel Deaconess Medical Center 93.242 1U01MH081928-03 164,638 164,638

Beth Israel Deaconess Medical Center 93.242 3RO1MH056956-12S1 81,071 81,071

Beth Israel Deaconess Medical Center 93.242 5P50MH080272-02 204,535 244,785 32,197 481,517

Beth Israel Deaconess Medical Center 93.242 5P50MH080272-03 579,894 94,106 674,000

Beth Israel Deaconess Medical Center 93.242 5R01MH056956-12 96,354 96,354

Boston University 93.242 5R21MH072165-04 (141) (141)

Brigham and Women's Hospital 93.242 1R01MH084676-01 12,354 12,354



Butler Hospital 93.242 1P50MH086400-01 160,671 160,671

Butler Hospital 93.242 5U01MH076179-03 99,334 99,334

Children's Hospital of Boston 93.242 1R01MH087786-01 22,396 22,396

Children's Hospital of Boston 93.242 5R01MH085143-02 5,062 5,062

CIMIT 93.242 1R01MH082922-01A2 10,806 10,806

CIMIT 93.242 1R01MH086026-01 61,581 61,581

CIMIT 93.242 1R01MH090326-01 21,571 21,571

CIMIT 93.242 5R01MH073445-03 123 123

CIMIT 93.242 5R01MH085542-02 74,875 74,875

Harvard Medical School 93.242 5R01MH040799-23 77,402 204,545 281,947

Harvard Medical School 93.242 5R01MH054693-11 58,137 58,137

Harvard Medical School 93.242 K01 MH071714 123,900 123,900

Harvard Medical School 93.242 R01 MH62028-03 (23,618) (23,618)

Harvard School of Public Health 93.242 5R01MH078928-04 375,139 40,994 416,133

Harvard University 93.242 2R01MH31340 (12,631) (12,631)

Harvard University 93.242 5R01MH057915-03 (301) (301)

Harvard University 93.242 5R01MH068376-05 50,964 50,964

Healthcare Technology Systems, Inc. 93.242 2R44MH068950-02 193,985 193,985

Internet Solutions for Kids, Inc. 93.242 1R01MH080662-01 12,285 12,285

Judge Baker Children's Center 93.242 7R01MH065877-05 50,978 50,978

Kennedy Krieger Institute 93.242 5R01MH059630-08 52,881 52,881

Mass General Hospital-CIMIT 93.242 5R01MH073445-04 105,897 105,897

Mass General Hospital-CIMIT 93.242 5R01MH073445-3 213,988 213,988

McLean Hospital 93.242 5P50MH060450-09 179,809 179,809

McLean Hospital 93.242 5R01MH070730-04 7,652 7,652

McLean Hospital 93.242 5R01MH073998-02 74,867 74,867

Medical College of Georgia 93.242 3U01MH070011-03-S2 2,772 2,772

Massachusetts General Hospital 93.242 5R01MH073445-03 29,305 29,305

Mount Sinai School of Medicine 93.242 5P5OMH066172-08 58,679 58,679

New England Research Institute, Inc. 93.242 R01MH081824 38,270 38,270

President and Fellows of Harvard College 93.242 1R01MH081862-01A2 52,195 52,195

President and Fellows of Harvard College 93.242 1R01MH087544-01 67,755 67,755


President and Fellows of Harvard College 93.242 5 R01 MH054693-11 43,720 43,720

President and Fellows of Harvard College 93.242 5R01MH060734-08 1 1


Research Foundation of State University 93.242 1U01MH085551801 67,999 67,999

Research Foundation of State University 93.242 5R01MH066877-09 70,990 70,990

Social and Scientific Systems, Inc. 93.242 1U01AI068632-01 4,201 4,201

Social and Scientific Systems, Inc. 93.242 BRS-IMPCT-Q-09-00341 241,012 241,012

Tourette Syndrome Association 93.242 5R01MH070802-04 16 16

Trustees of Boston University 93.242 1R21MH086079-01A2 5,696 5,696

University of California at Los Angeles 93.242 5R01MH078773-02 53,337 53,337

University of Iowa 93.242 5U01MH070010-05 4,228 4,228

University of Massachusetts 93.242 5U01MH088278-02 628,687 628,687

University of Massachusetts at Worcester 93.242 3U01MH088278-02S1 8,454 8,454

University of North Carolina, Chapel Hill 93.242 5R01MH077139-02 145,875 145,875

University of Puerto Rico 93.242 1R01MH081975-01A1 467,946 467,946

University of Rochester 93.242 1P50MH086400-02 317,001 317,001


61





Mental Health Research Grants University of Rochester 93.242 5R01MH073111-04 90,937 90,937

University of Southern California 93.242 1R01MH085548-01 53,016 53,016

University of Texas Southwestern Medical 93.242 2P50MH066172-06 (21,925) (21,925)

University of Texas Southwestern Medical 93.242 5P50MH66172-05 91 91

University of Texas Southwestern Medical 93.242 N01MH090003 15,751 15,751

University of Utah 93.242 1R01MH080826 25,013 25,013

University of Utah 93.242 5R01MH084795-02 145,529 145,529

University of Washington 93.242 1R01MH084759-01 18,522 18,522

Yale University School of Medicine 93.242 2R01MH65869-09 224,299 224,299

Microbiology and Infectious Diseases Research Aridis, LLC 93.856 5R41AI072866-02 (2,281) (2,281)

Beth Israel Deaconess Medical Center 93.856 5P50CA101942-05 6,334 6,334

Beth Israel Deaconess Medical Center 93.856 5R01AT002454-04 (1,907) (1,907)



BioScale, Inc. 93.856 5R43AI067050-02 2,022 2,022

Brandeis University 93.856 5U01AI075466-03 41,617 41,617

Brigham and Women's Hospital 93.856 5U19AI046130-08 (62,261) (62,261)

Children's Hospital of Boston 93.856 5U01AI025934-18S1 (18,374) (18,374)

Children's Hospital of Boston 93.856 N01-LM3-3515 (9,319) (9,319)

Dana Farber Cancer Institute 93.856 5P30AI028691-15 (26,177) (26,177)

Duke University 93.856 U19 AI067854 (20,161) (20,161)

Harvard Medical School 93.856 3U01AI027659-19 (297) (297)

Harvard Medical School 93.856 5P30AI060354 (1,569) (1,569)

Harvard Medical School 93.856 5P30AI060354-04 140,677 140,677


Harvard Medical School 93.856 5P30AI60354 (55) (55)

Harvard Medical School 93.856 P30AI060354 14 14

Harvard Medical School Centers for Aids 93.856 5P30AI060354-05 (20,654) (20,654)

Harvard Medical School Centers for Aids 93.856 P30AI060354 7,953 7,953

President and Fellows of Harvard College 93.856 5U54AI057159-03 (200) (200)

Primary Immunodeficiency Research Consortium 93.856 N01AI030070 (3,500) (3,500)

University of California at San Francisco 93.856 N01AI015416 (1,980) (1,980)

University of Massachusetts at Worcester 93.856 5R01AI052455-05 287 287

Minority Health and Health Disparities Research Harvard Pilgrim Health Care 93.307 1R01MD003963 373,400 373,400

University of Massachusetts 93.307 5P20MD002290-03 8,523 8,523

National Center for Research Resources American College of Radiology 93.389 U10CA021661 122,852 122,852

Brigham and Women's Hospital 93.389 2P41RR013218-13 29,661 29,661

Brigham and Women's Hospital 93.389 5U41RR019703-05 31,250 31,250

Harvard Catalyst - The Harvard Clinical 93.389 1UL1RR025758-01 105,145 88,422 193,567

Harvard Medical School 93.389 1UL1RR025758-01 3,636,931 3,636,931

Harvard Medical School 93.389 5UL1RR025758-02 840,805 840,805

Harvard Medical School Centers for Aids 93.389 (570) (570)

Harvard University 93.389 1 UL1 RR 025758-01 5,546 5,546

Harvard University 93.389 1 UL1 RR025758-01 1,480,999 1,480,999

Harvard University 93.389 1KL2RR025757-01 10,753 10,753

Harvard University 93.389 1UL1RR025758-01 17,148 51,579 68,727

Harvard University 93.389 5UL1 RR025758-02 454,484 454,484

Harvard University 93.389 5UL1 RR025758-03 1,523,727 1,523,727

Harvard University 93.389 5UL1RR025758-02 5,322,733 5,322,733

Harvard University 93.389 5UL1RR025758-03 258,105 258,105

Harvard University 93.389 61,197 61,197

Mass General Hospital-CIMIT 93.389 5U24RR021382-05 178,673 178,673

President and Fellows of Harvard College 93.389 1 UL 1 RR025758-01 14,588 14,588

President and Fellows of Harvard College 93.389 1U1RR025758-01 48,189 48,189

President and Fellows of Harvard College 93.389 1UL1RR025758 18,592 18,592

President and Fellows of Harvard College 93.389 1UL1RR025758-01 1,018 209,106 45,042 255,166

President and Fellows of Harvard College 93.389 1UL1RR025758-02 43,741 22,634 66,375

President and Fellows of Harvard College 93.389 1ULRR025758-02 3,918 3,918

President and Fellows of Harvard College 93.389 5 UL1 RR025758-02 35,562 35,562

President and Fellows of Harvard College 93.389 5UL1 RR025758-03 48,819 48,819

President and Fellows of Harvard College 93.389 5UL1RR025758-02 571,037 480,541 30,353 15,289 1,097,220

President and Fellows of Harvard College 93.389 5UL1RR025758-03 5,226 13,838 19,064

President and Fellows of Harvard College 93.389 5ULRR025758-02 46,923 46,923


62





National Center for Research Resources President and Fellows of Harvard College 93.389 5ULRR025758-03 2,259 2,259

President and Fellows of Harvard College 93.389 U01RR025758-01 50,316 50,316

President and Fellows of Harvard College 93.389 UL1RR025758 26,889 26,889

President and Fellows of Harvard College 93.389 UL1RR025758-01 47,157 47,157

President and Fellows of Harvard College 93.389 UL1RR025758-02 40,487 40,487

President and Fellows of Harvard College 93.389 4,344 4,344

Roger Williams General Hospital 93.389 2P20RR018757-06 14,152 14,152

University of California at Irvine 93.389 5U24RR021992-04 211,608 211,608

University of California at Irvine 93.389 5U24RR021992-05 356,143 356,143

University of Southern California 93.389 5U24RR025736-02 583,679 583,679

National Center on Sleep Disorders Research Beth Israel Deaconess Medical Center 93.233 1P01HL095491-01A1 111,873 111,873

Beth Israel Deaconess Medical Center 93.233 1R01HL074972-03 24,718 24,718

Beth Israel Deaconess Medical Center 93.233 5P50HL060292-10 (24) (24)

National Institutes of Health Contracts Abt Associates, Inc. 93. 24538 HHSA2902006000 145,315 145,315

Abt Associates, Inc. 93. HHSA290200600011I 44,308 44,308

Abt Associates, Inc. 93. 8,562

Altarum Institute 93. HHS2502006460281 17,675 17,675

Altarum Institute 93. HHSH250200646028I 300,992 300,992

American College of Radiology 93. CA80098 56,929 56,929

AstraZeneca 93. 27,179

Battelle, Columbus Division 93. TCN 07304 (34,243) (34,243)

Battelle, Columbus Division 93. W911NF-07-D-0001 309,583 309,583

Beth Israel Deaconess Medical Center 93. 7,302 7,302

Beth Israel Deaconess Medical Center 93. 06-149 IL-2 17,032 17,032

Beth Israel Deaconess Medical Center 93. 1-2004-355P (7) (7)

Beth Israel Deaconess Medical Center 93. 2R01NS040237-06 (10,634) (10,634)

Beth Israel Deaconess Medical Center 93. 5U19AI057330-05 (30,549) (30,549)

Beth Israel Deaconess Medical Center 93. 7UOIAI051706-05 (10) (10)

Boston BioCom LLC 93. N66001-10-1-2132-S01 113,139 113,139

Boston University 93. N01-HC-25195 740,168 740,168

Brigham and Women's Hospital 93. 16,271 16,271

Case Western Reserve University 93. HHSN275200503403C 132,750 132,750

Children's Hospital of Boston 93. HHS267200800001C 76,418 76,418

Children's Hospital of Boston 93. HHSN266200400030C 217,832 217,832

Children's Hospital of Boston 93. (2,815) (2,815)

CRP, Incorporated 93. 22,192 22,192

Dana Farber Cancer Institute 93. 999118 11,454 11,454

Duke University 93. N01A05419 16,022 16,022

Family Health International 93. 200-2006-19092 59,597 59,597

George Washington University 93. HHSP23320045013XI 222,872 222,872

Harvard Medical School 93. 5T32MH01625-92-7 (4,786) (4,786)

Harvard Medical School 93. 9920070047 273 273

Harvard Pilgrim Health Care 93. 200-2002-00732 64,435 64,435

Harvard Pilgrim Health Care 93. 5R01PH000032-02 15,084 15,084

Harvard Pilgrim Health Care 93. HHSA2902005003I-TO5 (1,738) (1,738)

Harvard Pilgrim Health Care 93. HHSF2232009100061 138,977 138,977

Johns Hopkins University 93. HHSN268200736197C 230,652 230,652

LiveData, Inc. 93. 45,063 45,063

Los Alamos National Laboratory 93. 74092-001-09 45,460 45,460

Luna Innovations 93. FA9550-09-C-0088 665 665

Massachusetts General Hospital 93. 10,578 10,578

Massachusetts Institute of Technology 93. NNX08AX15G 39,890 39,890

Mayo Clinic 93. N01-CN 35000 5,716 5,716

McGill University 93. (70,289) (70,289)

Michigan State University 93. 61-8794-995 7,085 7,085

Mount Sinai School of Medicine 93. HHSN272200900032C 236,476 236,476

NCIRE- 93. P41 RR02953 69,169 69,169

New England Research Institute, Inc. 93. 1N01HC45207 101 101

New England Research Institute, Inc. 93. HHSN268200425207C 213,839 213,839

New England Research Institute, Inc. 93. N01HC045207 536 536

NIH-NCI National Cancer Institute 93. HHSN261201000082C 6,727 6,727

Ohio State University 93. HHSN26800764316C (11,589) (11,589)

Physical Sciences, Inc. 93. W81XWH-06-C-0408 (11,822) (11,822)


63





National Institutes of Health Contracts Prostate Cancer Foundation 93. 52,443 52,443

Psychological Applications, LLC 93. R43N5061388-01A2 (241) (241)

Radiation Monitoring Devices, Inc. 93. A205336 30,373 30,373

RAND Corporation 93. HHSP23320095649WC 145,931 145,931

Regents of the University of California 93. N01-AI-15416 284 284

Rutgers University 93. W81XWH-08-2-0034 657,790 657,790

Rutgers University 93. (4,701) (4,701)

SAIC-Frederick, Inc. 93. 28XS091 165,915 165,915

SAIC-Frederick, Inc. 93. 28YS259 2,903 2,903

SAIC-Frederick, Inc. 93. 29XS119 222,150 222,150

SAIC-Frederick, Inc. 93. HHSN261200800001E 35,017 35,017

Stanford University 93. 745090-HHSN272200800 302,589 302,589

Starr Foundation 93. 27,787 27,787

Strang Cancer Prevention Center 93. N01-CN-95015 4,588 4,588

Strang Cancer Prevention Center 93. N01-CN-95015-MAO 4,143 4,143

T.R.U.E. Research Foundation 93. W81XH-06-2-0033 265,656 265,656

Tufts University 93. N01 AI30050 (25,426) (25,426)

Ultra Diagnostics, Inc. 93. W81XWH-08-1-0152 572,858 572,858

University of Alabama 93. N01HV58198 62,041 62,041

University of Arizona 93. 223-03-8723 (2,772) (2,772)

University of California at San Francisco 93. N01A115416 633,927 633,927

University of California at San Francisco 93. N01AI15416 100,439 100,439

University of Florida 93. HHSN26620070023C 214,145 214,145

University of Massachusetts Medical 93. N01LM63508 (31) (31)

University of Minnesota 93. HHSP233200800270A 26 26

University of Pittsburgh 93. HHSO1000C00800062C 87,350 87,350

University of Rochester 93. HHSN271200700018C 23,558 23,558

University of Texas 93. U19AI070412091 81,804 81,804

University of Texas Southwestern Medical 93. 205017 (3) (3)

University of Wisconsin - Madison 93. HHSN242200900052 23,600 23,600

University of Wisconsin - Madison 93. N01-AI025496 48,485 48,485

Wake Forest University 93. HHSN268200464221C 12,596 12,596

Washington University 93. N01-HD-2-3343 (3,198) (3,198)

Weill-Cornell Medical College 93. N01CN95015 167,056 167,056

Westat, Inc. 93. 24,597 24,597

NIEHS Superfund Hazardous Substances Basic Research Dartmouth College 93.143 5P42ES007373-16 25,870 25,870

and Education President and Fellows of Harvard College 93.143 70,648 70,648

Nursing Research Boston University 93.361 5R01NR010815-04 170,515 170,515

Columbia University 93.361 5R21NR010710-02 427 427

Occupational Safety and Health Program California Pacific Medical Center 93.262 R01AG026720 12,654 12,654

CIMIT 93.262 3U190H008861-03S1 57,660 57,660

Harvard School of Public Health 93.262 1U19OH008861-01 143,000 143,000

Ohio State Univ Research Foundation 93.262 1R01OH008649-01A1 (15,231) (15,231)

University of Maryland 93.262 7R01OH008649-04 17,586 17,586

University of Massachusetts at Lowell 93.262 5R01OH008254-04 (1,283) (1,283)

Oral Diseases and Disorders Research Brigham and Women's Hospital 93.121 1R01DE019938-01 115,604 115,604

Harvard Medical School 93.121 5 P01 DE012467-05 (25,389) (25,389)

New England Medical Center (NEMC) 93.121 5R01DE015302-05 6,884 6,884

Physical Sciences, Inc. 93.121 1R44DE019047-01A2 33,048 33,048

Physical Sciences, Inc. 93.121 4R22DE019047-02 137,693 137,693

Physical Sciences, Inc. 93.121 5R44DE014803-02 (30,704) (30,704)

University of Puerto Rico 93.121 5R01DE017176-03 48,544 48,544

Population Research Children's Hospital of Boston 93.864 1K99HD061981-01 75,106 75,106

President and Fellows of Harvard College 93.864 1R21HD059955-01A1 91,439 91,439

Rapid Expansion of Antiretroviral Therapy Programs for Harvard School of Public Health 93.266 U51HA02522-06 225,792 225,792

HIV-Infected Persons in Selected Countries in Africa and

the Caribbean Under the President's Emergency Plan for

AIDS Relief Weill-Cornell Medical College 93.266 6U91HA06801-04 105,468 105,468

Research and Training in Complementary and Alternative Albany Medical College 93.213 1R21AT00337-10-1A1 4,070 4,070

Medicine Boston University Medical Center 93.213 5R21AT004015-02 34,125 34,125

CIMIT 93.213 2R01AT004714-02 324,262 324,262

CIMIT 93.213 5R21AT004497-02 16,087 16,087

CIMIT 93.213 5U01AT000613-08 113,869 113,869


64





Research and Training in Complementary and Alternative CIMIT 93.213 5UO1AT000613-07 9,748 9,748

Medicine CIMIT 93.213 R01AT005280-01A1 175 175

Harvard Medical School 93.213 5R21AT003503-04 112,074 112,074

President and Fellows of Harvard College 93.213 5K24AT004095-03 242 242

President and Fellows of Harvard College 93.213 5K24AT004095-04 10,305 10,305

University of Maryland 93.213 5P01AT002605-04 60,891 60,891

University of Washington 93.213 1 R21 AT002895-01A2 33,280 33,280

Wake Forest University 93.213 5P50AT002782-05 299,921 299,921

Research on Healthcare Costs, Quality and Outcomes Board of Trustees of the University of Illinois 93.226 5U18HS016973-03 84,128 84,128

Brigham and Women's Hospital 93.226 1R18HS017030 1,981 1,981

Brigham and Women's Hospital 93.226 5 U18HS016970-03 35,762 35,762

Brigham and Women's Hospital 93.226 5R18HS017151-03 125,547 125,547

Children's Hospital of Philadelphia 93.226 5U18HS016678-02 (193) (193)

Harvard Pilgrim Health Care 93.226 5R18 HS017201-03 100,384 100,384

Harvard Pilgrim Health Care 93.226 5R18HS017045-02 186,146 186,146

Harvard School of Public Health 93.226 5R18HS17048-02 (418) (418)

President and Fellows of Harvard College 93.226 1R01HS018533-01 101,337 101,337

Radianse, Inc. 93.226 5R44RR018076-03 404 404

RAND Corporation 93.226 7R18HS017048-03 54,377 54,377

Rutgers University 93.226 1U18HS017918-01 139,264 139,264

University of Alabama, Birmingham 93.226 1U18HS017919-01 154,802 154,802

University of Massachusetts at Amherst 93.226 1R03HS018795-01 10,273 10,273

University of Massachusetts Medical Center 93.226 5R01HS015430-03 (196) (196)

Yale University School of Medicine 93.226 5U18HS016978-03 204,933 204,933

Research Related to Deafness and Communication Disorders Boston University 93.173 1R21DC010461-01 67,500 67,500

Boston University 93.173 5U19DC003610-11 (2,803) (2,803)

Harvard Medical School 93.173 5R01DC002281-13 (50) (50)

Harvard University 93.173 5R01DC006842-04 159,902 159,902

Regents of the University of California 93.173 2R01DK035423-19A1 162,327 162,327

Sensimetrics Corporation 93.173 1R41DC008722-01-A1 (10,805) (10,805)

University of South Carolina 93.173 1R01DC007640-01A2 155,651 155,651

Wesleyan University 93.173 5R01DC006267-04 (12,468) (12,468)

Resource and Manpower Development in the Environmental Massachusetts Institute of Technology 93.894 2P30ES002109 240 240

Health Services

Telehealth Network Grants Regional Medical Center at Lubec 93.211 G22TH07769 (3,772) (3,772)

Trans-NIH Recovery Act Research Support Allen Institute for Brain Science 93.701 1RC2MH089921-01 452,826 452,826

Arkansas Children's Hospital Research Institute 93.701 1R01MH089466-01 129,233 129,233

Beth Israel Deaconess Medical Center 93.701 1R01CA130895-01A2 36,499 36,499

Beth Israel Deaconess Medical Center 93.701 1R01HL091874-01A1 239,200 239,200

Beth Israel Deaconess Medical Center 93.701 1R21DK082987-01A1 51,538 51,538

Beth Israel Deaconess Medical Center 93.701 1RC1CA146596-01 12,041 12,041

Beth Israel Deaconess Medical Center 93.701 1RC1EB011001-01 11,584 11,584

Beth Israel Deaconess Medical Center 93.701 1RC1HL100110-01 211,941 211,941

Beth Israel Deaconess Medical Center 93.701 1RC2CA147940-01 520,558 520,558

Beth Israel Deaconess Medical Center 93.701 3U01AI066331-05S1 39,064 39,064

Boston Medical Center 93.701 3P30DK046200-17S1 9,511 9,511

Brigham and Women's Hospital 93.701 1R01HD057963-01A2 31,675 31,675


Brigham and Women's Hospital 93.701 1RC1LM010460-01 5,368 5,368

Brigham and Women's Hospital 93.701 2P30AR042689-16 24,916 24,916

Brigham and Women's Hospital 93.701 3U01AI063623-05S1 741,734 741,734

Brigham and Women's Hospital 93.701 3U54EB005149-05S3 135,630 135,630

Broad Institute 93.701 1RC2MH089905-01 103,944 103,944

Broad Institute 93.701 1RC2AG036547-01 18,448 18,448

Broad Institute 93.701 1RC2AG036650-01 12,249 12,249

Broad Institute 93.701 1RC2MH089905-01 9,855 9,855

Broad Institute 93.701 3U54HG004570-03S1 165,746 165,746

Brown University 93.701 1RC1HD063931-01 132,040 132,040

Case Western Reserve University 93.701 1RC2HL101417-01 286,556 286,556

Case Western Reserve University 93.701 3U19AI076981-03S1 9,418 9,418

Children's Hosp and Med Center, Seattle 93.701 1RC1AR058605-01 67,411 67,411

Children's Hospital 93.701 1RC2HL102815-01 87,482 87,482

Children's Hospital of Boston 93.701 1R21DK082661-01A1 74,934 74,934


65





Trans-NIH Recovery Act Research Support Children's Hospital of Boston 93.701 1RC1HL099618-01 92,412 92,412


Columbia University 93.701 3R01CA104842-05 84,452 84,452

Columbia University 93.701 5R01AI084074-03 35,026 35,026


Dana Farber Cancer Institute 93.701 1RC2CA148185-01 57,355 57,355

Dana Farber Cancer Institute 93.701 1RC2HL101367-01 110,830 110,830





Dana Farber Cancer Institute 93.701 3U01CA062490-16S1 164,084 164,084





Dartmouth College 93.701 2R01AR049834-06A1 36,792 36,792

Duke University 93.701 2R01CA076016-11A1 27,921 27,921

Fraunhofer ITWM 93.701 1R21AI079474-01A1 39,484 39,484

Fred Hutchinson Cancer Research Center 93.701 1RC2CA148286-01 42,020 42,020

Fred Hutchinson Cancer Research Center 93.701 3R01CA059045-12S1 188,715 188,715

Harvard Medical School 93.701 1RC2GM093080-01 558,568 558,568

Harvard Pilgrim Health Care 93.701 1RC1HD063590-01 75,568 75,568

Harvard School of Public Health 93.701 2R01HL060712-10 189,381 189,381

Harvard School of Public Health 93.701 3R01ES014433-3S1 191,478 191,478

Johns Hopkins University 93.701 1RC2NS069395-01 13,111 13,111

Johns Hopkins University 93.701 3P50ES015903-03S1 5,004 5,004

Joslin Diabetes Center 93.701 3P30DK036836-23S2 28,150 28,150

Kaiser Foundation Research Institute 93.701 1RC2HL101589 330,610 330,610

Louisiana State University 93.701 1RC2AT005909-01 441,242 441,242

Maine Medical Center 93.701 1R24DK084970-01 129,414 129,414

Maine Medical Center 93.701 3R01AR054604-03S1 265,072 265,072

Massachusetts Eye and Ear Infirmary 93.701 3R01EY015473-05S1 81,840 81,840

Massachusetts Eye and Ear Infirmary 93.701 7P01AI083214-02 138,050 138,050

Massachusetts Institute of Technology 93.701 1R01HL090856-01A1 174,876 174,876

Massachusetts Institute of Technology 93.701 1RC1AG035711-01 173,591 173,591

Massachusetts Institute of Technology 93.701 1RC1AI086152-01 74,097 74,097

Massachusetts Institute of Technology 93.701 1RC1NS088103-01 72,625 72,625

Massachusetts Institute of Technology 93.701 1RC1RR028241-01 25,517 25,517

Massachusetts Institute of Technology 93.701 1RC2DE020919-01 218,261 218,261

Massachusetts Institute of Technology 93.701 1RC2DE020919-1 34,638 34,638

Massachusetts Institute of Technology 93.701 3U54CA119349-05S1 164,345 164,345

MAT TEK, Inc. 93.701 2R44AR052982-02 36,654 36,654

Medical College of Georgia 93.701 3U24DK076169-04S2 66,506 66,506

MEEI 93.701 1P01AI083214-01 74,685 74,685

NCIRE- 93.701 1RC2AG036535-01 155,405 155,405

NCIRE- 93.701 3P41RR023953-02S1 70,530 70,530

New York University School of Medicine 93.701 1RC1HL100815-01 214,397 214,397

Ohio State University 93.701 1R01NS064275-01A1 75,581 75,581

Physical Sciences, Inc. 93.701 3R44CA128364-03S1 62,029 62,029

Physical Sciences, Inc. 93.701 4R44CA128364-02 150,541 150,541

President and Fellows of Harvard College 93.701 1R01HD056940-01A2 360,981 360,981

President and Fellows of Harvard College 93.701 1R03CA130068-01A2 29,979 29,979

President and Fellows of Harvard College 93.701 1RC1DK087289-01 145,664 145,664

President and Fellows of Harvard College 93.701 1RC2HG005693-01 238,782 238,782

President and Fellows of Harvard College 93.701 3UL1RR025758-02S1 42,626 321,370 363,996

President and Fellows of Harvard College 93.701 5R01CA067262-14S1 108,015 108,015

President and Fellows of Harvard College 93.701 P51RR000168-48S2 81,429 81,429

President and Fellows of Harvard College 93.701 R21MH083205-01A1 11,627 11,627

Regents of the University of California 93.701 1RC2DA029475-01 79,439 79,439

Regents of the University of Minnesota 93.701 3P50DK083007-02S2 16,943 16,943

Rush University Medical Center 93.701 1R21ES016829-01A1 58,734 58,734

Rush University Medical Center 93.701 1RC2AG036650-01 91,104 91,104


66





Trans-NIH Recovery Act Research Support Schepens Eye Research Institute 93.701 1P01AI083214-01 566,540 566,540

The Methodist Hospital Research Institute 93.701 3G08LM008937-02S1 21,630 21,630

Tourette Syndrome Association 93.701 3U01NS040024-07S1 456,883 456,883

Tufts University 93.701 1RC2ES018822-01 90,037 90,037

University of Alabama 93.701 3U01NS042685-04S1 1,067 1,067

University of Alabama, Birmingham 93.701 1RC2AR058964-01 39,203 39,203

University of California at Berkeley 93.701 3U01HG004258-03S1 40,643 40,643

University of California at Irvine 93.701 1RC2NS069422-01 291,962 291,962

University of California at Los Angeles 93.701 1RC1AG035664-01 39,927 39,927

University of California at San Diego 93.701 1RC2AG036535-01 312 312

University of California at San Diego 93.701 3P01AI074621-03S1 14,092 14,092

University of Chicago 93.701 1RC2HL101651-01 116,751 116,751

University of Cincinnati 93.701 2R01NS039512-06A1 57,365 20,493 77,858

University of Colorado 93.701 1RC2CA148394-01 83,016 165,750 248,766

University of Colorado 93.701 2R01DK060590-06A2 55,462 55,462

University of Colorado 93.701 3UL1RR025780-02S3 15,387 15,387

University of Medicine and Dentistry of New Jersey 93.701 1RC2HL101458-01 56,509 56,509

University of North Carolina, Chapel Hill 93.701 1U34DK084511-01 39,021 39,021

University of North Carolina, Chapel Hill 93.701 2R01CA074015-11A1 37,067 37,067

University of Pennsylvania 93.701 1RC2HL101864-01 490,747 490,747

University of Pittsburgh 93.701 1RC2AR058989-01 11,566 11,566

University of Pittsburgh 93.701 3P50GM076659-04S1 23,367 24,127 47,494

University of Pittsburgh, School of Medicine 93.701 1RC1NS068179-01 150,931 150,931


University of Washington 93.701 1RC2AG036528-01 3,240 3,240

University of Wisconsin - Madison 93.701 3P01NS042803-07S2 96,373 96,373

Vanderbilt Medical Center 93.701 3R24TW007988-02S1 17,686 17,686

Wistar Institute 93.701 1RC2CA148325-01 141,692 141,692

Yale University School of Medicine 93.701 1RC2NS070340-01 176,162 176,162

Trans-NIH Research Support Broad Institute 93.310 1RL1GM084437-02 17,653 17,653

Broad Institute 93.310 6RL1GM084437-03 98,253 98,253

Massachusetts Institute of Technology 93.310 1-RL1-GM084437-01 (11,562) (11,562)

President and Fellows of Harvard College 93.310 1R21NS059404-01 14,337 14,337

Scripps Research Institute 93.310 5R01CA132630-03 62,821 62,821

Vision Research Brigham and Women's Hospital 93.867 5R01EY017001-04 58,923 58,923

Massachusetts Eye and Ear Infirmary 93.867 2R01EY015473-06A1 82,395 82,395

Massachusetts Eye and Ear Infirmary 93.867 5R01EY015473-05 101,357 101,357

New England Medical Center (NEMC) 93.867 2R01EY011309-11 79,691 79,691

Schepens Eye Research Institute 93.867 1R01EY019470-01 43,106 43,106

Subtotal - Department of Health and Human Services 58,775,858 58,200,539 1,821,831 1,122,278 119,884,765


Centers for Homeland Security Northeastern University 97.061 2008-ST-061-ED0001 38,457 38,457

Northeastern University 97.061 31,026 31,026

Subtotal - Department of Homeland Security - 69,483 - - 69,483

Department of Transportation

National Highway Transportation Safety Administration Foster-Miller, Inc. 20.614 8,775 8,775

(NHTSA) Discretionary Safety Grants

Subtotal - Department of Transportation - - 8,775 - 8,775

Department of Veterans Affairs

Blind Rehabilitation Centers Boston Veterans Affairs Medical Center 64.007 VA241-P-0594 (69) (69)

Subtotal - Department of Veterans Affairs - (69) - - (69)

Environmental Protection Agency

Science To Achieve Results (STAR) Research Program University of Michigan 66.509 RD-83374001 44,542 44,542

Subtotal - Environmental Protection Agency 44,542 - - - 44,542

National Aeronautics and Space Administration

Aerospace Education Services Program Massachusetts Institute of Technology 43.001 NNG05GK27G 73,668 73,668

National Space Biomedical Research Institute 43.001 HFP00002 136,406 136,406



67





National Aeronautics and Space Administration National Space Biomedical Research Institute 43.001 HFP01603 318,721 318,721

Aerospace Education Services Program National Space Biomedical Research Institute 43.001 HFP01605 7,631 7,631


National Space Biomedical Research Institute 43.001 HPF01301 178,267 178,267

National Space Biomedical Research Institute 43.001 NBPF02001 88,153 88,153

National Space Biomedical Research Institute 43.001 NRA03OBPR04 1 1

National Space Biomedical Research Institute 43.001 PF02101 55,827 55,827

National Space Biomedical Research Institute 43.001 SMST02201 85,859 85,859

Thomas Jefferson University 43.001 NNX09AM68G 25,216 25,216

Subtotal - National Aeronautics and Space Administration 1,280,171 159,527 - - 1,439,698


Biological Sciences Duke University 47.074 IOS-0929226 194,971 194,971

Duke University 47.074 MCB-0519898 (31,214) (31,214)

Pennsylvania State University 47.074 DBI-0850103 73,034 73,034

Regents of the University of Minnesota 47.074 DBI-0923827 177,766 177,766

Computer and Information Science and Engineering Northeastern University 47.070 IIS-0803622 121,887 121,887

University of Illinois at Urbana Champaign 47.070 CNS-0834709 27,670 27,670

University of Pennsylvania 47.070 CNS-08-34524 27,699 27,699

Education and Human Resources The Exploratorium 47.076 ESI-0639656 (91) (91)

Engineering Grants Massachusetts Institute of Technology 47.041 NSF05610 125,649 125,649

Northeastern University 47.041 1R01CA119617-01 (2,206) (2,206)

Northeastern University 47.041 CBET-0828772 33,705 33,705

Northeastern University 47.041 EEC-0946463 13,495 13,495

Social, Behavioral, and Economic Sciences President and Fellows of Harvard College 47.075 BCS-0322611/135909 1,844 1,844

Subtotal - National Science Foundation 73,034 535,674 (91) 155,592 764,209

Total Research and Development Passed Through Other Organizations 62,259,953$ 60,342,737$ 3,162,822$ 1,720,804$ 127,486,316$


68



RESEARCH TRAINING DIRECT PROGRAM CLUSTER



Military Medical Research and Development 12.420 280,880$ 270,227$ -$ -$ 551,107$

Subtotal - Department of Defense 280,880 270,227 - - 551,107


Aging Research 93.866 1,277,803 1,049,968 2,327,771

Alcohol Research Career Development Awards for Scientists 93.271 112,795 92,550 205,345

and Clinicians

Alcohol Research Programs 93.273 172,728 172,728

Allergy, Immunology and Transplantation Research 93.855 2,087,838 2,282,822 4,370,660

Arthritis, Musculoskeletal and Skin Diseases Research 93.846 2,573,157 1,143,280 3,716,437

Biomedical Research and Research Training 93.859 687,395 719,682 1,407,077

Biomedical Research Technology 93.371 537,399 169,504 706,903

Blood Diseases and Resources Research 93.839 329,767 (15,331) 314,436

Cancer Research Manpower 93.398 1,364,464 5,841,042 7,205,506

Cancer Treatment Research 93.395 159 159

Cardiovascular Diseases Research 93.837 5,642,419 2,740,852 8,383,271

Career Development Awards 93.277 182,156 238,755 420,911

Child Health and Human Development Extramural Research 93.865 803,698 346,580 1,150,278

Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 2,294,490 4,957,236 7,251,726

Digestive Diseases and Nutrition Research 93.848 49,989 183,189 233,178

Discovery and Applied Research for Technological Innovations 93.286 196,440 413,617 610,057


Drug Abuse and Addiction Research Programs 93.279 200,735 501,192 1,072,288 1,774,215

Drug Abuse National Research Service Award for Research 93.278 6,883 6,883

Training

Environmental Health 93.113 152,013 152,013

Extramural Research Programs in the Neurosciences and 93.853 1,366,927 2,594,980 139,766 4,101,673

Neurological Disorders

Human Genome Research 93.172 4,044 4,044

International Research and Research Training 93.989 289,405 225,662 515,067

Kidney Diseases, Urology and Hematology Research 93.849 585,578 788,473 1,374,051

Lung Diseases Research 93.838 1,539,842 756,297 2,296,139

Mental Health National Research Service Awards for 93.282 204,057 17,969 222,026

Research Training

Mental Health Research Career/Scientist Development Awards 93.281 124,876 2,262,481 475,861 2,863,218

Mental Health Research Grants 93.242 81,733 1,212,511 289,155 1,583,399

Microbiology and Infectious Diseases Research 93.856 (123) (123)

National Center for Research Resources 93.389 236,452 289,828 526,280

National Center on Sleep Disorders Research 93.233 394,774 394,774

National Research Service Award in Primary Care Medicine 93.186 383,284 383,284

National Research Service Awards Health Services Research 93.225 42,147 42,147

Training

Nurse Education, Practice and Retention Grants 93.359 544,411 544,411

Nursing Research 93.361 49,166 49,166

Oral Diseases and Disorders Research 93.121 47,934 10,692 58,626

Research and Training in Complementary and Alternative 93.213 490,433 490,433

Medicine

Research on Healthcare Costs, Quality and Outcomes 93.226 376,489 192,535 569,024

Research Related to Deafness and Communication Disorders 93.173 88,683 88,683

Trans-NIH Recovery Act Research Support 93.701 544,777 938,566 27,329 1,510,672

Trans-NIH Research Support 93.310 317,861 317,861

Vision Research 93.867 87,468 87,468

Subtotal - Department of Health and Human Services 24,733,993 31,337,328 2,360,556 - 58,431,877


Mathematical and Physical Sciences 47.049 (287) (287)

Biological Sciences 47.074 16,962 16,962

Subtotal - National Science Foundation 16,962 (287) - - 16,675

U.S. Department of State

Academic Exchange Programs - Graduate Students 19.400 26,252 26,252

Subtotal - U.S. Department of State - 26,252 - - 26,252

Total Research Training Direct Program Cluster 25,031,835$ 31,633,520$ 2,360,556$ -$ 59,025,911$


71


Schedule of Expenditures of Federal Awards


RESEARCH TRAINING PASSED THROUGH OTHER ORGANIZATIONS


Department of Energy

Office of Science Financial Assistance Program Northeastern University 81.049 DE-SC0001781 -$ 43,035$ -$ -$ 43,035$

Subtotal - Department of Energy - 43,035 - - 43,035


Aging Research Beth Israel Deaconess Medical Center 93.866 3-T32AG023480-05S1 9,941 9,941

Boston University 93.866 5T32AG000277-08 49,174 49,174

Harvard Medical School 93.866 2T32AG00222-16 50,571 50,571

Harvard Medical School 93.866 5T32AG000222-15 (5,037) (5,037)


Harvard Medical School 93.866 5T32AG00222-17 (10,974) 5,299 (5,675)


President and Fellows of Harvard College 93.866 5T32AG000222-18 31,212 31,212

Allergy, Immunology and Transplantation Research Beth Israel Deaconess Medical Center 93.855 5T32AI074549-02 30,278 30,278


Harvard Medical School 93.855 2T32AI007245-26 39,515 39,515





Harvard Medical School 93.855 T32 AI07061-31 27,747 27,747

Harvard School of Public Health 93.855 5 T32 AI007433-17 39,160 39,160

Harvard School of Public Health 93.855 5 T32AI007433-18 36,516 36,516

Harvard School of Public Health 93.855 5T32AI007433-17 (7,353) (7,353)

Harvard School of Public Health 93.855 5T32AI007433-18 47,460 47,460

President and Fellows of Harvard College 93.855 5P30AI060354-05 29,818 29,818

President and Fellows of Harvard College 93.855 T32AI07061-32 100,954 100,954

Arthritis, Musculoskeletal and Skin Diseases Research Brigham and Women's Hospital 93.846 2T32AR007098-32 (1,339) (1,339)

Biological Basis Research in the Neurosciences Harvard School of Public Health 93.854 5T32NS048005-05 22,009 22,009

Blood Diseases and Resources Research Children's Hospital of Boston 93.839 5K12HL087164-04 30,469 30,469

Harvard Medical School 93.839 5T32HL007623-22 (253) (253)

Harvard Medical School 93.839 5T32HL007623-24 48,076 48,076

President and Fellows of Harvard College 93.839 T32 HL07623-25 7,730 7,730

Cancer Centers Support Grants Dana Farber Cancer Institute 93.397 5P50CA090381-07 50,222 50,222

Cancer Research Manpower CIMIT 93.398 5R25CA092203-08 72,900 72,900

Dana Farber Cancer Institute 93.398 5T32CA09361-28 50,356 50,356

Harvard Medical School 93.398 5 T32 CA09031-32 12,739 12,739

Harvard School of Public Health 93.398 5T32CA009001-32 (6,725) (6,725)

Harvard School of Public Health 93.398 5T32CA009078-30 (13,959) (13,959)

Northwestern University 93.398 5K07CA109361-02 (1,988) (1,988)

President and Fellows of Harvard College 93.398 5T32CA009001-35 9,226 9,226

Cardiovascular Diseases Research Brigham and Women's Hospital 93.837 5T32DK007754-07 (1,267) (1,267)

Brigham and Women's Hospital 93.837 T32DK07754-08 (1,072) (1,072)

President and Fellows of Harvard College 93.837 5T32HL007623-23 51,401 51,401

Center for Medical Rehabilitation Research Albert Einstein Healthcare Network 93.929 5K12HD001097-12 (264) (264)

Child Health and Human Development Extramural Research Albert Einstein Healthcare Network 93.865 5K 12HD001097 12 241,357 241,357

Children's Hospital of Boston 93.865 5K12HD052896-04 58,243 58,243

Children's Hospital of Boston 93.865 5T32HD007466-12 (5,783) (5,783)

Children's Hospital of Boston 93.865 5T32HD007466-13 157,441 157,441

Harvard Medical School 93.865 5T32HD052961-05 131,677 131,677

Diabetes, Digestive, and Kidney Diseases Extramural Research Boston Medical Center 93.847 5K08DK070706-05 6,716 6,716

Brigham and Women's Hospital 93.847 5T32DK07754 1,064 1,064

CIMIT 93.847 2T32DK007754-11 102,052 102,052

Joslin Diabetes Center 93.847 5T32DK007260-31 (24,122) (24,122)

Joslin Diabetes Center 93.847 5T32DK063702-05 (9,138) (9,138)

Digestive Diseases and Nutrition Research Brigham and Women's Hospital 93.848 5T32DK007754-09 (497) (497)

Digestive Diseases and Nutrition Research Children's Hospital of Boston 93.848 5K08DK064256-05 (2,275) (2,275)

Joslin Diabetes Center 93.848 1F32DK080635-01 (8,897) (8,897)

Discovery and Applied Research for Technological Innovations Harvard Medical School 93.286 5T32EB001632-05 (81,142) (81,142)


Environmental Health Boston Medical Center 93.113 5K23ES013173-05 82 82

Extramural Research Programs in the Neurosciences and Harvard School of Public Health 93.853 5T32NS048005-06 50,831 50,831

Neurological Disorders Harvard School of Public Health 93.853 T32NS048005-06 65,041 65,041


72




RESEARCH TRAINING PASSED THROUGH OTHER ORGANIZATIONS


Human Genome Research Massachusetts Institute of Technology 93.172 5 T32 HG002295 12,108 12,108

International Research and Research Training Vanderbilt Medical Center 93.989 5R24TW007988-04 17,153 17,153

Vanderbilt University 93.989 5R24TW00798802 (654) (654)

Lung Diseases Research Harvard School of Public Health 93.838 5T32HL007118-33 46,186 46,186

Maternal and Child Health Federal Consolidated Programs President and Fellows of Harvard College 93.110 2T76MC00001-55-00 30,632 30,632

Medical Library Assistance Massachusetts Institute of Technology 93.879 2T15LM007092-17 (14,119) (14,119)

President and Fellows of Harvard College 93.879 5T15LM007092-18 72,241 72,241

Mental Health National Research Service Awards for Research American Psychiatric Institute for Research 93.282 5T32MH19126 58,052 58,052

Training Harvard Medical School 93.282 2T32MH016259-29A (858) (858)

Judge Baker Children's Center 93.282 2T32MH016259-30 30,266 30,266

Judge Baker Children's Center 93.282 5T32MH016259-30 29,520 76,640 106,160

Mental Health Research Grants American Psychiatric Institute for Research 93.242 5T32MH019126-18 (15,696) (15,696)

American Psychiatric Institute for Research 93.242 5T32MH19126-19 15,307 15,307

American Psychiatric Institute for Research 93.242 T32 MH19128-19 52,906 52,906

Children's Hospital of Boston 93.242 5K08MH07458-04 8,632 8,632

Harvard Medical School 93.242 5 T32 MH01629-23 (5,622) (5,622)

Microbiology and Infectious Diseases Research Harvard Medical School 93.856 5U54AI057159-05 (15,080) (15,080)

Harvard University Center for AIDS Research 93.856 5P30AI060354-05 13,970 13,970

National Center for Research Resources Harvard Medical School 93.389 5K30RR022292-09 (7,574) (7,574)

Harvard University 93.389 1KL2RR025757-01 172,642 172,642

President and Fellows of Harvard College 93.389 5KL2RR025757-02 468,667 186,726 655,393

President and Fellows of Harvard College 93.389 5KL2RR025757-03 220,608 220,608

National Institutes of Health Contracts Harvard School of Public Health 93. 2T32AI007433-16 (7,812) (7,812)

Harvard School of Public Health 93. 5T32CA009078-33 (19,644) (19,644)

National Research Service Award in Primary Care Medicine Beth Israel Deaconess Medical Center 93.186 5T32HP011001-21 (12,336) (12,336)

Beth Israel Deaconess Medical Center 93.186 HP12706-01 60,420 60,420

Brigham and Women's Hospital 93.186 T32HP10251-01 (23,241) (23,241)

Children's Hospital 93.186 5T32HP10018-16-00 60,266 60,266

Children's Hospital of Boston 93.186 2t32HP10018-15-00 51,618 51,618

Children's Hospital of Boston 93.186 5T32HP10018-17-00 11,167 11,167

Children's Hospital of Boston 93.186 5T32HS000063-13 (4,755) (4,755)

Children's Hospital of Boston 93.186 5T32NP010018-15 (775) (775)

Oral Diseases and Disorders Research Harvard Medical School 93.121 K12DE014528 (162) (162)

Population Research University of Pennsylvania 93.864 5T32HD040135-07 (14,988) (14,988)

Trans-NIH Research Support Harvard University 93.310 5KL2RR025757-03 107,001 107,001

Vision Research Boston Medical Center 93.867 5K23EY018668-02 884 884

Subtotal - Department of Health and Human Services 1,687,398 1,348,130 170,555 241,093 3,447,176


Engineering Grants Massachusetts Institute of Technology 47.041 EEC-0609299 3,069 3,069

Subtotal - National Science Foundation - 3,069 - - 3,069

Total Research Training Passed Through Other Organizations 1,687,398 1,394,234 170,555 241,093 3,493,280

Total Research and Development and Research Training Cluster 378,648,180$ 444,582,425$ 29,162,896$ 3,513,489$ 855,906,990$


73

Partners HealthCare System, Inc, and Affiliates



OTHER PROGRAM CLUSTER

CFDA Agency/Program CFDA # Pass-Through Number BWH MGH McLean Other Total

Department of Agriculture

Special Supplemental Nutrition Program for Women, Infants, and Children 10.557 INTF3502M03700915066 114,197$ -$ -$ -$ 114,197$

Special Supplemental Nutrition Program for Women, Infants, and Children 10.557 410,821 410,821

WIC Grants To States (WGS) 10.578 INTF3502M03700915059 786,887 786,887

WIC Grants To States (WGS) 10.578 267,612 267,612

Subtotal - Department of Agriculture 525,018 1,054,499 - - 1,579,517


Bilingual/Bicultural Service Demonstration Grants 93.105 0502503 62,083 62,083

Centers for Disease Control and Prevention Investigations and Technical Assistance 93.283 (417) 156,269 155,852

Coordinated Services and Access to Research for Women, Infants, Children, and Youth 93.153 INTF3712MM3802213228 75,908 75,908

Coordinated Services and Access to Research for Women, Infants, Children, and Youth 93.153 (17,924) (17,924)

Family Planning Services 93.217 FPHPA010203-37-00 7,315 7,315

Family Planning Services 93.217 122,917 122,917

Maternal and Child Health Services Block Grant to the States 93.994 INTF3314MM3703615003 (7,896) (7,896)

Maternal and Child Health Services Block Grant to the States 93.994 43,105 43,105

National Bioterrorism Hospital Preparedness Program 93.889 ASPR FFY2009 8,214 8,214

National Bioterrorism Hospital Preparedness Program 93.889 INTF6207PP1W97209837 (86) (86)

National Bioterrorism Hospital Preparedness Program 93.889 239,427 132,076 512,182 883,685

Subtotal - Department of Health and Human Services 366,710 454,281 - 512,182 1,333,173


Urban Areas Security Initiative 97.008 46,709 46,709

Subtotal - Department of Homeland Security 46,709 - - - 46,709

Department of Justice

Drug-Free Communities Support Program Grants 16.729 2005-JW-BX-K013 32,284 32,284

Subtotal - Department of Justice - 32,284 - - 32,284

Total Other Program Cluster 938,437$ 1,541,064$ -$ 512,182$ 2,991,683$

TOTAL FEDERAL EXPENDITURES 379,586,617$ 446,123,489$ 29,162,896$ 4,025,671$ 858,898,673$


74

Partners HealthCare System, Inc. and AffiliatesNotes to Schedule of Expenditures of Federal AwardsSeptember 30, 2010

75

1. Organization

Partners HealthCare System, Inc. (PHS) is the sole member of the Massachusetts GeneralHospital (MGH), Brigham and Women’s/Faulkner Hospitals, Inc. (BWF), NSMC HealthCare, Inc.(NSMC), Newton-Wellesley Health Care System, Inc. (NWHCS), Partners Continuing Care, Inc.(PCC), and Partners International Medical Services, LLC. PHS appoints the two physicians whoare the member of Partners Community Healthcare, Inc. (PCHI). The individual serving as thePHS President and Chief Executive Officer is the sole member of Partners Harvard MedicalInternational, Inc. (PHMI). PHS, together with all of its affiliates, is referred to as "Partners HealthCare."

2. Summary of Significant Accounting Policies

Basis of PresentationThe accompanying Schedule of Expenditures of Federal Awards includes the federal grant activityof Partners HealthCare System, Inc. and Affiliates ("Partners HealthCare") and is recorded on theaccrual basis of accounting. The Schedule does not include the federal grant activity of the MGHInstitute of Health Professions, Inc. (IHP), also an affiliate of Partners HealthCare. IHP maintains adifferent fiscal year-end (June 30) and has its own stand alone audit performed in accordance withthe OMB Circular A-133.

The information in this Schedule is presented in accordance with the requirements of OMB CircularA-133, Audits of States, Local Governments, and Non-Profit Organizations. Therefore, someamounts presented in this Schedule may differ from amounts presented in or used in thepreparation of the basic financial statements. Negative amounts represent adjustments to amountsreported as expenditures in prior years. Full CFDA and pass-through numbers are provided whereavailable.

The Schedule identifies expenditures (in separate columns) of The Brigham and Women'sHospital, Inc. (BWH), The General Hospital Corporation (MGH) and The McLean HospitalCorporation (McLean). The Schedule combines expenditures of The Spaulding RehabilitationHospital Corporation (Spaulding), North Shore Medical Center, Inc. (North Shore),Newton-Wellesley Hospital (NWH) and Faulkner Hospital, Inc. (Faulkner) under the column"Other". These entities are all affiliates of Partners HealthCare.

All expenditures reported in the Other column for Research and Development Direct Programs andResearch Training Pass Through Programs were made by Spaulding. In addition to Spaulding, theResearch and Development Pass Through Cluster includes expenditures of NWH under CFDAnumbers 12.420 and 93.371.

Under Other Programs, the Schedule includes total expenditures of $512,182 for CFDA number93.889 reported in the Other column. These expenditures include $368,642 for North Shore,$84,632 for NWH and $58,908 for Faulkner. In addition, expenditures for CFDA numbers 10.557,10.578, 93.105, 93.153, 93.217, 93.889 and 93.994 passed through the Commonwealth ofMassachusetts.

3. Brigham MRI Research Center

In March 2010, BWH received award #1G20RR031051-01, CFDA number 93.701 totaling$6,089,770 from the National Center for Research Resources of the Department of Health andHuman Services for purposes of constructing the Brigham MRI Research Center (BMRC). A


76

portion of the fiscal 2010 costs are included in the Construction Programs Cluster of the Schedule.Additional construction costs of $12,640 are capitalized in the Hospital’s financial statements andare therefore not reported on the face of the Schedule.

4. Facilities and Administrative Costs

The predetermined facilities and administrative cost rates were based on financial informationsubmitted utilizing the method prescribed in OASC-3. The Hospitals negotiated and were awardedpredetermined facilities and administrative cost rates and fringe benefit rates as follows:

Hospital Rate Type Period Covered Rate

BWH On-site research Oct 1, 2009 – Sep 30, 2010 78%

Off-site research Oct 1, 2009 – Sep 30, 2010 27%Fringe Oct 1, 2009 – Sep 30, 2010 27% - 35%

MGH On-site research Oct 1, 2009 – Sep 30, 2010 77%

Off-site research Oct 1, 2009 – Sep 30, 2010 27%

Fringe Oct 1, 2009 – Sep 30, 2010 11% - 35%

McLean Research Oct 1, 2009 – Sep 30, 2010 58%

Fringe Oct 1, 2009 – Sep 30, 2010 30%

Spaulding Research Oct 1, 2009 – Sep 30, 2010 65%

Fringe Oct 1, 2009 – Sep 30, 2010 10% - 35%

5. Subrecipients

During fiscal 2010, Partners HealthCare provided $101,550,990 to subrecipients in the Researchand Development and Research Training Cluster as follows. The amounts reported in the "Other"column are forSpaulding exclusively. These amounts are included in the accompanying Scheduleof Expendituresof Federal Awards:

MGH BWH McLean Other Total

Adcare Hospital of Worcester, Inc. -$ -$ 22,546$ -$ 22,546$

Albert Einstein Collegeof Medicine 435,467 435,467

American Academy ofPediatrics 137,022 137,022

American College of Radiology 131,036 131,036

American Medical Informatics Association 51,875 51,875

Arizona State University 240,360 44,190 284,550Arkansas Children's Hospital 137,013 137,013

Auburn University 177,900 177,900

Autism Speaks, Inc. 236,026 236,026

Battelle 912,709 912,709

Baylor College of Medicine, Inc. 457,591 468,513 926,104

Bedford VA ResearchCorporation, Inc. 269,015 269,015

Beth Israel DeaconessMedical Center 2,687,142 3,062,552 68,485 14,902 5,833,081

Boston College 79,179 45,838 125,017

Boston Medical Center 615,013 158,876 773,889

Boston University 1,384,287 1,466,358 245,654 111,206 3,207,506

Boston V A ResearchInstitute, Inc. 105,009 114,692 21,510 241,212

Brigham and Women'sHospital 4,663,427 44,986 4,708,413

Brown University 309,102 69,431 378,533

Butler Hospital 38,239 38,239

CAB Health & Recovery Services, Inc. 15,878 15,878

California Pacific Medical Center 79,347 79,347

Cambridge Health Alliance, Inc. 28,288 28,288


77


Cambridge Polymer Group, Inc. 71,732 71,732

Cardiff University 151,269 151,269Carnegie Mellon University 21,299 21,299

Case Western Reserve University 549,328 549,328

Centre National de la Recherche Scientifique 50,786 50,786

Charles Stark Draper Laboratory, Inc. 105,919 25,743 131,662

Children'sHospital Boston 1,261,133 1,801,965 11,784 3,074,882

Children'sMercy Hospital 35,897 35,897

CincinnatiChildren's HospitalMedical Center 185,062 185,062

ClevelandClinic 462,745 206,808 669,553

Colorado State University 11,621 377,044 388,665

ColumbiaUniversity 191,376 275,953 91,776 559,105

Dana Farber Cancer Institute 1,121,348 3,223,885 4,345,232

DartmouthCollege 442,522 1,428 443,950

Duke University 224,049 224,049

East Tennessee State University 35,962 35,962

Emory University 6,852 6,852

Fallon Clinic, Inc. 285,887 285,887

Fraunhofer ITWM 32,434 32,434

Fred Hutchinson Cancer Research Center 167,683 167,683

G E Global Research 445,917 445,917

George Washington University 127,596 127,596

Georgetown University 25,449 25,449Georgia Tech Research Corp 296,021 296,021Harvard Clinical Research Institute 261,156 261,156

Harvard Medical School 1,215 7,425 8,640

Harvard Pilgrim Healthcare 8,023 143,869 151,891

Harvard Vanguard Medical Assoc, Inc. 283,082 283,082

Harvey Mudd College 43,373 43,373

Hebrew Rehabilitation Center 57,517 57,517

Henry MJackson Foundation 355,450 355,450

Heriot Watt University 9,450 9,450

Holland Bloorview Kids Rehabilitation Hospital 241,222 241,222

Hospital for Special Surgery 82,219 82,219

IBM Corporation 100,240 100,240

Imperial College London 40,035 40,035

Indiana University 25,702 25,702

Institut National de la Recherche Scientifique 47,628 47,628

Instituto Nacional de Salud Publica 85,267 85,267

InternationalCentre for Diarrhoeal Disease Research 110,171 110,171

JacksonLaboratory 300,512 300,512

Johns Hopkins University 412,226 683,788 81,245 1,177,259

Joslin Diabetes Center, Inc. 1,149,102 260,103 1,409,205

Kaiser Foundation Research Institute 157,973 188,497 346,470

KarolinskaInstitute 10,337 64,800 75,137Kennedy Krieger Research Institute 94,475 94,475

Kitware, Inc. 653,344 653,344

Lahey Clinic, Inc. 265,160 265,160

Leiden University Medical Center 54,299 54,299

LouisianaState University 86,484 86,484

Loyola University Chicago 44,460 44,460

Magee Women's Hospital Corp 55,799 55,799

Massachusetts Eye and Ear Infirmary 41,078 77,202 118,280

Massachusetts General Hospital 8,145,559 89,857 113,692 8,349,108

Massachusetts Institute of Technology 4,270,493 1,636,872 5,907,365

Max Planck Institute 26,422 26,422

Mayo Clinic 18,800 67,771 48,427 134,998

McCord Hospital 10,141 10,141

McGill University 147,039 147,039

McLean Hospital 493,325 493,325

MemorialSloan Kettering Cancer Center 45,633 45,633

Mind Research Network 195,946 195,946

Miriam Hospital and Rhode Island Hospital 970,112 42,894 1,013,007

Mirtech, Inc. 167,048 167,048

Mount Sinai School of Medicine 163,751 205,278 369,028

National Institute of Public Health 35,150 35,150National Jewish Health 1,403,200 1,403,200National Research Institute of Tuberculosis and Lung Disease 79,683 79,683

Nederlands Kanker Institute - Antoni van Leeuwenhoek 69,080 69,080

New YorkMedical College 325,778 325,778

New YorkUniversity 66,615 13,000 79,615

Newark Beth Israel Medical Center 20,000 20,000

Northeastern University 278,195 105,589 79,172 462,956

Northwestern University 810,442 119,926 930,368

Ohio State University 189,365 189,365

Oregon Health and Science University 233,507 271,874 505,380

Ottawa Health Research Institute 139,683 139,683

Partners inHealth, Inc. 41,992 41,992

Pennsylvania State University 31,229 31,229

Presidentsand Fellows of Harvard College 2,201,683 7,615,015 44,332 5,702 9,866,733


78


Princeton University 124,998 124,998

Purdue University 49,382 49,382Queen's University 206,679 206,679

Queen's University Belfast 4,098 4,098

Regents of the University of Minnesota 15,000 169,235 184,235

Rensselaer PolytechnicInstitute 40,953 40,953

Research Foundation Mental Hygiene, Inc. 267,631 267,631

Research Foundation of the City University of New York 45,232 45,232

Research Foundation of the State University of New York 642,051 230,303 160,744 1,033,098

Research Institute of Nationwide Children's Hospitals 90,392 90,392

Rhode Island Hospital 409,415 10,770 420,185

Rush University Medical Center 111,393 24,544 135,937

Rutgers University 20,190 20,190

San Diego State University Foundation 297,653 297,653

Scripps Research Institute 824 824

Seoul National University Hospital 48,882 48,882

Socios en Salud Sucursal Peru 368,157 368,157

Southern Methodist University 134,806 134,806

Spaulding Rehabilitation Hospital 120,461 17,045 137,505

Stanford University 2,024,346 807,190 2,831,536TechEn, Inc. 147,634 147,634

Technion R&D Foundation 62,374 62,374

Temple University 5,067 108,393 113,460

The Emmes Corporation 101,364 101,364

The Hebrew Universityof Jerusalem 39,472 39,472

The Hospital for Sick Children Research Institute 40,288 40,288

The Methodist HospitalResearch Institute 2,500 2,500

The University of HongKong 151,674 151,674

Thomas Jefferson University 40,505 40,505

Translational GenomicsResearch Institute 2,524 2,524

True Research Foundation 88,652 88,652

Tufts Medical Center 180,409 77,083 257,491

Tufts University 313,802 559,182 872,984

Umkhuseli Fund Management 1,514 1,514

Universitat Pompeu Fabra 9,764 9,764

University Medical Center Hamburg-Eppendorf 100,694 100,694

University of Alabama 162,171 5,500 167,671

University of Arizona 19,765 377,317 397,082

University of Birmingham 31,824 31,824University of Bristol 10,856 10,856

University of California 1,777,012 1,257,739 13,050 3,047,801

University of Cape Town 33,486 33,486

University of Chicago 3,418 524,860 528,279

University of Cincinnati 39,819 39,819

University of Colorado 274,494 33,910 308,404

University of ColoradoHealth Sciences Center 23,393 24,415 47,808

University of Connecticut 81,380 81,380

University of Dundee 9,450 9,450

University of Florida 564,236 564,236

University of Frankfurt 25,000 25,000

University of Hamberg 93,762 93,762

University of Illinois 101,675 101,675

University of Iowa 105,392 56 105,448

University of KentuckyResearch Foundation 1,203 1,203

University of KwaZulu Natal 62,291 62,291

University of Maryland 232,721 294,753 527,474

University of Massachusetts 613,735 415,785 4,408 1,033,928

University of Melbourne 32,021 32,021University of Michigan 58,304 34,412 92,717

University of Missouri Health Care System 112,997 112,997

University of Nebraska 149,344 149,344

University of New Mexico 72,122 72,122

University of North Carolina 100,639 433,929 57,024 591,592

University of North Dakota 7,260 7,260

University of Oklahoma 1,584 1,584

University of Oregon 46,270 46,270

University of Oxford 230,902 230,902

University of Pennsylvania 386,871 429,209 159,958 976,038

University of Pittsburgh 895,129 1,074,139 1,969,269

University of Puerto Rico 646,640 10,531 657,171

University of RochesterMedical Center 685,430 393,431 68,477 1,147,338


79


University of South Carolina 132,544 124,086 256,630

University of South Florida 5,764 5,764University of Southern California 1,938,967 1,223,018 3,161,986

University of Texas Health Science Center 1,806,482 179,986 149,501 2,135,969

University of Texas Southwestern Medical Center 12,009 69,271 81,280

University of Utah 118,684 727,919 58,733 905,336

University of Virginia 22,400 299,063 321,463

University of Washington 619,352 285,594 904,947

University of Wisconsin 12,328 15,926 130,634 158,888

Vanderbilt University 535,531 259,410 794,940

Wake Forest University Health Sciences 229,355 229,355

Washington University 241,748 280,250 521,998

Weill Medical College of Cornell University 82,527 82,527

Wellesley College 67,124 67,124

Whitehead Institute 39,052 99,621 138,673

Wistar Institute 304,501 304,501

Yale University 224,964 373,743 598,707

46,821,794$ 52,044,729$ 2,317,457$ 367,010$ 101,550,990$

Part II

Reports on Compliance and Internal Controls

Report of Independent Auditors on Internal Control over Financial Reporting and on Compliance and

Other Matters Based on an Audit of Financial Statements Performed in

Accordance with



We have audited the financial statements of Partners HealthCare System, Inc. and Affiliates ("Partners

HealthCare") as of and for the year ended Sept

December 10, 2010. We conducted our audit in accordance with auditing standards generally accepted in

the United States of America and the standards applicable to financial audits contained in Gover

Auditing Standards, issued by the Comptroller General of the United States.

Internal Control Over Financial Reporting

In planning and performing our audit, we considered Partners HealthCare’s internal control over financial

reporting as a basis for designing our auditing procedures for the purpose of expressing our opinion on the

financial statements, but not for the purpose of expressing an opinion on the effectiveness of Partners

HealthCare's internal control over financial reporting. Accordingly,

effectiveness of Partners HealthCare's internal control over financial reporting.

A deficiency in internal control exists when the design or operation of a control does not allow management

or employees, in the normal course of performing their assigned functions, to prevent, or detect and correct

misstatements on a timely basis. A material weakness is a deficiency, or combination of deficiencies, in

internal control, such that there is a reasonable possibility that a ma

financial statements will not be prevented, or detected and corrected on a timely basis.

Our consideration of internal control over financial reporting was for the limited purpose described in the first

paragraph of this section and was not designed to identify all deficiencies in internal control over financial

reporting that might be deficiencies, significant deficiencies, or material weaknesses. We did not identify any

deficiencies in internal control over financial r

defined above.



Accordance with Government Auditing Standards



HealthCare") as of and for the year ended September 30, 2010, and have issued our report thereon dated

10, 2010. We conducted our audit in accordance with auditing standards generally accepted in

the United States of America and the standards applicable to financial audits contained in Gover

Auditing Standards, issued by the Comptroller General of the United States.

Internal Control Over Financial Reporting


esigning our auditing procedures for the purpose of expressing our opinion on the


HealthCare's internal control over financial reporting. Accordingly, we do not express an opinion on the

effectiveness of Partners HealthCare's internal control over financial reporting.


urse of performing their assigned functions, to prevent, or detect and correct


internal control, such that there is a reasonable possibility that a material misstatement of the entity's



section and was not designed to identify all deficiencies in internal control over financial


deficiencies in internal control over financial reporting that we consider to be material weaknesses, as




30, 2010, and have issued our report thereon dated

10, 2010. We conducted our audit in accordance with auditing standards generally accepted in

the United States of America and the standards applicable to financial audits contained in Government


esigning our auditing procedures for the purpose of expressing our opinion on the


we do not express an opinion on the


urse of performing their assigned functions, to prevent, or detect and correct


terial misstatement of the entity's



section and was not designed to identify all deficiencies in internal control over financial


eporting that we consider to be material weaknesses, as

PricewaterhouseCoopers LLP, 125 High Street, Boston, MA 02110T: (617) 530 5000, F: (617) 530

Compliance and Other Matters

As part of obtaining reasonable assurance about whether Partners HealthCare’s financial statements are free

of material misstatement, we performed tests of

contracts and grant agreements, noncompliance with which could have a direct and material effect on the

determination of financial statement amounts. However, providing an opinion on compliance

provisions was not an objective of our audit and, accordingly, we do not express such an opinion. The

results of our tests disclosed no instances of noncompliance or other matters that are required to be reported

under Government Auditing Stand

We noted certain matters that we reported to management of Partners HealthCare in a separate letter dated

December 1, 2010.

This report is intended solely for the information and use of Partners HealthCare’s Board of Directors,

management, federal awarding agencies and pass

be used by anyone other than these specified parties.

December 10, 2010

PricewaterhouseCoopers LLP, 125 High Street, Boston, MA 02110T: (617) 530 5000, F: (617) 530 5001, www.pwc.com/us

Compliance and Other Matters


of material misstatement, we performed tests of its compliance with certain provisions of laws, regulations,


determination of financial statement amounts. However, providing an opinion on compliance



under Government Auditing Standards.



warding agencies and pass-through entities, and is not intended to be and should not

be used by anyone other than these specified parties.


its compliance with certain provisions of laws, regulations,


determination of financial statement amounts. However, providing an opinion on compliance with those





through entities, and is not intended to be and should not

Report of Independent Auditors on Compliance with Requirements

That Could Have a Direct and Material Effect on Each Major Program and on Internal Control Over

Compliance in Accordance



Compliance

We have audited the compliance of Partners HealthCare System, Inc. and Affiliates ("Partners HealthCare")

with the types of compliance requireme

could have a direct and material effect on each of its major federal programs for the year ended September

2010. Partners HealthCare's major federal programs are identified in the summ

of the accompanying schedule of findings and questioned costs. Compliance with the requirements of laws,

regulations, contracts and grants applicable to each of its major federal programs is the responsibility of

Partners HealthCare’s management. Our responsibility is to express an opinion on Partners HealthCare’s

compliance based on our audit.

We conducted our audit of compliance in accordance with auditing standards generally accepted in the United

States of America; the standards applicable to financial audits contained in Government Auditing Standards,

issued by the Comptroller General of the United States; and OMB Circular A

Governments, and Non-Profit Organizations. Those standards and OM

and perform the audit to obtain reasonable assurance about whether noncompliance with the types of

compliance requirements referred to above that could have a direct and material effect on a major federal

program occurred. An audit includes examining, on a test basis, evidence about Partners HealthCare’s

compliance with those requirements and performing such other procedures as we considered necessary in the

circumstances. We believe that our audit provides a reasonab

provide a legal determination of Partners HealthCare’s compliance with those requirements.

In our opinion, Partners HealthCare complied, in all material respects, with the requirements referred to above

that could have a direct and material effect on each of its major federal programs for the year ended

September 30, 2010. However, the results of our auditing procedures disclosed an instance of noncompliance

with those requirements, which is required to be repo

described in the accompanying schedule of findings and questioned costs as item 10



Compliance in Accordance with OMB Circular A-133



with the types of compliance requirements described in the OMB Circular A-133 Compliance Supplement that

could have a direct and material effect on each of its major federal programs for the year ended September

2010. Partners HealthCare's major federal programs are identified in the summary of auditor's results section



HealthCare’s management. Our responsibility is to express an opinion on Partners HealthCare’s


standards applicable to financial audits contained in Government Auditing Standards,

issued by the Comptroller General of the United States; and OMB Circular A-133, Audits of States, Local

Profit Organizations. Those standards and OMB Circular A-133 require that we plan



red. An audit includes examining, on a test basis, evidence about Partners HealthCare’s


circumstances. We believe that our audit provides a reasonable basis for our opinion. Our audit does not



uld have a direct and material effect on each of its major federal programs for the year ended

30, 2010. However, the results of our auditing procedures disclosed an instance of noncompliance

with those requirements, which is required to be reported in accordance with OMB Circular A

described in the accompanying schedule of findings and questioned costs as item 10-




133 Compliance Supplement that

could have a direct and material effect on each of its major federal programs for the year ended September 30,

ary of auditor's results section



HealthCare’s management. Our responsibility is to express an opinion on Partners HealthCare’s


standards applicable to financial audits contained in Government Auditing Standards,

133, Audits of States, Local

133 require that we plan



red. An audit includes examining, on a test basis, evidence about Partners HealthCare’s


le basis for our opinion. Our audit does not



uld have a direct and material effect on each of its major federal programs for the year ended

30, 2010. However, the results of our auditing procedures disclosed an instance of noncompliance

rted in accordance with OMB Circular A-133 and which is

-1.

Internal Control Over Compliance

Management of Partners HealthCare is responsible for establishing and maintaini

over compliance with the requirements of laws, regulations, contracts, and grants applicable to federal

programs. In planning and performing our audit, we considered Partners HealthCare’s internal control over

compliance with the requirements that could have a direct and material effect on a major federal program in

order to determine the auditing procedures for the purpose of expressing our opinion on compliance and to

test and report on internal control over compliance in ac

purpose of expressing an opinion on the effectiveness of internal control over compliance. Accordingly we do

not express an opinion on the effectiveness of Partners HealthCare's internal control over compl

A deficiency in internal control over compliance exists when the design or operation of a control over

compliance does not allow management or employees, in the normal course of performing their assigned

functions, to prevent, or detect and correct

program on a timely basis. A material weakness in internal control over compliance is a deficiency, or

combination of deficiencies, in internal control over compliance, such that there is a

material noncompliance with a type of compliance requirement of a federal program will not be prevented, or

detected and corrected on a timely basis.

Our consideration of internal control over compliance was for the limited purp

paragraph of this section and was not designed to identify all deficiencies in internal control over compliance

that might be deficiencies, significant deficiencies, or material weaknesses. We did not identify any

deficiencies in internal control over compliance that we consider to be material weaknesses, as defined above.

Partner HealthCare's response to the finding identified in our audit is described in the accompanying schedule

of findings and questioned costs. We did not au

express no opinion on the response.

This report is intended solely for the information and use of Partners HealthCare's of Directors, management,

and federal awarding agencies, and pass

anyone other than these specified parties.

March 31, 2011

nternal Control Over Compliance

Management of Partners HealthCare is responsible for establishing and maintaining effective internal control



the requirements that could have a direct and material effect on a major federal program in


test and report on internal control over compliance in accordance with OMB Circular A


not express an opinion on the effectiveness of Partners HealthCare's internal control over compl



functions, to prevent, or detect and correct noncompliance with a type of compliance requirement of a federal


combination of deficiencies, in internal control over compliance, such that there is a reasonable possibility that


detected and corrected on a timely basis.

Our consideration of internal control over compliance was for the limited purpose described in the first



n internal control over compliance that we consider to be material weaknesses, as defined above.


of findings and questioned costs. We did not audit Partners HealthCare's response and, accordingly, we

express no opinion on the response.


and federal awarding agencies, and pass-through entities and is not intended to be and should not be used by

anyone other than these specified parties.

ng effective internal control



the requirements that could have a direct and material effect on a major federal program in


cordance with OMB Circular A-133, but not for the


not express an opinion on the effectiveness of Partners HealthCare's internal control over compliance.



noncompliance with a type of compliance requirement of a federal


reasonable possibility that


ose described in the first



n internal control over compliance that we consider to be material weaknesses, as defined above.


dit Partners HealthCare's response and, accordingly, we


es and is not intended to be and should not be used by

Part III

Federal Award Findings and Questioned Costs

Partners HealthCare System, Inc. and AffiliatesSchedule of Findings and Questioned CostsYear Ended September 30, 2010

86

I. Summary of Auditor's Results

Financial StatementsType of auditor's report issued Unqualified

Internal control over financial reportingMaterial weakness(es) identified? yes X noSignificant deficiency(ies) identified that are notconsidered to be material weaknesses? yes X none reported

Noncompliance material to financial statements noted? yes X no

Federal AwardsInternal control over major programsMaterial weakness(es) identified? yes X noSignificant deficiency(ies) identified that are notconsidered to be material weaknesses? yes X none reported

Type of auditor's report issued on compliance formajor programs Unqualified

Any audit findings disclosed that are requiredto be reported in accordance with section 510(a)of OMB Circular A-133? X yes no

Identification of Major Programs Name of Federal Program or Cluster

Various CFDA numbers Research and Development andResearch Training Cluster

Dollar threshold used to distinguish between Type Aand Type B programs $3,000,000

Auditee qualified as low-risk auditee? X yes no

II. Financial Statement Findings

No findings to report.


87

III. Federal Award Findings and Questioned Costs

10-1 Research and Development Cluster - Cost TransfersAward Name: National Resource for Imaging Mass SpectrometryBrigham and Women's Hospital Award #: P41EB001974Grantor: National Institute of Health (National Institute of Biomedical Imaging and Bioengineering)Budget Period: 9/1/2009 through 8/31/2010CFDA: 93.286

Award Name: Translational Studies of Prefrontal Control of FearMassachusetts General Hospital Award #: R01MH81975-01A1Grantor: National Institute of Health passed through the University of Puerto RicoBudget Period: 1/1/2010 through 12/31/2010CFDA: 93.242

CriteriaPartners HealthCare is subject to compliance requirements within OASC-3 Hospital Cost PrinciplesSection III B, Circular A-110 Section 21 and the National Institute of Health policy manual.

ConditionOf the 15 cost transfers and 99 direct cost selections tested, we noted two instances wheremanagement's internal review procedures identified required cost transfers on a timely basis,however these transfers were not processed on a timely basis.

The first instance (CFDA 93.286) concerns one employee who charged 100% of their effort to thisaward while the employee's actual level of effort was 80% due to a change in actual workperformed. The change in effort was identified on a timely basis through routine grant monitoringactivities.

The second instance (CFDA 93.242) concerns a vendor who was debarred while performingservices for Partners HealthCare. The vendor was identified by the Comquarterly review of debarred vendors.

For both of these instances, management identified in June and April, 2010, respectively, the needfor a cost transfer through its normal review procedures. However, through our audit procedureswe determined that the actual processing of the cost transfers did not take place. We informedmanagement and the transfers were then processed in December and November, 2010,respectively.

CauseThese processing delays appear to be the result of a lack of timely follow up to ensure costtransfers are processed on a timely basis.

EffectThe two awards were erroneously charged $3,280 and $9,300, respectively. Lack of follow upresulted in an untimely correction to the awards.

RecommendationWe recommend that management review the process for monitoring the processing of costtransfers, and enhance the follow-up process as needed to ensure cost transfers are completed ona timely basis.


88

Management's Views and Corrective Action PlanFollowing this finding is management's view and corrective action plan.

.

Partners HealthCare System, Inc. and AffiliatesSummary Schedule of the Status of Prior Audit FindingsYear Ended September 30, 2010

89

Summary Schedule of Prior Audit FindingsBrigham and Women's Hospital, Inc. is subject to compliance with the cost principles for travel setforth in OASC-3 Hospital Cost Principles Section IX and OMB Circular A–110 Section 21.

Of the seven travel expense direct costs selected for testing, PwC noted one selection includedalcohol charges of $297 charged to CFDA # 93.839.

Current StatusAdditional training has been provided to Departmental Administrators in the area of allowable andunallowable costs. The “Employee Business Expense Report” form was revised in January 2010to itemize alcoholic beverages from meals. The check box for the employee attestation that noalcoholic beverages have been charged to federal funds was also added at that time. During the2010 audit, there were no exceptions noted in PwC's testing of travel expenses during the directcost testing.

Date post:	11-Oct-2020
Category:	Documents
Upload:	others
View:	0 times
Download:	0 times

Report on Federal Awards in Accordance with OMB Circular A ... · 1. Organization and Community...

Documents